書籍詳細

はじめに

P.7 掲載の参考文献

• 1) 川極勝三郎 :原発実質性肝癌「ヘパトーム論」(Zur Kenntnis des primaren parenchymatosen Le bercarcinoms"Hepatom"s) 癌 5, 225-282, 1911.

• 2) 貴家学而 :東大病理学教室に於ける原発性肝癌110例の統計的研究, 附, 原発性肝癌に於ける副枝血行に就て. 癌 23,341-397,1925.

• 3) Eggel, H.:Uber des primare Carcinom der Leber. Beitrage zur pathol. Anat. Jena.30, 506-604, 1901.

• 4) Rossle, R.:Enzundungen der Leber, S. 243-505, in Handbuch der speziellen pathologischen Anatomie und Histologie. Funfter Band, Verdauungsdrusen. Erster Teil, Leber, Verlag von J.Springer. Berlin 1930.

• 5) Snell, A. M.:Clinical aspects of portal cirrhosis. Ann. Intern. Med.5, 338-375, 1931.

• 6) Fiessinger N., G. Albot et F. Thiebaut:Les poussees d'hepatites parenchymateuse au cours de levolution des cirrhoses alcoolique des foie. Presse medicale. 40, 901-905,1932.

• 7) Barchasch, P. A.:Zur Klinik der Fruhformen der Lebererkrankungen. Hepatitiden und Prazirrhosen. Archiv fur Verdauungskrankheiten. 5, 282-295, 1934.

• 8) Bloomfield, A. L.:The natural history of chronic hepatitis(cirrhosis of the liver) Amer. J. Med. Sci.195, 429-444, 1938.

• 9) Sheldon, W.H. and James, D. F.:Cirrhosis following infectious hepatitis. A report of five cases, in two of which there were superimposed primary liver cell carcinoma, Arch. Intern. Med. 81, 666-689, 1948.
  pubmed

• 10) Walsche, J. W. and Wolffe, H. H.:Primary carcinoma of the liver following viral hepatitis. Report of two cases. Lancet. 2, 1007-1010, 1952.

• 11) Pellissier, A.:Sclero-hepatites dislocantes et cancer primitif du foie en Afrique Equatoriale Frangaise. Schweiz Zeitschrift fur allg Pathol 16, 420-429, 1953.

• 12) Ellermann, V. und Bang O.:Experimentelle Leukamie bei Huhnern. Zentralblatt fur Bakteriol. 46, 595-609, 1908.

• 13) Lucke, B. and Ratcliffe, H. L.:Virus hepatitis of birds and its possible relation to epidemic hepatitis in man. Trans. Assoc. Amer. Physicians. 62, 83-88, 1949.

• 14) Ratcliffe, H. L.:Records of the Penrose Research Laboratory:Zoological Society of Philadelphia, 1948-1949.

• 15) Ratcliffe, H. L.:Incidence and nature of tumors in captive wild mammals and birds. Amer. J. Cancer. 17, 116-135, 1933.

• 16) Lombard, L. S. and Witte, E. J.:Frequency and types of tumors in mammals and birds of the Philadelphia Zoological Garden. Cancer Research. 19, 127-141, 1959.

• 17) Ratcliffe, H. L.:Hepatitis, cirrhosis and hepatoma in birds. Cancer Research. 21, 26-35, 1961.
  pubmed

• 18) 弘好文, 織田敏次:肝炎の治療, 金沢における講演 (昭和58年8月28日)より引用, 1941.

• 19) Maccallum, F.O. and Bradley, W.H.:Transmission of infective hepatitis to human volunteers. Lancet. 1, 622-627, 1944.

• 20) Blumberg, B. S., Alter H. J. and S, Virnich.:A "new"antigen in leukemia sera. JAMA. 191, 541-546, 1965.

• 21) Okochi, J. and Murakami, S.:Observations on Australia antigen in Japanese. Vox Sang. 15, 374-385, 1968.

• 22) Prince, A. M.:An antigen detected in the blood during the incubation period of serum hepatitis.Proc.Natl. Acad.Sci.USA.60,814-821,1968.
  pubmed

• 23) Dane, D. S., Cameron, C. H. and M, Briggs.:Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1, 695-698, 1970.

• 24) Nishioka, K.:Hepatocellular carcinoma and hepatitis B virus. In Hepatitises Virus ed. by T. Oda. p.p. 247-255, Tokyo University Press, 1978.

• 25) Snyder, R. L.:Hepatomas of captive woodchucks. Amer. J. Pathol. 52, 32a-33a, 1968.

• 26) Snyder, R. L. and Ratcliffe, H. L. Marmota monax:A model for studies of cardiovascular, cerebrovascular and neoplastic disease. Acta zoologica et pathologica anterpiensia. 48, 265-273, 1969.

• 27) Summers, J., Jo Marie Smolec and Snyder, R.:A virus similar to human hepatitis B virus, associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acael. Sci. USA.75, 4533-4537, 1978.

• 28) Stanley, W.M.:Relationships between cancer and virus. Arch. Intern. Med. 102, 939-947, 1958.
  pubmed

• 29) Marion, P.,Salazan, F. H. and J. J. Alex ander.:State of hepatitis B viral DNA in a humar hepatoma cell line. J. Virol. 33, 795-806, 1980.

• 30) Galibert, F., Chen, T. N. and Mandart, E.:Nucleotide sequence of a cloned woodchuck hepatitis virus genome:Comparison with the hepatitis B virus sequence. J. Virol.41, 51-65, 1982.
  pubmed

• 31) Marion, P. L. Knight, S. S., Salazar, F. H., Popper, H. and Rabinson, W.S.:Ground squirrel hepatitis virus infection. Hepatology. 3, 519-527, 1983.

• 32) Huebner, R. H. and Todaro, G. J.:Oncogenes of RNA tumor viruses as determinants of cancer. Proc. Natl. Acad. Sci. USA.64, 1087-1094, 1969.

• 33) Hino, O., Kitagawa,T., Koike, K., Kobayashi, M., Hara, M., Mori, W., Nakashima, T., Hattori, N.and Sugano, H.:Detction of hepatitis B virus DNA in hepatocellular carcinomas in Japan. Hepatolology In press.

• 34) 西岡久寿弥:金沢大学医学部における講義より引用 (昭和54年).

• 35) 市田文弘, 曾我憲二:散発性非A非B型急性肝炎の臨床. 日本臨牀 39, 3226-3234, 1981.

• 36) 厚生統計協会 厚生の指標 がん特集昭和55年.

• 37) Farber, E. and Cameron, R.:The sequential analysis of cancer development. Advances in Cancer Reseach, Vol. 31, 125-226, Academic Press, New York, London, Toronto, Sydney,San Francisco,1980.

肝炎ウイルス研究の進歩

P.21 掲載の参考文献

• 1) Summers, J., Smolec, J.M. and Snyder, R.:A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks, Proc. Natl. Acad. Sci. USA, 75, 4533-4537, 1978.

• 2) Marion, P. L., Oshiro, L. S., Regnery, D. C. et al.:A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc. Natl. Acad. Sci. USA.77, 2941-2945.1980.
  pubmed

• 3) Mason, W. S., Seal G. and Summers, J.:Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J. Virol. 36, 829-836, 1980.
  pubmed

• 4) Robinson, W. S.:Genetic variation among hepatitis B and related viruses. Ann. New York Acad. Sci. 354, 371-378, 1980.

• 5) Robinson, W. S., Marion, P. L, Feitelson, M. et al.:The hepadna virus group:hepatitis and related viruses. In:Szmuness, W., Alter, H. J. and Maynard, J. E. eds."Viral Hepatitis" Franklin Institute Press, 57-68, 1982.

• 6) Galibert, F, Mandart, E., Fitoussi, F. et al.:Nucleotide sequence of the hepatitis B virus genome(subtype ayw) cloned in E. coli. Nature(Lond). 281, 646-650, 1979.

• 7) Valenzuela, P., Gray, P., Quiroga, M. et al.:Nucloetide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature(Lond). 280. 815-819, 1979.

• 8) Pasek, M., Goto, T., Gilbert, W. et al.:Hepatitis B virus genes and their expression in Ecoli. Nature(Lond) . 282, 575-579, 1979.

• 9) Brechot, C., Hadchouel, M., Scotto, J. et al.:State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and negative liver diseases. Proc. Natl. Acad. Scie. USA. 78, 3906-3910, 1981.

• 10) Szmuness, W.:Hepatocellular carcinoma and the hepatitis B virus:evidence for a causal association. Prog. Med. Viral. 24, 40-69, 1978.

• 11) Tooze, J.:"Molecular biology of tumor viruses. 2nd Edition, Part 2, DNA tumor viruses. Cold Spring Harbor Laboratories, Cold Spring Harbor, New York. 1980.

• 12) Melnick, J. L.:Taxonomy and Nomenculture of viruses, 1982. Prog. Med. Virol. 28, 208 221, 1982.

• 13) Perterson, D. L., Roberts, J. M. and Vyas, G. N.:Pardal amino acid sequence of two major component polypeptides of hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA. 74, 1530-1534, 1977.

• 14) Shiraishi, H., Shirachi, R. and Akiyama, K.:Glycopeptide composition of hepatitis B surface antigen. J. gen. Virol. 48, 31-38, 1980.
  pubmed

• 15) Courouce, A. M., Holland, P. V., Muller, J. Y. et al.:HBs antigen subtypes. Proceedings of the International Workshop on HBs antigen subtypes. Bibliotheca Haematologica. 42, 1158, 1976.

• 16) Shih, J. W.K. and Gerin J. L.:Immunochemistry of hepatitis B surface antigen (HBsAg) :Preparation and characterization of antibodies to the constituent polypeptides. J. Immunol. 115, 634-639, 1975.

• 17) Gavilanes, F., Gonzales-Ros, J. M. and Peterson, D. L.:Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral protein. J. Biol. Chem. 257, 7770-7777, 1982.

• 18) Murphy, B. L., Maynard, J. E. and Le Bouvier, G. L.:Viral subtype and cross-protection in hepatitis B virus infection of chimpanzees. Intervirology. 3, 378-381, 1974.
  pubmed

• 19) Lerner, R. A., Green, N., Alexander, H. et al.:Chemically synthesized peptide predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc. Natl. Acad. Sci. USA. 78, 3403-3407, 1981.
  pubmed

• 20) Gerin, J. L., Alexander, H., Shih, J. W.K. et al.:Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in Chimpanzees. Proc. Natl. Acad. Sci. USA. 80, 2365-2369, 1983.

• 21) Bhatnagar, P. K., Papas, E., Blum, H. E. et al.:Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc. Natl. Acad. Sci. USA. 79, 4400-4404, 1982.
  pubmed

• 22) Peterson, D. L., Nath, N. and Gavilanes, F.:Structure of hepatitis B surface antigen. J, Biol. Chem. 257 :10414-10420, 1982.
  pubmed

• 23) Prince, A. M., Ikram, H. and Hopp, T. P.:Hepatitis B virus vaccine:Identification of HBs Ag/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immumogenic Peptide. Proc. Natl. Acad. Sci. USA. 79, 579-582, 1982.

• 24) Dreesmall, G.R., Sanchez, Y., Ionescu-Matiu, I. et al.:Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature. 295, 158-160, 1982.

• 25) Mackay, D., Pasek, M., Magazin, M. et al.:Production of immunologically active surface antigens of hepatitis B virus by Escherichia coli. Proc. Natl. Acad. Sci. 78, 4510-4514, 1981.

• 26) Tiollais, P., Pourcel, C, Brechot, C. et al.:Structure and Expression of the hepatitis B virus Genome.ln:Szmuness, W., Alter, H. J. and Maynard, J. E. eds. "Viral Hepatitis"Franklin Institute Press. 81-96, 1982.

• 27) Hitzeman, R. A., Chen, C. T., Hagie, F. et al.:Expression of hepatitis B virus surface antigen in yeast. Nucleic Acid. Res. 11, 2745-2763, 1983.

• 28) Miyanohara, A., Toh-e, A., Nozaki, C. et al.:Expression of hepatitis B virus surface antigen gene in yeast. Proc. Natl. Acad. Sci. USA. 80, 1-5, 1983.
  pubmed

• 29) Smith, G. L, Mackett, M. and Moss, B.:Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature. 302, 490-495, 1983.
  pubmed

• 30) Almeida, J. D., Rubenstein, D. and Stott, E. J.:New antibody system in Australia antigen positive hepatitis. Lancet. II, 1225-1227, 1971.

• 31) Ohori, H., Yamaki, M., Onodera, S. et al.:Antigenic conversion from HBcAg to HBeAgby degradation of hepatitis B core particles. lntervirology. 13, 74-82, 1980.
  pubmed

• 32) Robinson, W. S., Clayton, D. A. and Greenman, R. L.:DNA of a human hepatitis B virus candidate. J. Virol. 14, 384-391, 1974.

• 33) Kaplan. P. M., Greenman. R. L, Gerin, J. L. et al.:DNA polymerase associated with human hepatitis B antigen. J Virol. 12, 995-1005, 1973.
  pubmed

• 34) Albin, C. and Robinson, W. S.:Protein kinase activity in hepatitis B virus. J. Virol. 34, 297-302, 1980.
  pubmed

• 35) Onodera, S., Ohori, H., Yamaki, M. et al.:Electron microscopy of human hepatitis B virus cores by negative staining-carbon film technique. J. Med. Virol. 10, 147-155, 1982.
  pubmed

• 36) Yamaki, M,, Ohori, H., Onodera, S. et al.:Circular dichroism and biochemical properties ofthe hepatitis B virus core antigen. Biochim. Biophys. Acta. 706, 165-175, 1982.

• 37) Magnius, L.O. and Espmark, J. A.:New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J. Immunol. 109, 1017-1021, 1972.

• 38) Nordenfelt, E. and Kjellen, L.:Dane particle, DNA polymerase, and e-antigen in two different categories of hepatitis B antigen carriers. lntervirology. 5, 225-232, 1975.

• 39) Maynard, J. E., Barrett, D. H., Murphy, B. L. et al.:Relationship of e-antigen to hepatitis B virus infection in an sera of hyperendemicity. J. Infect. Dis. 133, 339-342, 1976.

• 40) Werner, B. G., O'Connel, A. P. and Summers, J.:Association of e antigen with Dane particle DNA in sera from asymptomatic carriers of hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA. 24, 2149-2151, 1977.

• 41) Lam, K., Tong, M. J. and Rakela, J.:Release of e antigen from Dane particle-rich preparation of hepatitis B virus. Infection Immunity. 16, 403-404, 1977.

• 42) Ohori, H., Onodera, S. and Ishida, N.:Demonstration of hepatitis B e antigen (HBeAg) in association with intact Dane particles. J. gen. Viror. 43, 423-427, 1979.

• 43) Takahashi, K., Akahane, Y,, Gotanda, T. et al.:Demonstration of hepatitis B e antigen in the core of Dane particles. J. Immunol. 122, 275-279, 1979.
  pubmed

• 44) Mackay, P., Less, J. and Murray, K.:The conversion of hepatitis B core antigen synthesized in E. coli. into e antigen. J. Med. Virol. 8, 237-243, 1981.

• 45) Yamada, E., Ohori, H. and Ishida, N.:Physicochemical heterogeneity of hepatitis B e antigen detected in asymptomatic carriers and carriers in hemodialysis unit. J. Med. Virol. 4, 33-42, 1979.
  pubmed

• 46) Yamada, E., Ohori, H. and Ishida, N.:Molecular heterogeneity of hepatitis B e antigen in liver and serum. J. gen. Virol. 55, 75-76, 1981.

• 47) Yamada, E., Ishida, N. and Ohori, H.:Comparison of the antigenicity and protein composition of hepatitis B virus e antigen subtypes HBeAg/1 HBeAg/2. J. gen. Virol. 64, 895-903, 1983.
  pubmed

• 48) Takahashi, K., Imai, M., Gotanda, T. et al.:Hepatitis B e antigen polypeptides isolated from sera of individuals infected with hepatitis B Virus:Comparison with HBeAg polypeptide derived from Dane particIes. J. gen. Virol. 50, 49-57, 1980.

• 49) Williams, A. and Le Bouvier, G. L.:Heterogeneity and thermolability of "e". Bibliotheca haematologica. 42, 71-75, 1976.

• 50) Ohori, H., Yamada, E., Tateda, A. et al.:Prevalence of Williams el antigen in comparison. with e2 antigen in hepatitis B antigen in comparison with carriers and patients in hemodialysis unit. J. Med. Virol. 6, 61-74, 1980.

• 51) Tabor, E., Gerety, R.J. and Barker, L. F.:Detection of e antigen during acute and chronic hepatitis virus infection in chimpanzees. J. Infect. Dis., 136, 541-547, 1977.
  pubmed

• 52) Ohori, H., Shimizu, N., Yamada, E. et al.:Immunological and Morphological Properties of HBeAg subtype (HBeAg/1 and HBeAg/2) in hepatitis B virus core particles. J. gen. Virol. (in Press) .

• 53) Hruska, J. F., Clayton, D. A., Rubenstein, J, L. R. et al.:Structure of hepatitis B Dane particle DNA before and after the Dane particle DNA polymerase reaction. J. Virol 21, 666-672, 1977.

• 54) Robinson, W. S.:The genome of hepatitis B virus. Ann. Rev. Microbiol. 31, 357-377, 1977.

• 55) Gerlich, W. H. and Robinson, W. S.:Hepatitis B virus contains protein to the 5' terminus of its complete DNA strand. Cell. 21, 801-809, 1980.

• 56) Delius, H., Gough, N. M,, Cameron, C. et al.:Structure of the hepatitis B virus genome. J.virol. 47, 337-343, 1983.
  pubmed

• 57) Summers, J. and Mason, W. S.:Replication of the genome of a hepatitis B-like virus byreverse transcription of an RNA intermediate. Cell. 29, 403-415, 1982.

• 58) Gudat, F., Bianchi, O. and Sonnabend, W.:Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B. Lab. Invest. 32, 1, 1975.

• 59) Ray, M. B., Desmet, V.I. and Braburne, A. F.:Distribution pattern of hepatitis B surface antigen (HBsAg in liver of hepatitis pateints) . Gastroenterol. 71, 462, 1976.

• 60) Almeida, J. D., Watterson, A. P., Trowel, J. M. et al.:The finding of vicus-like particles in two Australia-antigen-positive human livers. Microbiol. 2, 145-153, 1970.

• 61) London, T. and Blumberg, B.:A cellular model of the role of hepatitis B virus in the pathogenesis of primary hepatocellular carcinoma. Hepatology. 2, 105-145, 1982.

• 62) Miller, R. and Robinson, W. S.:Hepatitis B virion from plasma and particles from liver ofinfected patients synthesize DNA of DNA-RNA hybrid molecule. Proc. Natl. Acad. Sci. USA. (in Press) .

• 63) Miller, R. H. and Robinson, W. S.:Hepatitis B viral DNA forms in infected liver. J. Virol., (in Press) .

• 64) Varmus, H. and Swanstrom, R.:Replication of retroviruses. In:Weiss R., Teich, N., Varmus, H., Coffin, J. eds. RNA Tumor Viruses. New York:Cold spring Harber Press.:369-512, 1982.

• 65) Molnar-Kimber, K. L., Summers, J., Taylor, J. M. et al.:Protein covaletly bound to minus-strand DNA intermediates of duck hepatitis B virus. J. Virol. 45, 165-172, 1983.

• 66) Hirschman, S. Z., Price, P., Garfinkel, E. et al.:Expression of cloned hepatitis B virus DNA in human cell cultures. Proc. Natl. Acad. Sci. 77, 5507-5511, 1980
  pubmed

• 67) Chakraborty, P. R., Ruiz-Opazo, N. and Shafritz, D. A.:Transcription of human hepatitis B virus core antigen gene sequences in an in vitro HeLa cellular extract. Virology. 111, 647-652, 1981.

• 68) Pourcel, C., Louise, A., Gervais, M. et al.:Transcription of the hepatitis B surface antigen gene in mouse cell transformed with cloned viral DNA. J. Virol. 42, 100-105, 1982.
  pubmed

• 69) Gough, N. M. and Murry, K.:Expression of the hepatitis B virus surface, core and e antigen genes by stable rat and mouse cell lines. J. Mol. Biol. 162, 43-67, 1982.

• 70) Dubois, M.F, Pourcel, C., Rousset, S. et al.:Expression of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc. Natl. Acad. Sci. USA. 77, 4549-4553, 1980.
  pubmed

• 71) Gough, N. M.:Core and e antigen synthesis in rodent cells transformed with hepatitis B virus DNA in association with greater than genome length viral messenger RNAs. J. Mol. Biol. 165, 683-699, 1983.

• 72) Summers, J. and Mason, W.S.:Properties of the hepatitis B-like viruses related to their taxonomic classification. Hepatology. 2,61S-66S, 1982.

• 73) Pfeiffer, P. and Hohn, T.:Involvement of reverse transcription in the replication of cauliflower mosaic virus:a detailed model and test of some aspects. Cell. 33, 781-789, 1983.
  pubmed

P.37 掲載の参考文献

• 1) Blumberg, B. S.:Polymorphisms of serum proteins and the development of isoprecipitins in transfused hepatitis. Bull. N. Y. Acad. Med. 40, 377-386, 1964.

• 2) Feinstone, S. M., Kapikian, A. Z. and Purcell, R. H.:Hepatitis A;Detection by immune electron microscopy of a virus-like antigen associated with acute illness. Science. 182, 1026-1028, 1973.

• 3) Prince, A. M., Brotman, B., Grady, G. F. et al.:Long-incubation posttransfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet. 1, 241, 1974.

• 4) Oda, T. and Suzuki, H.:Non-A, non-B hepatitis in Japan In Grety, R. J. ed. Non-A, non-B Hepatitis, p.153, Academic Press, New York. 1981.

• 5) Villarijos, V. M., Visona, K. A. and Eduarte, C. A.:Evidence for viral hepatitis other than type A or type B among persons in Costa Rica. N. Engl J. Med. 293, 1350-1352, 1975.
  pubmed

• 6) 松下 寛, 杉江善夫, 肥田規矩男 :非A非B型肝炎の疫学-清水市における流行例の中間報告を中心として-. 胆肝膵 3, 159-167, 1981.

• 7) Shimizu, Y. K., Feinstone, S. M., Purcell, R. H., et al.:Non-A, non-B hepatitis:Ultrastructural evidence for two agents in experimentally infected chimpanzees. Science 205, 197-200, 1979.
  pubmed

• 8) Khuroo, M. S.:Study of an epidemic of non-A, non-B hepatitis, possibility of another human hepatitis virus distinct from post-transfusion non-A. non-B type. Am. J. Med. 68, 818-824, 1980.

• 9) Tabor, E., Gerety, R. J., Drucker, J. A. et al.:Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet. 1, 463-466, 1978.

• 10) Hollinger, F. B., Gitnick, G. L, Ach, R. D. et al.:Non-A, non-B hepatitis transmission in chimpanzees:A project of the transfusion-transmitted viruses study group. Intervirology. 10, 60-68, 1978.

• 11) Shikata, T.,Karasawa, T., Abe, K, et al.:Non-A, non-B hepatitis in experimentally injected chimpanzees with the NIH strains F and H. Acta Pathol Jpn. 32, 315-327, 1982.

• 12) 志方俊夫, 阿部賢治, 柄沢 勉・他 :清水市に流行した非A非B型肝炎のチンパンジー感染実験. 肝臓 22, 1204, 1981.

• 13) Shirachi, R., Taketa, A., Kikuchi, K. et al.:Hepatitis C antigen in non-A, non-B posttransfusion hepatitis. Lancet. 11, 853-856, 1978.

• 14) 藤松順一, 守本富昭, 塚越 茂・他 :非A非B型肝炎剖検例のホモジネート中に見い出した2種類の抗原抗体系, 肝臓 21, 1594, 1980.

• 15) Yoshizawa, H., Itoh, Y., Iwakiri, S. et al.:Demonstration of two different types of non-A, non-B hepatitis by reinjection and cross-challenge studies in chimpanzees. Gastroenterology. 81, 107-113, 1981.
  pubmed

• 16) Wong, D. C., Purcell, R. H., Sreenivasan, M. A. et al.:Epidemic and endemic hepatitis in India:Evidence for a non-A, non-B hepatitis virus aetiology. Lancet. 25, 876-879, 1980.

• 17) Tandon, B. N, Joshi, Y. K., Jain, S. K. et al.:An epidemic of non-A, non-B hepatitis in north India. Indian J. Med. Res. 75, 739-744, 1982.

• 18) Dienstag, J. L., Stevens, C. E. and Szmuness, W.:The epidemiology of non-A, non-B hepatitis:emerging patterns. In Gerety R. J. ed. Non-A, non-B Hepatitis 119-138, Academic press, New york 1981.

• 19) Balayan, M. S., Andjaparidze, A. G.,Savinskaya, S. S. et al.:Epidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 20, 23-31, 1983.
  pubmed

• 20) Sreenivasan, M. A., Aarnkalle, V. A., Sehgal, S. et al.:Non-A, non-B epidemic hepatitis:Visualization of virus-like particles in the stool by immune electron microscopy. Hepatitis Scientific Memoranda No. 11, 1983.

P.44 掲載の参考文献

• 1) Summers, J., Smolec, J.M. and Snyder, R.:A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. USA. 75, 4533-4537, 1978.

• 2) Marion, P. L., Oshiro, L. S., Regnery, D. C. et al.:A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc. Natl. Acad. Sci. USA. 77, 2941-2945, 1980.
  pubmed

• 3) Mason, W.S., Seal. G. and Summers, J.:Virus of Pekin ducks with structural and biologicalrelatedness to human hepatitis virus. J. Virol. 36, 829-836, 1980.

• 4) Robinson, W. S.:Genetic variation among hepatitis B and related viruses. Ann. N. Y. Acad. Sci. 354, 371-378, 1980.
  pubmed

• 5) Peterson, D. L.:Isolation and characterization of the major protein and glycoprotein of hepatitis B surface antigen. J. Biol. Chem. 256, 6975-6983, 1981.
  pubmed

• 6) Budkowska, A., Shin, J. W. K. and Gerin, J. L:Immunochemistry and polypeptide composition of hepatitis B core antigen (HBcAg). J. Immunol. 118, 1300-1305, 1977.

• 7) Takahashi, K., Akahane, Y., Gotanda, T. et al.:Demonstration of hepatitis Be antigen inthe core of Dane particles. J. Immunol 122, 275-279, 1979.

• 8) Summers, J., O'Connel, A. and Millman, I.:Genome of hepatitis B virus:Restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc Natl. Acad. Sci. USA. 72, 4597-4601, 1975.

• 9) Hruska, J. F., Clayton, D. A. and Rubinstein, J. L. R.:Structute of hepatitis B Dane particle DNA before and after Dane particle DNA polymerase reaction. J. Virol. 21, 666-672, 1977.

• 10) Landers, T. A., Greenberg, H. B. and Robinson, W. S.:Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. J. Virol. 23, 368-376, 1977.
  pubmed

• 11) Delius, H.,Gouch, N. M., Cameron, C. H. et al.:Structure of the hepatitis B virus genome. J. Virol. 47, 337-343, 1983.

• 12) Sattler, F. and Robinson, W. S.:Hepatitis B viral DNA molecules have cohesive ends. J. Virol. 32, 226-233, 1979.
  pubmed

• 13) Molner-Kimber, K. L., Summers, J., Taylor, J. H. et al.:Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virus. J. Virol. 45, 165-172, 1983.

• 14) Gerlich, W. H, and Robinson, W. S.:Hepatitis B virus contains protein attached to the 5'terminus of its complete DNA strand. Cell. 21, 801-809, 1980.

• 15) Peterson, D. L, Roberts, I. M. and Vyas, G. N.:Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA. 74, 1530-1534, 1977.
  pubmed

• 16) Werner, B. G., Smolec, J. M., Snyder, R. et al.:Serological relationship of woodchuck hepatitis virus to human hepatitis B virus. J. Virol. 32, 314-322, 1979.
  pubmed

• 17) Cote, P. J. Jr. Dapolito, G. M., Shih, J. W. K. et al.:Surface antigenic determinants of mammalian "Hepadnaviruses"defined by group and class-specific monoclonal antibodies. J. Virol. 42, 135-142, 1982.

• 18) Cote, P. J. Jr. and Gerin, J. L.:Nonoverlapping antigenic sites of woodchuck hepatitis virus surface antigen and their cross-reactivity with ground squirrel hepatitis virus and hepatitis B virus surface antigens. J. Virol. 47, 15-23, 1983.
  pubmed

• 19) Feitelson, M. A., Marion, P. L. and Robinson, W. S.:Antigenic and structural relationships of the surface antigens of hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis virus. J. Virol. 39, 447-454, 1981.
  pubmed

• 20) Galibert, F., Mandart, E., Fitoussi, F. et al.:Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature. 281, 646-650, 1979.

• 21) Galibert, F., Chen, T. N. and Mandart, E.:Nucleotide sequence of a cloned woodchuck hepatitis virus genome:Comparison with the hepatitis B virus sequence. J, Virol. 41, 51-65, 1982.
  pubmed

• 22) Summers, J.,Smolec, J. M., Werner, B. G. et al.:Hepatitis B virus and woodchuck hepatitis virus are members of a novel class of DNA viruses.in Viruses in naturally occurring cancers. (ed. Essex, M., Todaro, G. and zur Hausen, H.)pp. 459-470, Cold spring Harbor Laboratory, N. Y., 1980.

• 23) Ganem, D., Weiser, B., Barchuk, A. et al.:Biological characterization of acute infection with ground squirrel hepatitis virus. J. Virol. 44, 366-373, 1982.
  pubmed

• 24) Mitamura, K., Hoyer, B. H., Ponzetto, A. et al.:Woodchuck hepatitis virus DNA in woodchuck liver tissues. Hepatology. 2, 47S-50S, 1982.

• 25) Shafritz, D. A., Shouval, D., Sherman, H.I. et al.:Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in per cutaneous liver biopsies and post-mortem tissue specimens. N. Engl J. Med. 305, 1067-1073, 1981.

• 26) Summers, J. and Mason, W. S.:Replication of the genome of a hepatitis B-like virus by reverse transcriptation of an RNA intermediate. Cell 29, 403-415, 1982.

• 27) Miller, R. H. and Robinson, W. S.:Integrated hepatitis B virus DNA sequences specifying the major viral core polypeptide are methylated in PLC/PRF/5 cells. Proc. Natl. Acad. Sci. USA. 80, 2534-2538, 1983.
  pubmed

• 28) Dejean, A., Brechot, C, Tiollais, B. et al.:Characterization of integrated hepatitis B virus DNA cloned from a human hepatoma and the hepatoma-derived cell line PLC/PRF/5. Proc. Natl. Acad. Sci. USA. 80, 2505-2509, 1983.
  pubmed

• 29) Summers, J.:Three recently descrived animal virus models for human hepatitis B virus. Hepatology. 1, 179-183, 1981.

P.53 掲載の参考文献

• 1) Blumberg, B. S.:Viruses similar to hepatitis B virus (Icrons). Human Pathology. 12, 1107-1113, 1981.
  pubmed

• 2) Summers, J., Smolec, J. M. and Snyder, R.:A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. USA. 75, 4533-4537, 1978.

• 3) Werner, B. G., Smolec, J. M., Snyder, R. et al.:Serological relationship of woodchuck hepatitis virus to human hepatitis B virus. J. Virol. 32, 314-322, 1979.
  pubmed

• 4) Summers, J., Smolec, J. M., Werner, B. G. et al.:Hepatitis B virus and woodchuck hepatitis virus are members of a novel class of DNA viruses. In:Essex M, Todaro G, zur Hansen H, eds.:Viruses in naturally occurring cancers. Cold Spring Harbor, N Y.:Cold Spring Harbor Laboratory, 459-470, 1980.

• 5) Peterson, D. L., Roberts, I. M. and Vyas, G. N.:Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA. 74, 1530-1534, 1977.
  pubmed

• 6) Feitelson, M. A., Marion, P. L. and Robinson, W. S.:Antigenic and structural relationships of the surface antigens of hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis virus. J. Virol. 39, 447-454, 1981.
  pubmed

• 7) Cote, P. J. Jr., Dapolito, G. M., Shih, J. W. K. et al.:Surface antigenic determinants of mammalian "hepadnaviruses"defined by group and class-specific monoclonal antibodies. J. Virol. 42, 135-142, 1982.

• 8) Summers, J., Smolec, J. M., Werner, B. G. et al.:Properties and distribution of woodchuck hepatitis virus. in Virus and the Liver, ed by Bianchi, L, Gerok, W., Sickinger, K, Stalder G.A. 223-233, 1980, MTP Press, Lancaster.

• 9) Galibert, F., Chen, T. N. and Mandart, E.:Localization and nucleotide sequence of the gene coding for the woodchuck hepatitis virus surface antigen:Comparison with the gene coding for the human hepatitis B virus surface antigen, Proc. Natl. Acad. Sci. USA. 78, 5315-5319, 1981.
  pubmed

• 10) Tyler, G. V., Summers, J. W. and Snyder, R. L.:Woodchuck hepatitis virus in natural woodchuck populations. J. Wildlife Dis. (ln press.)

• 11) Wong, D. C., Shin, J. W. K., Purcell, R. H. et al.:Natural and experimental infection of woodchucks with woodchuck hepatitis virus, as measured by new, specific assays for woodchuck surface antigen and antibody. J. Clin. Microbiol. 15, 484-490, 1982.

• 12) Snyder, R. L.:Longevity and disease patterns in captive and wild woodchucks. In Proceedings, AAZPA Regional Workshop, Indianapolis, Indiana, 1977-1978.

• 13) Popper, H., Shih, J. W. K., Gerin, J. L. et al:Woodchuck hepatitis and hepatocellular carcinoma:correlation of histologic with virologic observations. Hepatology. 1, 91-98, 1981.

P.58 掲載の参考文献

• 1) Summers, J., Smolec. J., Snyder, R. et al.:A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchuck. Proc Natl Acad Sci USA 75, 4533-4537, 1978.

• 2) Marion, P. L., Oshiro, L. S., Regnery, D. C. et al.:A virus in Beechey ground squirrel that is related to hepatitis B virus of humans. Proc Natl Acad Sci USA 77, 2941-2945, 1980.
  pubmed

• 3) Mason, W.S., Seal, G. and Summers, J.:Virus of pekin ducks with structual and biological relatedness to human hepatitis B virus. J. Virol 36, 829-836, 1980.

• 4) 小俣政男, 今関文夫, 横須賀収・他:Slab gel電気泳動及びオートラジオグラフィーによるHepadna virus DNAの検索, 肝臓 24, 468, 1983.

• 5) Mandart, E., Kay, A. and Galibert, F.:Nucleotide sequence of a cloned duck hepatitis virus genome:comparison with the human and woodchuck hepatitis B virus sequence (in press) .

• 6) Snyder, R. L.:Hepatomas of captive woodchucks. Am J Path. 52, 32a (abstr). 1968.

• 7) 小俣政男, 内海勝夫, 横須賀収・他:肝炎ウイルス-アヒル, 肝胆膵 5, 701-706, 1982.

• 8) 横須賀収, 小俣政男, 内海勝夫・他:ダックB型肝炎ウイルスのDNAポリメラーゼ活性及びDHBV-DNAに関する研究, 肝臓 25, 12-23, 1984 (印刷中).

• 9) 小俣政男, 内海勝夫, 伊藤よしみ・他:ダックにおける肝病変とウイルス様粒子 (Duck Hepatitis B virus)の検索. 肝臓 23, 482-488, 1982.

• 10) Omata, M., Uchiumi, K., Ito, Y. et al.:Duck hepatitis B virus and liver diseases. Gastroenterology, 85, 260-267, 1983.
  pubmed

• 11) Popper, H., Shin, J. W. K., Gerin, J. L. et al.:Woodchuck hepatitis and hepatocellular carcinoma:correlation of histologic with virologic observations. Hepatology. 1, 91-98, 1981.

• 12) Omata, M., Aschcavai, M., Liew, C. T. et al.:Hepatocellular carcinoma in the U.S.A., etiologic consideration. Localization of hepatitis B antigens. Gastroenterology. 76, 279-287, 1979.

• 13) Omata, M., Mori, J., Yokosuka, O. et al.:Hepatitis B antigens in the liver tissue in hepatocellular carcinoma and advanced chronic liver disease. Liver. 2, 125-132, 1982.
  pubmed

• 14) Omata, M., K., Yokosuka, O., Imazeki, F. et al.:Transmission of duck hepatitis B virus (DHBV) from Chinese carrier ducks to Japanese ducklings:a study of viral DNA in serumand tissue. Hepatology. (in press).

• 15) Barker, L.F., Maynard, J. E., Purcell, R. H. et al.:Hepatitis B virus infection in chimpanzees:titration of subtypes. J Infect Dis. 132, 451-458, 1975.
  pubmed

• 16) Summers, J., Smolec, J. M., Werner, B. G. et al.:Hepatitis B virus and woodchuck hepatitis virus are members of a novel class of DNA viruses. In Cold Spring Harbor Conferenceson Cell Proliferation. Volume 7. New York, Cold Spring Harbor Press. 459-470, 1980.

• 17) Ganem, D., Weiser, B., Barchuck, A. et al.:Biological characterization of acute infection with ground squirrel hepatitis virus. J Virol 44, 366-373, 1982.

• 18) Summers, J. and Masaon, W. S.:Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell. 29, 403-415, 1980.

• 19) 横須賀収, 小俣政男, 今関文夫・他:Southern blot hybridizationによる肝内Duck Hepatitis B virusの検索.肝臓 24, 676, 1983.

ウイルス性肝炎の病理 I

P.82 掲載の参考文献

• 1) Dienstag JL, Popper H, Purcell RH:The pathology of viral hepatitis types A and B in chimpanzees. A comparison. Am J Path 85, 131, 1976.

• 2) Schaffner F:The structual basis of altered hepatic function in viral hepatitis. Amer J Med 49, 658, 1970.

• 3) Peters RL:Viral hepatitis:A pathologic spectrum. Am J Med Sci 270, 17, 1975.
  pubmed

• 4) Ishak KG:Light microscopic morphology of viral hepatitis. Amer. J. Clin. Path. 65, 787, 1976.

• 5) Kerr JFR, Wyllie AH, Currie AR:Apoptosis:A basic biological phenomenon with wide-ranging implications in tissue kinetics. Brit J Cancer 26, 239, 1972.

• 6) Bianchi L, Zimmerli-Ning M, Gudat F:Viral hepatitis in "Pathology of The Liver"Ed Macsween, Anthony & Scheuer. Churchill Livingstone, p. 175, 1979.

• 7) Rappaport AM:The microcirculatory acinar concept of normal and pathological structure. Beitr Pathol 157, 215, 1976.
  pubmed

• 8) Scheuer PJ:Acute viral hepatitis. In "Liver Biopsy Interpertation" Ed. Scheuer p. 63, 1980.

• 9) Bianchi L, Degroot J. Desmet VJ, et al.:Acute and chronic hepatitis revisted. Lancet 2, 914, 1977.

• 10) Boyer JL, Klatskin G:Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis) New Engl J Med 283, 1063, 1970.
  pubmed

• 11) Conn HO:Chronic hepatitis:Reducing an iatrogenic enigma to a workable puzzle. Gastroenterol 70, 1182, 1976.

• 12) Bianchi L, DeGroote J, Desmet VJ, et al.:Morphologic criteria in viral hepatitis. Lancet 1, 333, 1971.

• 13) Fauerholdt L, Asnaes S, Rane K, et al:Significance of suspected chronic aggressive hepatitisin acute hepatitis. Gastroenterol 73, 543, 1977.

• 14) Dietrichson O, Juhl E, Christoffersen P, et al.:Acute viral hepatitis:Factors possibly predicting chronic liver disease. Acta Path Micro Scandinav A 83, 183, 1975.

• 15) Gudat F, Bianchi L:HBsAg:A target antigen on the liver cell? In Membrane Alterations as Basis of Liver Injury. Ed. Popper et al.:Lancaster, MTP p. 171, 1977.

• 16) Aenishaenvlin HW, Stalder GA, Bianchi I, et al.:Hepatitis bei Drogensuechtigen Verlaufskontrollen anhand bioptish-histologischer Kriterien. Deut Med Wochensch 100, 857, 1975.

• 17) 高橋善弥太, 清水 勝, 吉田 洋, 他:過去5年間における全国集計の成績からみた劇症肝炎の実態. 肝胆膵 3, 637, 1981.

• 18) Sherlock S:Acute (fulminant) hepatic failure. "In Diseases of the Liver and Billiary System"Blackwell Scientific Publications 6th Ed. p. 107, 1981.

• 19) 西野広:急性および亜急性肝萎縮の肉眼分類. 十全医会誌 84, 463, 1975.
  Medical*Online

• 20) Karvountizis GG, Redeker AG, Peters RL:Long term follow-up studies of patients surviving fulminant viral hepatitis. Gastroenterol 67, 870, 1974.

• 21) Desmet VJ, De Groote J, Van Damme B:Hepatocellular failure:A study of 17 patientstreated with exchange transfusion. Hum Path 3, 167, 1972.

• 22) De Groote J. Desmet VJ, Gedigk P, et al.:A classification of chroic hepatitis. Lancet 2, 626, 1968.

• 23) Bhathal PS, Powell LW, Mackay IR :Apoptosis in autoimmune chronic active hepatitis (abstract). Presentation of IASL Meeting in Hong Kong February 1982.

• 24) Popper H, Schaffner F:Chronic hepatitis toxonomic, etiologic, and therapeutic problems. in"Progress in Liver Diseases"Ed. Popper & Schaffner vol. V, p. 531, Grune & Straton New York 1976.

• 25) Shirachi R, Shiraishi H, Tatada A, et al:Hepatitis "C"antigen in non-A, non-B posttransfusion hepatitis. Lancet 2, 853, 1979.

• 26) Suh DJ, White Y, Eddleston ALWF, et al.:Specificity of an immuno-precipitin test for non-A, non-B hepatitis. Lancet 1, 178, 1981.

• 27) Hopkins R, Robertson AE, Haase G, et al.:Non-A, non-B hepatitis. Lancet 1, 946, 1981.

• 28) Wong DC, Purcell RH, Sreenivasan MA, et al.:Epidemic and endemic hepatitis in India:Evidence for a non-A, non-B hepatitis virus etiology. Lancet 2, 867, 1980.

• 29) 山内真義, 鬼沢信明, 藤沢 洌, 他:清水市興津・小島地域に流行した非A非B型肝炎の臨床像. 肝臓 22, 1678, 1981.

• 30) 古田精一, 長田敦夫, 清沢研道, 他:非A非B型肝炎-その臨床像およびウィルス学的側面-. 内科 46, 242, 1980.

• 31) Berman M, Alter HJ, Ishak KG, et al.:The chronic sequelae of non-A, non-B hepatitis. Ann Int Med 91, 1, 1979.

• 32) Vitvitski L, Trepo C, Prince AM. et al.:Detection of virus associated antigen in serum and liver of patients with non-A, non-B hepatitis. Lancet 2, 1263, 1979.

• 33) Bamber M, Murray A, Arborch BAM, et al.:Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrated in patients with congenital coagulation disorders. Gut 22, 854, 1981.

• 34) Alter HJ, Purcell RM, Holland PV, et al.:Transmission agent in non-A, non-B hepatitis. Lancet 1, 459, 1978.

• 35) Hruby A, Schan FV:Transfusion related short incubation hepatitis in haemophyliac patients. JA. MA 240, 1355, 1978.

• 36) Poulsen H, Christofferson P:Abnormal bile duct epithelium in liver biopsies with histological signs of viral hepatitis. Acta Pathol Microbiol Scand (B) 76, 383, 1969.

• 37) Desmet VJ:Personal communication

• 38) Rakela J, Redeker AG:Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterol 77, 1200, 1979.

• 39) Knodell RG, Conrad ME, Ishak KG:Development of chronic liver diseases after acute non-A, non-B post-transfusion hepatitis. Gastroenterol 72, 902, 1977.

• 40) Ohta Y, Onji M, Kanaoka M:Morphology of viral hepatitis, comparison between type B and type non-A, non-B(abstruct). Asian Pacific Association for the study of the Liver in Hong Kong 1982. p. 51, 1982.

• 41) Shimizu YK, Feinstone SM, Purcell RM, et al.:Non-A, non-B hepatitis:Ultrastructural evidence for two agents in experimentally infected chimpanzees. Science 205, 197, 1979.

• 42) Popper H, Dienstag JL, Feinstone SM, et al.:The pathology of viral hepatitis in chimpanzees. Virchow Arch A Path Anat Histol 387, 91, 1980.

• 43) Dienstag JL, Popper H, Purcell, RH:The pathology of viral hepatitis types A and B in chimpanzees. A comparison. Amer J Pathol 85, 131, 1976.

• 44) 安倍弘彦, 池尻直幹, 谷川久一:A型肝炎の肝組織像. 肝胆膵 2, 477, 1981.

• 45) Rakela J, Redeker AG, Edwards VM, et al.:Hepatitis A virus infection in fulminant hepatitis and chronic active hepatitis. Gastroenterol. 74, 879, 1978.

• 46) 田中智之, 田中市子, 古賀満明, 他:VIII型急性肝炎の病理組織学的検討. 肝臓 22, 494, 1981.

• 47) Mathiesen LR, Skinoj P, Nielsen JO, et al.:Hepatitis type A, B and non-A, non-B infulminant hepatitis. Gut 21, 72, 1980.

ウイルス性肝炎の病理 II-非A非B肝炎の最近の知見-

P.97 掲載の参考文献

• 1) Kryger, P.:Non-A, non-B hepatitis. Serological, clinical, morphological and prognostic aspects. Liver. 3, 176, 1983.

• 2) Dienstag, J. L.:Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterol. 85, 439, 1983.

• 3) Alter, H. J. et al.:Transmissible agent in non-A, non-B hepatitis. Lancet 1, 459, 1978.

• 4) Prince, A. M. et al.:Non-A, non-B hepatitis;Identification of a virus specific antigen and antibody. A preliminary report. Viral Hepatitis. Ed by Vyas et al. Philadelphia. Franklin Institute Press. p. 633, 1978.

• 5) Popper, H. et al.:The pathology of viral hepatitis in chimpanzees. Virch. Arch. Path. Histol. 387, 91, 1980.

• 6) Shimizu, Y. et al.:Non-A, non-B hepatitis:Ultrastructural evidence for two agents in experimentally infected chimpanzees. Science 205, 197, 1979.

• 7) Hruby, M. A. et al.:Transfusion-related short-incubation hepatitis in hemophiliac patients. JAMA. 240, 1355, 1978.

• 8) Yoshizawa, H. et al.:Demonstration of two different types of Non-A, non-B hepatitis by reinjection and cross-challenge studies in chimpanzees. Gastroenterol. 81, 107, 1981.

• 9) Kim, H. C. et al.:Prevalence of type B and non-A, non-B hepatitis in hemophilia:relationship to chronic liver disease. Gastroenterol. 79, 1159, 1980.

• 10) Yoshizawa, H. et al.:Virus-like particles in a plasma fraction (fibrinogen) and in the circulation of apparantly healthy blood donors capable of inducing non-A, non-B hepatitis in humans and chimpanzees. Gastroenterol. 79, 512, 1980.

• 11) Simon, N. et al.:A non-A, non-B hepatitis epidemic in a HB antigen-free hemodialysis unit:demonstration of serological markers of non-A, non-B virus. Proc. Eur Dial Transplant Assoc. 17, 173, 1980.

• 12) Dienstag, J. L. et al.:The epidemiology of non-A, non-B hepatitis:emerging pattern. In:Gerety RJ. ed. Non-A, non-B Hepatitis. New York:Academic Press, pp. 119, 1981.

• 13) Mosley, J. W. et al.:Multiple hepatitis viruses in multiple attacks of acute viral hepatitis. N. Engl. J. Med. 296, 75, 1977.
  pubmed

• 14) Iwarson, S. et al.:Multiple attacks of hepatitis in drug addicts:biochemical, immunochemical, and morphologic characteristics. J. Inf. Dis. 127, 544, 1973.

• 15) Norkrans, G. et al.:Multiple hepatitis attacks in drug addicts. JAMA. 243, 1056, 1980.
  pubmed

• 16) Iwarson, S. et al.:Hepatitis B and non-A, non-B in a Swedish blood center during 10 years of HBsAg screening. Vox Sang. 39, 79, 1980.

• 17) 市田文弘・他:散発性非A非B急性肝炎の臨床. 日本臨牀 39, 3226, 1981.

• 18) Dienstag, J. L. et al.:Etiology of sporadic hepatitis B surface antigen negative hepatitis. Ann. Intern. Med. 87, 1, 1977.
  pubmed

• 19) Norkrans, G. et al.:Clinical, epidemiological and prognostic aspects of hepatitis non-A, non-B;a comparison with hepatitis A and B. Scand. J. Infect. Dis. 11, 259, 1979.

• 20) Szmuness, W. et al.:Hepatitis B vaccine:demonstration of efficacy in a controlled clinical trial in a high-risk population in the United State:N. Engl. J. Med. 303, 833, 1980.

• 22) Wong, D. C. et al.:Epidemic and endemic hepatitis in India:Evidence for a non-A, non-B hepatitis virus etiology. Lancet 2, 876, 1980.

• 23) Khuroo, M. S. et al.:Failure to detect chronic liver disease after epidemic non-A, non-Bhepatitis. Lancet 2, 97, 1980.

• 24) 藤沢 洌・他:非A非B肝炎の流行例:臨床像と疫学. 日本臨牀 39, 3235, 1981.

• 25) Alter, H. J.:The dominant role of non-A, non-B in the pathogenesis of post-transfusion hepatitis:a clinical assessment. Clin Gastroenterol. 9, 155, 1980.

• 26) Mosley, J. W. et al.:Immunoglobulin M level in the diagnosis of type A hepatitis. Am. J. Clin. Path. 75, 86, 1981.
  pubmed

• 27) Rakela, J. et al.:Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterol. 77, 1200, 1979.

• 28) Schmid, M. et al.:Acute hepatitis non-A, non-B:are there any specific light microscopicfeatures? Liver. 2, 61, 1982.
  pubmed

• 29) Kryger, P. et al.:Light microscopic morphology of acute hepatitis non-A,non-B. A comparison with hepatitis type A and B. Liver 2, 200, 1982.

• 30) Poulsen, H. et al.:Abnormal bile duct epithelium in liver biopsies with histological signs of viral hepatitis. Acta. Pathol. Microbiol. Scand. 76, 383, 1969.
  pubmed

• 31) Kryger, P. et al.:Acute type B hepatitis among HBsAg negative patients detected by anti-HBc IgM. Hepatology 2, 50, 1982.

• 32) Dienes, H. P. et al.:Histologic observations in human hepatitis non-A, non-B. Hepatology 2, 562, 1982.

• 33) Kryger, P. et al.:Liver histopathology of the hepatitis A virus infection:a comparison with hepatitis type B and non-A, non-B. J. clin. Path. 36, 650, 1983.

• 34) Omata, M. et al.:Clinico-pathological study of acute non-A, non-B post-transfusion hepatitis:histological features of liver biopsies in acute phase. Liver 1, 201, 1981.

• 35) Thorne, C. H. M. et al.:A histologic comparison of hepatitis B with non-A, non-B chronicactive hepatitis. Arch. Pathol. Lab. Med. 106, 433, 1982.

• 36) Iwarson, S. et al.:Progression of hepatitis non-A, non-B to chronic active hepatitis. J. Clin Path. 32, 351, 1979.

• 37) Peters, R. L.:第19回日本肝臓学会総会(昭和58年) にて発表.

• 38) Kobayashi, K. et al.:The correlation of non-A, non-B hepatitis virus with hepatocellular carcinoma (abstr.). Hepatology 2, 117, 1982.

• 39) Ayoola, E. A. et al.:Primary liver cancer after Non-A,non-B hepatitis(abstr). Hepatology 2, 154, 1982.

• 40) Brechot, C. et al.:Evidence that hepatitis B virus has a role in liver cell carcinoma in alcoholic liver disease. N. Engl. J. Med. 306, 1384, 1982.

• 41) 清沢研道・他:母から長女へ家族内感染をみた散発性非A非B型急性肝炎の2例. 肝臓 23, 165, 1982.

• 42) 古田精市:内科学の展望-肝疾患について-B3. 非A非B型肝炎. 日内誌 71, 592, 1982.

• 43) Gmelin, K. et al.:Intranuclear virus-like particles in a case of sporadic non-A, non-B hepatitis. J. Med. Virol. 5, 317, 1980,

• 44) Grimand, J. A. et al.:Hepatic intranuclear particles in patients with non-A, non-B hepatitis. N. Engl. J. Med. 303, 818, 1980.

• 45) DeVos, R. et al.:Are nuclear particles specific for non-A, non-B hepatitis? Hepatology 3, 532, 1983.

P.99 掲載の参考文献

• 21) Khuroo, M. S.:Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from posttransfusion non-A, non-B type. Amer. J. Med. 68, 818, 1980.

B型肝炎ウイルスDNAのintegration

P.110 掲載の参考文献

• 1) Tiollais, P., Charnay, P. and Vyas, G. N.:Science 213, 406-411, 1981.
  pubmed

• 2) Szmuness, W.:Proc. Med. Viol. 24, 40-69, 1978.

• 3) Kew, M. D.:Viral Hepatitis (eds. G. N. Vyas et al.) Franklin Institute Press, Philadelphia, p. 439, 1978.

• 4) Blumberg, B. S. and London, W. T.:N. Engl. J. Med. 304, 782-784, 1981.
  pubmed

• 5) Koike, K. et al.:Proc. Japan Acad. 58, serB, 140-144, 1982.

• 6) Koike, K. et al.:Nucleic Acids Res. 16, 5391-5402, 1983.
  pubmed

• 7) Shouval, D. et al.:Proc. Natl. Acad. Sci. U.S.A. 10, 6147-6151, 1980.
  pubmed

• 8) London, W. T.:Human Pathol. 12, 1085-1097, 1981.
  pubmed

• 9) Brechot, C. et al.:Proc. Natl. Acad. Sci. U.S.A. 78, 3906-3910, 1981.
  pubmed

• 10) Shafritz, D. A. et al.:N. Engl. J. Med. 305, 1067-1073, 1981.
  pubmed

• 11) Marion, P. L. et al.:J. Virol. 33, 795-806, 1980,
  pubmed

• 12) Chakraborty, P. R. et al.:Nature. 286, 531-533, 1981.

• 13) Koike, K. et al.:Proceedings of the Japanese Cancer Association, The 41th annual Meeting, August, 1982 at Osaka, p. 333 (in Japanese).

• 14) Mizusawa, H., Koike, K. et al.:投稿中.

• 15) Dejean, A. et al:Proc. Natl. Acad. Sci. U.S.A. 80, 2505-2509, 1983.
  pubmed

• 16) Koshy, R. et al.:Cell., 34, 215-223, 1983.
  pubmed

• 17) Southern, E. M.:J. Mol. Biol. 98, 503-517, 1975.
  pubmed

• 18) Rigby, P. W. J. et al.:J. Mol. Biol. 13, 237-251, 1977.

• 19) Denhardt, D. J.:Biochem. Biophys. Res. Commun. 23, 641-646, 1966.

• 20) Yaginuma, K., Koike, K. et al.:投稿中.

P.117 掲載の参考文献

• 1) Brechot, C., Hadchouel, M., Scotto, J., Fonk,., Potet, F., Vyas, G. N. and Tiollais, P.:State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and negative liver diseases. Proc. Nat. Acad. Sci. U.S.A, 78, 3906-3910, 1981.

• 2) Koshy, R., Maupas, P., Maupas, P., Muller, R. and Hofschneider, P. H.:Detection of hepatitis B virus-specific DNA in the genomes of human hepatocellular carcinoma and liver cirrhosis tissues. J. Gen. Virol. 57:95-102, 1981.
  pubmed

• 3) Chakraborty, P. R., Ruiz-Opazo, N., Shouval, D. and Shafritz, D. A.:Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line. Nature. 286:531-533, 1980.

• 4) Brechot, C., Poucel, C., Louise, A., Rain, B. and Tiollais, P.:Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature. 286:533-535, 1980.

• 5) Edman, J. C., Gray, P., Valenzuella, P., Rall, L. B. and Rutter, W. J.:Integration of HBV sequences and their expression in a human hepatoma cell line. Nature. 286:535-537, 1980.

• 6) Fujiyama, A., Miyanohara, A., Nozaki, C., Yoneyama, T., Ohtomo, N. and Matsubara, K.:Cloning and structural analysis of hepatitis B virus DNAs, subtype adr. Nucleic Acids Res. 11:4601-4610, 1983.

• 7) Miyanohara, A., Toh-e, A., Nozaki, C, Hamada, F., Ohtolno, N. and Matsubara, K:Expression of hepatitis B surface antigen in yeast. Proc. Nat. Acad. Sci. U.S.A. 80:1-5, 1983.

• 8) Blattner, F., Williams, B., Blechel, A., Denniston-Thompson, K., Faber, H., Furlong, L., Grunwald, D., Kiefer, D., Moore, D., Schumm, J., Sheldon, F. and Slnithies, F, and Smithies, O.:Charon phages:Safer derivatives of bacteriophage lambda for DNA cloning. Science. 196:161-169, 1977.

• 9) Valenzuela, P., Quiroga, M., Zaldivar, J., Gray, P. and Rutter, W. J.:The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes. Animal Virus Genetics (Fields, B., Jalnisch, R. and Fox, C. F. eds.). Academic Press, Inc, New York. pp. 57-70, 1981.

• 10) Galibert, F., Mandart, E., Fitoussi, F., Tiollais, P. and Charney, P.:Nucleotide sequence of the hepatitis B virus (subtype ayw) cloned in E. coli. Nature. 281:646-650, 1979.

• 11) Pasek, M., Goto, T., Gilbert, W., Zink, B, Schaller, H., MacKay, P., Leadbetter, G. and Murray, K.:Hepatitis B virus genes and their expression in E. coli. Nature. 282:575-579, 1979.

• 12) Southern, E. M.:Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517, 1975.
  pubmed

• 13) Kafatos, F. C., Jones, C. W. and Efstratiadis, A.:Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure. Nucleic Acids Res. 7:1541-1552, 1979.
  pubmed

• 14) Rigby, P. W. J., Dieckman, M., Rhodes, C. and Berg, P.:Labeling deoxyribonucleic acids to high specific activity in vitro by nick translation with DNA polymerase I. J. Mol. Biol. 113, 237-251, 1977.

• 15) 蛋白質 核酸 酵素:26:No. 4,「遺伝子操作」1981.

P.128 掲載の参考文献

• 1) Szmuness, W.:Hepatocellular carcinoma and the hepatitis B virus:Evidence for a causal association. Prog. Med. Virol. 24, 40-69, 1978.
  pubmed

• 2) Beasley, R. P.:Hepatitis B virus as the etiologic agent in hepatocellular carcinoma-epidemiologic considerations. Hepatology. 2, 21S-26S, 1982.

• 3) Shafritz, D., Shouval, D., Sherman, H.I. et al.:Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N. Engl. J. Med. 305, 1067-1073, 1981.
  pubmed

• 4) Brechot, C., Pourcel, C., Hadchouel, M. et al.:State of hepatitis B virus DNA in liver disease. Hepatology. 2, 27S-34S, 1982.

• 5) Koshy, R.,Maupas, R., Muller, R. et al.:Detection of hepatitis B virus-specific DNA in the genomes of human hepatocellular carcinoma and liver cirrhosis tissues. J. gen. virol. 57, 95-102, 1981.

• 6) Chen, D. S., Hoyer, B. H., Nelson, J. et al.:Detection and properties of hepatitis B viral DNA in liver tissues from patients with hepatocellular carcinoma. Hepatology. 2, 42S-46S. 1982.

• 7) Alexander, J. J., Bey, E. M., Geddes, E. M. et al.:Establishment of a continuously growing cell line from primary carcinoma of the liver. S. Afr. Med. J. 50, 2124-2128, 1976.

• 8) Sninsky, J. J., Siddiqui, A., Robinson, W. et al.:Cloning and endonuclease mapping of the hepatitis B viral genome. Nature (Lond). 279, 346-348, 1979.
  pubmed

• 9) Galibert, F., Mandart, E., Fitoussi, F. et al.:Nucleotide sequence of the hepatitis B virus genome(subtype ayw) cloned in E. Coli. Nature (Lond.). 281, 646-650, 1979.

• 10) Ono, Y., Onda, H., Sawada, R. et al.:The complete neucleotide sequences of the cloned hepatitis B virus DNA;Subtype adr and adw. Nucleic Acids Res. 11, 1747-1757, 1983.

• 11) Chakraborty, P. R., Ruiz-Opazo, N., Shouval, D. et al.:Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line. Nature. 286, 531-533, 1980.

• 12) Shouval, D., Reid, L. M., Chakraborty, P. R. et al.:Tumorigenicity in Nude Mice of a human hepatoma cell line containing hepatitis B virus DNA. Cancer Res. 41, 1342-1350, 1981.
  pubmed

• 13) Shafritz, D. A.:Hepatitis B virus DNA molecules in the liver of HBsAg carriers;Mechanistic considerations in the pathogenesis of hepatocellular carcinoma. Hepatology. 2, 35S-40S, 1982.

• 14) Brechot, C., Pourcel, C., Louise, A. et al.:Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature (Lond). 286, 533-535, 1980.
  pubmed

• 15) Dejean, A., Brechot, C., Tiollais, R. et al.:Characterization of integrated hepatitis B viral DNA cloned from a human hepatoma and the hepatoma-derived cell line PLC/PRF/5. Proc. Natl. Acad. Sci. USA. 80, 2505-2509, 1983.

• 16) Edman,J. C., Gray, P., Valenzuela, P. et al.:Integration of hepatitis B virus sequences and their expression in a human hepatoma cell. Nature (Lond). 286, 535-538, 1980.

• 17) Marion, P. L., Salazar, F. H., Alexander, J. J. et al.:State of Hepatitis B viral DNA in a human hepatoma cell line. J. Virol 33, 795-806, 1980.

• 18) Koshy, R., Koch, S., Loringhoven, F. V. et al.:Integration of hepatitis B virus DNA:Evidence for integration in the single-stranded gap. Cell. 34, 215-223, 1983.

• 19) Miller, R. and Robinson, W.S.:Integrated hepatitis B virus DNA sequences specifying the major core polypeptide are methylated in PLC/PRF/5 cells. Proc. Natl. Acad. Sci. USA. 80, 2534-2538, 1983.
  pubmed

• 20) Monjardino, J. P., Fowler, M. J. F. and Thomas, H. C.:Defective hepatitis B virus DNA molecules detected in a stable integration pattern in a hepatoma cell line, and in induced tumours and derived cell line. J. gen. Virol. 64, 2299-2302, 1983.

• 21) Koike, K., Kobayashi, M., Mizusawa, H. et al.:Rearrangement of the surface antigen gene of hepatitis B virus integrated in the human hepatoma. Nucleic Acids Res. 11, 5391-5402, 1982.
  pubmed

• 22) Tiollais, P., Charnay, P, and Vyas, G. N.:Biology of hepatitis B virus. Science. 213, 406-411, 1981.
  pubmed

• 23) Ogston, C. W.,Jonak, G. J., Rogler, C.F. et al.:Cloning and structual analysis of integrated woodchuck hepatitis virus sequence from hepatocellular carcinoma of woodchucks. Cell. 29, 385-394, 1982.

• 24) Summers, J. and Mason, W. S.:Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell. 29, 403-415, 1982.
  pubmed

• 25) Hayward, W. S., Neel, B. G. and Artrin, S. M.:Activation of a cellular oncogene by promoter insertion in ALV induced lymphoid leukosis. Nature (Lond). 290, 475-480, 1980.

• 26) Benedict, W.F., Murphree, A.C., Bonerjee, A. et al.:Patient with 13 chromosome deletion:evidence that the retinoblastoma gene is a recessive cancer gene. Science. 219, 973-975, 1982.

• 27) 樋野興夫, 北川知行, 小池克郎・他:日本の肝癌症例におけるB型肝炎ウイルスDNAの組み込み. 肝臓 24, 358, 1983.

• 28) Hino, O., Kitagawa, T., Koike, K. et al.:Detection of hepatitis B virus DNA in hepatocellular carcinoma in Japan. Hepatology. 4, 90-96, 1984.
  pubmed

• 29) 樋野興夫, 北川知行, 菅野晴夫・他:日本人の肝癌症例におけるB型肝炎ウィルス感染とウィルスDNAの組み込み. 肝臓 25(4), 1984 (印刷中).

• 30) Brechot, C., Nalpas, B., Courouce, A. M. et al.:Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcholic liver disease. N. Engl. J. Med. 306, 1384-1387, 1982,

• 31) Sherlock, S. and Thomas, H. C.:Hepatitis B virus infection:the impact of molecular biology. Hepatology. 3, 455-456, 1983.

• 32) Kam, W., Rall, L B., Smuckler, E. A. et al.:Hepatitis B viral DNA in liver and serum of asymptomatic carriers. Proc. Natl. Acad. Sci. USA. 79, 7522-7526, 1982.
  pubmed

• 33) Scotto, J., Hadchovel, M., Hery, C. et al.:Hepatitis B virus DNA in children's liver disease:detection by blot hybridization in liver and serum. Gut. 24, 618-624, 1983.

• 34) 樋野興夫, 北川知行, 菅野晴夫・他:急性肝炎におけるB型肝炎ウィルスDNAの宿主細胞DNAの組み込み. 肝臓 25, 268, 1984 (印刷中).

• 35) Cairns, J.:The origin of human cancers. Nature (Lond). 289, 353-357, 1981.
  pubmed

P.134 掲載の参考文献

• 1) Snyder, R. L. and Summers, J.:Woodchuck hepatitis virus and hepatocellular carcinoma. In Viruses in naturally occuring cancers. Essex, M., Todaro, G. and zur Hansen, H. (eds.), pp 447-457, Cold spring Harbor Laboratory, New York, 1980.

• 2) Popper, H., Shih, J. W. K., Gerin, J. L. et al.:Woodchuck hepatitis and hepatocellular carcinoma:correlation of histologic with virologic observation. Hepatology. 1, 91-98, 1981.

• 3) Snyder, R. L., Tyler, S. G. and Summers, J.:Chronic hepatitis and hepatocellular car-cinoma associated with woodchuck hepatitis virus. Am. J. Pathology, 107, 422-425, 1982.

• 4) Summers, J., Smolec, J. M. and Snyder, R.:A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. 75, 4533-4537, 1978.

• 5) Summers, J., Smolec, J. M., Werner, B. G. et al.:Hepatitis B virus and woodchuck hepatitis virus are members of a novel class of DNA viruses. In Viruses in naturally occuring cancers. Essex, M., Todaro, G. and zur Hansen, H.(eds.) pp 459-470, Cold Spring Harbor Laboratory, New York, 1980.

• 6) Mitamura, K., Hoyer, B. H. Ponzetto, A. et al.:Woodchuck hepatitis virus DNA in woodchuck liver tissues, Hepatology. 2, 47S-50S, 1982.

• 7) Hoyer, B. H. and Neurath, A. R.:The state of HBV DNA and woodchuck hepatitis virus (WHV) DNA in infected liver cells. In Viral hepatitis, 1981 International symposium, Szmuness, W., Alter, H. J., Maynard, J. E.(eds), PP 801-802, The Franklin Institute Press, 1982・

• 8) Ogston, C. W., Jonak, G. J., Rogler, C. E. et al.:Integrated woodchuck hepatitis virus DNA in hepatocellular carcinomas from woodchucks. In Viral hepatitis, 1981 International symposium, Szmuness, W., Alter, H. J., Maynard, J. E.(eds) . PP 809-810, The Franklin Institute Press, 1982.

• 9) Ogston, C. W., Jonak, G. J., Rogler, C. E. et al.:Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from hepatocellular carcinomas of woodchucks. Cell. 29, 385-394, 1982.
  pubmed

• 10) Botchan, M., Stringer, J., Mitchison, T. et al.:Integration and excision of SV40 DNA from the chromosome of a transformed cell. Cell. 20, 143-152, 1980.
  pubmed

• 11) Clayton, C. E. and Rigby, P. W. J.:Cloning and characterization of the integrated viral DNA from three lines of SV 40-transformed mouse cells. Cell 25, 547-559, 1981.

• 12) Sambrook, J., Green, R., Stringer, J. et al.:Analysis of the sites of integration of viral DNA sequences in rat cells transformed by adenovirus or SV40, Cold Spring Harbor Symp Quant. Biol 44, 569-584, 1980.
  pubmed

ウイルス肝炎の追跡調査

P.142 掲載の参考文献

• 1) 古田精市・他:肝炎ウィルスのasymptomatic carrier-定義ならびにその予後, 悪化因子を中心に. 綜合臨床 28, 1065, 1979.

• 2) Nielsen, J.O. et al.:Incidence and meaning of persistence of Australia antigen in patiellts with acute viral hepatitis:development of chronic hepatitis. N. Engl. J. Med. 285, 1157, 1971.
  pubmed

• 3) 鈴木 宏・他:急性B型肝炎の一過性感染例と持続感染例の比較. 第10回犬山シンポジウム「肝 in situにおける反応論」犬山シンポジウム記録刊行会編, p. 3, 中外医学社, 1978.

• 4) 小林健一:ウイルス肝炎と追跡調査. IB型肝炎.「ウイルス肝炎から肝細胞癌へ」服部 信編, p. 93, 癌と化学療法社, 1982.

• 5) 古田精市・他:B型急性肝炎の病像-血中HBs抗原持続陽性例と一過性陽性例の比較-. 第10回犬山シンポジウム「肝 in situにおける反応論」犬山シンポジウム記録刊行会編, p. 30, 中外 医学社, 1978.

• 6) Magnius, L.O.:New specificities in Autralia antigen positive sera distinct from the Le Bouvier determinants. J. Immunol. 109, 1017, 1972.

• 7) 渡辺省三・他:各種B型肝疾患におけるHBe systemとDNA polymerase activityの比較検討. 肝臓 20, 531, 1979.

• 8) 曾我憲二・他:B型肝炎における肝組織内HBc抗原,HBe抗原の局在に関する研究. 肝臓 22, 1393,1981.

• 9) Shikata, T. et al.:Hepatitis B e antigen and infectivity of hepatitis B virus. J. Infect. Dis. 136, 571, 1977.
  pubmed

• 10) Okada, K. et al.:e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N. Engl. J. Med. 293, 746, 1976.

• 11) 袖山 健:HBs抗原陽性の慢性肝炎におけるHBe抗原抗体系の臨床的意義. 肝臓 23, 731, 1982.

• 12) 小坂義種・他:慢性肝炎の予後に関する臨床的検討-特に反覆肝生検所見と臨床所見の関連性につ いて. 日消誌 78, 667, 1981.

• 13) 本間 明:肝細胞癌127例の臨床病理学的研究. 肝臓 24, 989, 1983.

• 14) 市田文弘・他:肝硬変. 日本臨床(本邦臨床統計集), 496, 551, 1983.

• 15) 小幡 裕・他:肝炎・肝硬変・肝癌の関連-臨床の立場より. 肝胆膵 5, 955, 1982.

P.153 掲載の参考文献

• 1) 古田精市, 長田敦夫, 清沢研道・他:非A非B型肝炎-その臨床像およびウイルス学的側面-. 内科 46, 242-247, 1980.

• 2) Nagata, A., Kiyosawa, K., Akahane, Y. et al.:A case of acute Non-A, Non-B sporadic hepatitis with evolution of liver cirrhosis on serial histologic follow-up. Gastroenterol Jap. 17, 591-595, 1982.

• 3) Trepo, C. and Lindberg, J.:Non-A Non-B hepatitis. Scand J Gastroenterol Suppl. 77, 75-92, 1982.
  pubmed

• 4) Kryger, P.:Non-A, Non-B hepatitis. Serological, clinical, morphological and prognostic aspects. Liver 3, 176-198, 1983.
  pubmed

• 5) Dienstag, J. L.:Non-A, Non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85, 439-462, 1983.
  pubmed

• 6) Rakela, J. and Redeker, A.G.:Chronic liver disease after acute Non-A, Non-B viral hepatitis. Gastroenterology 77, 1200-1202, 1979.

• 7) Kryger, P., Christoffersen, P., Aldershvile, J. et al.:The long-term prognosis of non-transfusion-associated Non-A, Non-B hepatitis. Scand J Gastroenterol 18, 519-527, 1983.

• 8) Berman, M., Alter, H. J., Ishak, K. G. et al.:The chronic sequelae of Non-A, Non-B hepatitis. Ann Intern Med. 91, 1-6, 1979.
  pubmed

• 9) Iwarson, S., Lindberg, J., Lundin, P. et al.:Progression of hepatitis Non-A, Non-B to chronic active hepatitis:a histological follow-up of two cases. J. Clin. Pathol. 32, 351-355, 1979.

• 10) Koretz, R. L., Stone, O. and Gitnick, G. L.:The long-term course of Non-A, Non-B posttransfusion hepatitis. Gastroenterology 79, 893-898, 1980.

• 11) Realdi, G,, Alberti, A., Rugge, M. et al.:Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis:evidence of progression to liver cirrhosis. Gut. 23, 270-275, 1982.

• 12) 矢野右人, 古賀満明, 古河隆二:輸血後肝炎,臨床と研究 56, 726-781, 1979.
  Medical*Online

B型肝炎の発生予防

P.164 掲載の参考文献

• 1) 市田文弘,小島健一・他:抗HBグロブリンによるHBウイルス汚染事故例の肝炎発症防止効果に関する研究. 基礎と臨床 13, 4294-4306, 1979.
  Medical*Online

• 2) 矢野右人:B型肝炎ウイルスの母児感染遮断, Medicina 18, 1548-1549, 1981.

• 3) 松本修三:抗HBヒト免疫グロブリン(HBIG)による新生児HBウイルス感染の予防. 周産期医学 9, 615-622, 1978.

• 4) 志方俊夫:e抗原e抗体について. 臨床成人病 8, 47, 1978.

• 5) 矢野右人,古賀満明:輸血後肝炎.内科 46, 236-241, 1980.

• 6) 矢野右人:B型肝炎. 臨床成人病 11, 1163-1167, 1981.

• 7) 白木和夫・他:HBウイルスの垂直感染. 日本新生児学会雑誌 16, 80-84, 1980.

• 8) N.Inaba, J. Kudoh. et al.:A study on the possibility of HBsAg transmission during sexual contact HBsAg Infection from HBsAg carrier state wives to their husbands, Acta Obst Gynaec Jpn. Vol.31, 1348-1352, 1979.

• 9) 工藤純孝,稲葉憲之:B型肝炎ウイルスの垂直感染. 臨床婦人科産科 32, 931-940, 1978.

• 10) 岡田 清:B型肝炎ウイルス母児間感染の実態. 診断と治療 66, 928, 1979.

• 11) 富樫武弘, 松本修三・他:HBIGによるB型肝炎ウイルス母児感染の予防. 小児内科 13, 547-553, 1981.

• 12) R.P. Beasley. et al.:Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state, Lancet II, 388-392, 1981.

• 13) 矢野右人, 佐藤 彬・他:HBウイルス母児間感染の防止. 診断と治療 69, 29-34, 1981.

• 14) Szmunes, W., Stevens, C. et al.:New Eng J. Med. 303 0ct. 9, 834-841, 1980.

• 15) 矢野右人, 佐藤彬・他:HBワクチンによる能動免疫. 肝臓 22, 1331, 1981.

P.174 掲載の参考文献

• 1) Shikata, T., Karasawa, T., Abe, K. et al.:Hepatitis Be antigen and infectivity of hepatitis B virus J. Infect. Dis. 136, 571-576, 1977.
  pubmed

• 2) Charnay, P., Pourcel, C., Louise, A. et al.:Cloning in Escherichia coli and physical structure of hepatitis B virion DNA. Proc. Natl. Acad. Sci. USA. 76, 2222-2226, 1979.
  pubmed

• 3) Galibert, F., Mandart, E., Fitoussi, F. et al.:Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature (London). 281, 646-650, 1979.

• 4) Chakraborty, P. R., Ruiz.Opazo, N, Shouval, D. et al.:Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line. Nature (London). 286, 531-533, 1980.

• 5) Huh, N. and Utakoji, T.:Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone. Gann. 72, 178-179, 1981.
  pubmed

• 6) Smith, G. L., Mackett, M. and Moss, B.:Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature. 302, 490-495, 1983.
  pubmed

• 7) Shikata, T., Karasawa, T., Yano, M. et al.:Hepatitis B vaccille:strategy of application in Asian-African countries in Viral Hepatitis Szmuness, W., Alter, H. J., and Maynard, J. E. ed. Franklin Inst. Philadelphia. pp 399-410, 1982.

• 8) Shikata, T., Karasawa, T., Abe, K. et al.:Incomplete inactivation of hepatitis B virus after heat treatment at 60?C for 10 hours. J. Infect. Dis. 138, 242-244, 1978.

• 9) Karasawa, T., Shikata, T., Ab., K. et al.:Efficacy of hepatitis B vaccine in chimpanzees given transfusion of highly infective blood. J. Infect Dis. 147, 327-335, 1983.

• 10) Szmuness, W., Stevens, C. E., Harley, E. J. et al.:Hepatitis B vaccine:Demonstration of efficacy in a controlled clinical trial in a high risk population in the United States. New Engl, J. M, 303, 833-841, 1980.

• 11) Maupas, P., Chiron, J. P., Barin, F. et al.:Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Lancet 1, 289-292, 1981.
  pubmed

B型慢性肝炎の治療

P.186 掲載の参考文献

• 1) Muller, W. E. G.:Antiviral agents and viral diseases of man. 1st Ed., (edited by Galasso, G.J., et al.), Raven Press, New York, p. 77,1979.

• 2) Scullard, G. H. et al.:J. Inf. Dis. 143, 772, 1981.

• 3) 飯野四郎:Prog, Med., 2, 1645, 1982.
  Medical*Online

• 4) 鈴木司郎・他:肝臓病学の進歩, 7, 23, 1981.

• 5) Watanabe, S. et al.:Hepatogastroenterol. 29, 102, 1982.

• 6) 渡辺省三:未発表データ.

• 7) 鈴木 宏・他:厚生省特定疾患難治性の肝炎調査研究班昭和56年度研究報告. p. 29.

• 8) 斉藤純夫・他:投稿中

• 9) Sacks, S, L. et al.:Antimicrobial Agents Chemotherapy. 21, 93, 1982.
  pubmed

• 10) Sherlock, S.:Management of chronic active hepatitis type B. ウイルス肝炎研究財団記念講演会. 昭和58.3.12.東京.

• 11) 横須賀収・他:肝臓 24, 492, 1983.

P.194 掲載の参考文献

• 1) Borden, E. C, and Ball, L. A.:Interferons. Progress in Heamatology 12, Grune and Stratton, New York, 299-339, 1981.

• 2) Hirsch, M. S. and Swartz, M. N.:Drug therapy:Antiviral agents. New Engl. J. Med. 302, 949-953, 1980.
  pubmed

• 3) 特集"インターフェロン", 臨床科学 18(12) ,1982.

• 4) Nagano, Y. and Kojima, Y.:Pouvoir immunisant du virus vaccinal inactive par des rayonsultraviolets. C. R. Soc. Biol. 148, 1700, 1954.

• 5) Greenberg, H. B. et al,:Effect of human leukocyte interferon on hepatitis B virus infectionin patients with chronic active hepatitis. New Engl. J. Med. 295, 517-522, 1976.

• 6) Desmyter, J. et al.:Administration of human fibroblast interferon in chronic hepatitis-B infection. Lancet. II, 645-647, 1976.

• 7) Kingham, J. G. C. et al.:Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon. Gut. 19, 91-94, 1978.

• 8) Dolen, J. G. et at.:Fibroblast lnterferon treatment of a patient with chronic active hepatitis. Am. J. Med. 67, 127-131, 1979.

• 9) Weimar, W.et'al.:Differential effects of fibroblast and leucocyte interferon in HBsAg positive chronic active hepatitis. Europ. J. Clin. Invest. 9, 151-154, 1979.
  pubmed

• 10) Weimar, W. et al.:Double-blind study of leucocyte interferon administration in chronic HBs-Ag-positive hepatitis. Lancet. 1, 336-338, 1980.

• 11) Schalm, S. W. and Heijtink, R. A.:Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg-positive chronic active hepatitis:Results of a placebo vs. interferon trial Hepatology. 2, 791-794, 1984.

• 12) Vladutiu, A.O. et al.:Effect of human fibroblast interferon on hepatitis B virus DNA in serum. Biomedicine, 36, 162-164, 1982.

• 13) 厚生省特定疾患難治性の肝炎調査研究班, 昭和55年度研究報告.p.18-51.

• 14) 厚生省特定疾患難治性の肝炎調査研究班, 昭和56年度研究報告. p.27-75.

• 15) 厚生省特定疾患難治性の肝炎調査研究班, 昭和57年度研究報告. 印刷中.

• 16) Scullard, G. H. et al.:Antiviral treatment of chronic hepatitis B virus infection. I. Changed in viral markers with interferon combined with adenine arabinoside. J. Infect. Dis.143, 772-783, 1981.
  pubmed

• 17) Sacks, S. L. et al.:Antiviral treatment of chronic hepatitis B virus infection;Pharmacokinetics and side effects of interferon and adenine arabinoside. Antimicrobial Agents Chemotherapy. 21, 93-100, 1982.
  pubmed

• 18) Smith, C.I. et al.:Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection. JAMA. 247, 2261-2265, 1982.
  pubmed

P.202 掲載の参考文献

• 1) Krohn, K., Votila, A., Grohn, P. et al.:Uracil in transfer factor. Lancet. ll, 1209-1209, 1975.

• 2) 松本脩三,崎山幸雄,伊藤碩候・他:Transfer factor. 診断と治療 69, 203-206, 1981.

• 3) Krohn, K.:Studies on the chemical composition and biological proparties of transfer factor.Z Immun Forsch. 153, 394-411, 1977.

• 4) Valentine, F. T. and Lawrence, H. S.:Lymphocyte stimulation;Transfer of cellular hypersensitivity to antigen in vitro. Science. 165, 1014-1016, 1969.
  pubmed

• 5) 鈴木成欣, 星野 弘, 柴崎正修・他:Transfer factorの化学特性・伝達性の局在およびリンパ球3H-thymidine取り込みの抑制に関する研究. アレルギー 25, 122-127, 1976.

• 6) Gottlieb, A. A., Saito, K., Sutcliff, S. et al.:Biochemical analysis of dialyzable leukocyte extracts. J Reticuloendothol Soc. 21, 403-416, 1977.

• 7) Bullock, W. E,, Fields, J. P. and Brandriss, M. W.:An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy. New Engl J Med. 287, 1053-1059, 1972.
  pubmed

• 8) Holzman, R. S. and Lawrence, H. S.:121 In vitro augmentation of lymphocyte sheep cell rosette formation by leukocyte dialystates. J Immunol. 118, 1672-1676, 1977.

• 9) Gallin, J, L and Kirkpatrick, C. H.:Chemotactic activity in dialyzable transfer factor(granulocytes/monocytes/immuno response/lymphokines/primate/delayed hypersensitivity) . Proc Nath Acad Sci.71,498-502,1974.

• 10) 松本修三, 山崎幸雄,南 秀樹・他:免疫不全状態の治療における trans factorの意義. 日児誌 80,876-884, 1976.

• 11) Eddleston, A. L. W. F. and Williams, R.:Inadequate antibody response to HBsAg or suppressor T cell defect in development of active chronic hepatitis. Lancet. II, 1543-1545, 1974.

• 12) Kohler, P. F., Trembath, J., Merrill, D. A. et al.:Immunotherapy with antibody, Lymphocytes and transfer factor in chronic hepatitis B. Clin Immunol Immunopathol 2, 465-471, 1974.

• 13) Shulman,S.,Schulkind, M. and Ayoub, E.:Transfer-factor therapy of chronic active hepatitis.Lancet. II, 650-650, 1974.

• 14) Shulman, S.:Transfer factor therapy of chronic aggressive hepatitis. In:Transfer Factor. Edited by Ascher MS, et al. Academic Press, New York, 1976, p.439-448.

• 15) Tong, M. J., Nystrom, J. S., Redeker, A. G. et al.:Failure of transfer factor therapy in chronic active type B hepatitis. New Engl J Med, 295, 209-211, 1976.
  pubmed

• 16) Jain, Sadouble., Thomas, H. C. and Sherlock, S.:Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease. Clin Exp Immunol. 30, 10-15, 1977.

• 17) Ellis-Pegler, R., Sutherland, D. C., Douglas, R. et al.:Transfer factor and hepatitis B:a double blind study. Clin Exp Immunol. 36, 221-226, 1979.
  pubmed

• 18) Basten, A. and Croft, S.:Immunological engineering. Edited by Jirsch D. W, M T P Press, Baltimore,1978, p.83.

• 19) Kirkpatrick, C H., Khan, A. and Hill, N.O.;Third international symposium on transferfactor. Cell immunol. 46, 184-187, 1979.

P.211 掲載の参考文献

• 1) 熊田博光, 池田健次, 村島直哉・他:B型慢性肝炎のステロイドrebound 療法の有効例と無効例の検討. 第19回日本肝臓学会総会, 昭58.7.

• 2) 熊田博光, 池田日健次,吉場 朗:副腎皮質ステロイドの離脱療法. 肝胆膵 7, 409-416,1983.

• 3) 古賀満明, 南野 毅, 矢野右人・他:e抗原陽性慢性肝炎に対する副腎皮質ホルモン離脱療法-有効群と無効群の比較を中心に-. 第19回日本肝臓学会総会, 昭58,7.

• 4) 斉藤正之, 岩間章介, 奥田邦雄・他:B型ウイルス肝炎のステロイド療法に対する問題点. 第19回 日本肝臓学会総会, 昭58.7.

• 5) 日野邦彦, 宮川 浩, 高橋 淳・他:B型慢性肝疾患に対するPrednisolone, Ara-Aの併用療法. 第19回日本肝臓学会総会, 昭58.7.

• 6) 横須賀収, 小俣政男, 奥田邦雄・他:HBe抗原陽性慢性肝疾患に対するプレドニゾロン -Ara-A併用療法の試み-特にHBVマーカーの変動に関して-. 肝臓 24,492-500,1983.

• 7) 辻 孝夫:第13回犬山シンポジウム討論.

• 8) Thomas, H. C., Brown, D., Routhier, G. et al.:Inducer and suppressor T-cells in hepatitis B virus-induced liver disease. Hepatology.2,202-204,1982.
  pubmed

• 9) 恩地森一, 山下善正, 近藤 一・他:副腎皮質ホルモン投与による末梢血T cell subsetsの変動, 第12回日本臨床免疫学会総会講演抄録集 (昭59.6. 東京) .

• 10) 山下善正, 恩地森一,近藤 一・他:慢性肝疾患における末梢血単球機能の検討 -とくに免疫応答補助能とI領域関連抗原陽性単球数の測定. 医学のあゆみ 123,257-258,1982.

• 11) 近藤 一, 恩地森一, 山下善正・他:慢性肝炎患者末梢血リンパ球のインターロイキン2産生能の測定. 第19回日本肝臓学会総会講演集 (昭58.7.久留米) .p.76.

• 12) 松田吉貢, 恩地森一,山下苫正・他:慢性肝疾患における肝組織内リンパ球T cell subsetsの検討 第25回日本消化器病学会抄録集. 日消誌80巻臨時増刊号, 1983,p.2131.

• 13) Sasaki, H., Ichida, F., Kamimura, T. et al.:Ultrastructural study of interaction of lymphocytes and hepatocytes bearing hepatitis B antigen, in Berk and Chalmers(Eds.):Frontiers in Liver Disease. Thieme-Stratton, New York, p.196-207,1981.

• 14) Brechot, C.,Pourcel, C., Hadchouel, M. et al.:State of hepatitis B virus DNA in liver diseases. Hepatology. 2, 27S-34S, 1982.

• 15) Shafritz, D., Shouval, D., Sherman, H. L et al.:Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N. Engl. J. Med. 305, 1067-1073, 1981.

肝硬変症の病理

P.230 掲載の参考文献

• 1) 三宅 仁・他:肝硬変症の形態分類基準-肝硬変症分類研究班, 肝臓 6, 177-182, 208-215, 1965.

• 2) Popper, H. and Orr, W.:Current concepts in cirrhosis. Scandinav. J. Gastroenterol. 6, 203-222, 1970.

• 3) 伊東俊夫:人のクップェル氏星細胞と肝毛細管壁にみられる脂肪摂取細胞の研究. 解剖誌 26, 2, 1951.

• 4) Bronfenmajor, S., Schaffner, F. and Popper, H.:Fat-storing cells(lipocytes) in human liver. Arch. Pathol. 82, 447-453, 1966.

• 5) Kent, G. and Schneider, K. A.:Cirrhosis and iron overload. In the Liver and its Diseases. (Eds) Schaffner, F., Sherlock, S., Leevy, C. M. Intercontinental Medical Book corp., New York. 1974.

• 6) Boyer, J. and Klatskin, G.:Pattern of necrosis in acute viral hepatitis:Prognostic value of bridging (subacute hepatic necrosis) . New England J. Med. 283, 1063-1071, 1970.

• 7) Sherlock, S.(chairman) :Report of the board for classification and nomenclature of cirrhosis of the liver. Fifth Pan American Congress of Gastroenterology, Havana, Cuba. Gastroenterology. 31, 213, 1956.

• 8) 三宅 仁:肝臓の病理-肝硬変症を中心として. 日病会誌 49, 589, 1960.

• 9) Sherlock, S.:Diseases of the liver and biliary system. 4th Ed., Blackwell, Oxford, p. 403, 1968.

• 10) Gall, E. A.:Post hepatitic, postnecrotic and nutritional cirrhosis:A pathological analysis. Amer. J. Pathol. 36, 241-259, 1960.

• 11) Steiner, P. E.:Evolution of research in the etiological types of cirrhotic disease of the liver. 1931-1961. Pathol. Microbiol. (Basel) 27,890-924, 1964.
  pubmed

• 12) Leevy, C. M., Popper, H. and Sherlock, S.:Diseases of the liver and biliary tract:Standardization of nomenclature, diagnostic criteria and diagnostic methodology. Year Book Med. Publ., Chicago, P.9, 1976.

• 13) 森 亘:肝硬変症の分類. 医学のあゆみ 48, 371-381,1964.

• 14) Galanbos, J. T.:Classification of cirrhosis. Amer. J. Gastroenterology. 64, 437-451, 1975.

• 15) 中島敏郎・神代正道:肝硬変の病理-ウイルス肝炎を中心に-医学のあゆみ 118,633-638,1981.

• 16) 森 亘:ウイルス肝炎の予後, その1 :特に肝硬変との関係. 肝臓, 山村雄一, 織田敏次, 市田 文弘監修, 中山書店, p.104, 1977.

• 17) 佐々木憲一・北爪伸仁・奥平雅彦:肝血管・リンパ管構築の検査. 臨床検査 24, 271-279, 1980.

• 18) Hales, M. R., Allan, J. S. and Hall, E. M.:Injection corosion studies of normal and cirrhotic livers. Amer. J. Pathol. 35, 909-941, 1959.

• 19) Edmondson, H. A. and Steiner, P. E.:Primary carcimoma of the liver:A study of 100 cases among 48,900 necropsies. Cancer.7, 462-503, 1954.

• 20) Steiner, P. E. and Davies, J. N. P.:Cirrhosis and primary liver carcinoma in Uganda Africans. Brit. J. Cancer. 11, 523-534,1957.

• 21) Higginson, J. and Steiner, P. E.:Definition and classification of malignant epithelial neoplasms of the liver. Acta. Un. Int. cancer. 17, 593-603, 1961.

• 22) Anthony, P. P.:Primary carcinoma of the liver:A study of 282 cases in Uganda Africans. J.Pathol. 110, 37-48, 1973.
  pubmed

• 23) Anthony, P. P., Vogel, C. L. and Barker, L F.:Liver cell dysplasia:A Premalignant condition. J. Clin. Pathol 26, 217-223, 1973.
  pubmed

• 24) Sakurai, M.:Liver cell dysplasia and hepatitis B surface and core autigens in cirrhosis and hepatocellular carcinoma of autopsy cases. Acta Path. Jpn.28, 705-719, 1978.

• 25) 坂本真一・川原田信・谷内 昭:肝硬変結節のもつ前癌病変としての意義. 肝臓 19,1093-1095,1978.

• 26) Popper, H.:Primary liver Tumor(Eds) Remmer, H., Bolt. H. M., Bannasch, P., Popper, H., University Park Press. Baltimore, pp.140-142, 1978.

• 27) Edmondson, H. A.:Benign epithelial tumors and tumor-like lesions of the liver. In Okuda, K.and Peters, R. L.:Hepatocellular Carcinoma. The Wiley and Son, New York, pp.309-330, 1976.

• 28) Gibson, J. B. and Sobin, L. H.:Histological typing of tumours of the liver. biliary tract and pancreas. WHO, geneva, 1978.

• 29) Sasaki, K.:Adenomatous hyperplasia in liver cirrhosis:An approach from a microangiographical point of view. In GANN monograph on Cancer Research 25, Cancer Cell Biology. (Eds) Nagayo, T., Mori, W. Japan Scientific Societies Press, Tokyo. pp.127-140,1980.

日本と米国, 日本と英国の肝硬変対比

P.241 掲載の参考文献

• 1) 長与又郎:宿題肝硬変, 第二, 病理解剖学的方面. 日病会誌 4, 31-72, 1914.

• 2) 三宅 仁:肝臓の病理-肝硬変症を中心として. 日病会誌 49, 589-632, 1960.

• 3) 森 亘:肝硬変の分類. 医学のあゆみ 48, 371-381, 1964.

• 4) Anthony, P. P., Ishak, K. G., Nayak, N. C., Poulsen, H. E., Scheuer, P. J. and Sobin, L. H.:The morphology of cirrhosis:definition, nomenclature, and classification. Bulletin of the World Health Organization. 55, 521-540,1977.
  pubmed

• 5) Mori, W.:Cirrhosis and primary cancer of the liver. Comparative study in Tokyo and Cincinnati. Cancer.20, 627-631, 1967.
  pubmed

• 6) Gall, E. A.:Posthepatitic, postnecrotic, and nutritional cirrhosis, A pathologic analysis. Amer. J.Pathol. 36, 241-271, 1960.

• 7) Mori, W. and Shah, M.:A comparative geo-pathological study of liver cirrhosis and rpimary hepatic cancer between Cambridge and Tokyo. Gann. 63, 765-771, 1972.

• 8) Shikata, T., Uzawa, T., Yoshiwara, N,, Akatsuka, T. and Yamazaki, S.:Staining methods of Australia antigen in paraffin sections. Jap. J. exp. Med. 44, 25-36, 1974.
  pubmed

• 9) Tanaka, K., Mori, W. and Suwa, K.:Victoria blue-nuclear fast red stain for HBs antigen detection in paraffin section. Acta. Pathol. Jpn. 31, 93-98, 1981.
  pubmed

• 10) Mori, W.,Machinami, R. and Tanaka, K.:Pathology of hepatocellular carcinoma. Path. Res. Pract. 169, 4-20, 1980.

• 11) Karasawa, T., Kushida, T., Shikata, T. and Kaneda, H.:Morphologic spectrum of liver diseases among chronic alcoholics. A comparison between Tokyo, Japan and Cincinnati, U.S.A. Acta Pathol. Jpn. 30, 505-514,1980.
  pubmed

• 12) Lee, F.I.:Cirrhosis and hepatoma in alcoholics. Gut. 7, 77-95, 1966.
  pubmed

• 13) Peters, R. L.:Pathology of hepatocellular carcinoma. In Okuda, K. and Peters, R. L.(Editors) :Hepatocellular Carcinoma. pp.107-168, John Wiley & Sons, New York, London,Sydney, Toronto, 1975.

• 14) Johnson, P. J.,Krasner, N., Portmann, B., Eddleston, A. L. W. F. and Williams, R.:Hepatocellular carcinoma in Great Britain:influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis. Gut. 19, 1022-1026, 1978.

肝硬変症の追跡調査, とくに肝細胞癌への進展

P.256 掲載の参考文献

• 1) 奥平雅彦:肝硬変症と肝細胞癌. 内科 52, 427-430,1 983.

• 2) 日本肝癌研究会:原発性肝癌に関する追跡調査-第5報-, 肝臓 23, 675-681, 1982.

• 3) 古田精市・他:肝癌発生の臨床病理学的研究-肝炎・肝硬変からの追跡例44例を中心に-.肝臓 20, 839-851, 1979.

• 4) 小幡 裕・他:慢性肝疾患におけるヘバトーマ発生について. 肝臓 17, 335-347, 1976.

• 5) Purtilo, D. T. et al.:Cirrhosis and hepatoma occurring at Boston city hospital(1917〜1968). Cancer 32, 458-462, 1973.

• 6) Kobayashi, K. et al.:Hepatoma development during long term follow. up period of liver cirrhosis. Acta Hepato-Gastroent. 25, 344-349,1978.

• 7) 古賀満明・他:シンポジウム「肝炎から肝癌への進展とその対策」. S-3. HB抗原系のマーカーからみた肝硬変, 肝癌の経過と予後. 肝臓 23, 965, 1982.

• 8) Chen, D. S. et al.:Small hepatocellular carcinoma-a clinicopathological study in thirteen patients. Gastroenterology. 83, 1109-1119, 1982.
  pubmed

• 9) 福田善弘・他:肝細胞癌における血中HBe抗原, 抗体の検索と考察. 肝臓 22, 859-865, 1981.

• 10) Brechot, C. et'zl.:Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. N. Engl. J. Med. 306, 1384-1386, 1982.

• 11) Beasley, R, P. et al.:Hepatocellular carcinoma and hepatitis B virus. Lancet. II, 1129-1133, 1981.

• 12) Sakuma, K. et al.:Prognosis of hepatitis B virus surface antigen carriers in relation to routine function tests:a prospective study. Gastroenterology. 83, 114-117,1983.

• 13) 高橋善弥太編:劇症肝炎-生存117例の検討. 中外医学社, 東京, 8頁,1982.

• 14) Rike, M. C. et al:'Hormonal'risk factors,'breast tissue age'and the age-incidence of breast cancer. Nature. 303, 767-770, 1983.

• 15) 成瀬優知:糖尿病における心虚血性変化の発生予知に関する研究. 日本公衛誌 26, 245-256, 1979.

• 16) Takashima, T. and Matsui,O.:Infusion hepatic angiography in the detection of small hepatocellular carcinomas. Radiology. 136,321-325,1980.
  pubmed

• 17) 幕内雅敏・他:肝細胞癌の早期診断法.I. 超音波検査. 服部 信編「ウイルス肝炎から肝細胞癌へ」,癌と化学療法社, 東京, 309頁, 1982.

• 18) 斎藤明子・他:画像診断 a. 超音 波内科 52, 453-459, 1983.

• 19) Takashima, T. et al,:Diagnosis and screening of small hepatocellular carcinomas. Radiology.145, 635-638, 1982.
  pubmed

• 20) Matsui,O. et al.:Work in progress:Dynamic sequential CT during arterial portography in the detection of hepatic neoplasma. Radiology. 146,721-727, 1983.

• 21) Okuda, K. et al.:Clinicopathological studies of minute hepatocellular carcinoma. Analysis of 20 cases, including 4 with hepatic resection. Gastroenterology. 73, 109-115, 1977.
  pubmed

• 22) Sung, J. L. and Chen, D. S.:Hepatitis B surface antigen and antibody in liver disease in Taiwan. In:Lee, S. K. etal. eds. Proceedings of the 5th Asian Pacific Congress of Gastroenterology. Singapore:Gastroenterological Society of Singapore. 265-268, 1976.

• 23) 奥田邦雄:肝癌の疫学. 服部 信編,内科 MOOK 18 肝癌.金原出版, 東京, 51頁,1982.

肝細胞癌の病理

P.275 掲載の参考文献

• 1) Falk symposium 25:Primary liver tumors, eds. Remmer, H., Bolt, H., Bannasch, P., Popper,H.:MTP Press Limited Falcon House, Lancaster, England, 125-185, 1978.

• 2) 小林昭二:人口動態統計からみた悪性新生物, 厚生の指標 27 (16), がん特集, 4-121, 1980.

• 3) Doll, R., Payne, P.M. and Waterhouse, J.A.H.:Cancer incidence in five continents. Berlin,Springer Verlag(UICC publication) ,1966.

• 4) Eggel, H.:Uber das primtire Carcinom der Leber. Beitr. Z. Path. Anat. u. z. allg. Path. 30, 506-604, 1901.

• 5) 日本肝癌研究会編:臨床・病理:原発性肝癌取扱い規約, 東京, 金原出版, 1983.

• 6) Berman, C.:Primary carcinoma of the liver. A study in incidence, clinical manifestations, pathology and etiology. London, H. K. Lewis & Co. Ltd,1951.

• 7) Peters, R. L.:Pathology of hepatocellular carcinoma. In Hepatocellular carcinoma, eds. Okuda, K. and Peteres, R.L., Wiley and Sons, New York, 107-168, 1976.

• 8) 中島敏郎, 神代正道, 坂本和義, 奥田邦雄・他:原発性肝癌に関する研究, 第1報, 原発性肝細胞癌の新しい肉眼分類. 肝臓 15, 279-291, 1974.

• 9) Nakashima, T. and Sakamoto, K.:A study of hepatocellular carcinoma among Japanese from the point of view of morphodevelopmental pathology. Gross anatomical types classified in its relation to capsule formation. Kurume Med. J.24(Suppl.) ,43-62, 1977.

• 10) Ziegler:cited from Handbuch der speziellen pathologischen Anatomie und Histologie V/l(Leber). eds, Henke, F and Lubarsch,0., Berlin, Springer Verlag, p.827, 1930.

• 11) Hanot, V.C. and Gilbert A.:Etude sur les maladies du foie. Paris, Asselin & Houzeau, 1888.

• 12) 荒川正博, 鹿毛政義, 磯村 正, 元山福祥・他:原発性肝癌の病理形態学的研究, 肝外に巨大な腫瘤を形成したいわゆる有茎性肝細胞癌7例の検討, 肝臓 23(8), 86-92, 1982.

• 13) Horie, Y., Katoh, S., Yoshida, H. et al.:Pedunculated hepatocellular carcinoma. Report of three cases and review of literature. Cancer. 51,746-751,1983.
  pubmed

• 14) 岡部正之:原発性肝癌の病理形態学的研究, 肝細胞癌における癌結節の被膜ならびに隔壁の形成機転について, 肝臓 20, 144-156, 1979.

• 15) Nakashima, T.:Vascular changes in hepatocellular carcinoma, In Hepatocellular Carcinoma. eds. Okuda, K and Peters, RL, New York, Wiley & Sons, 169-203, 1976.

• 16) 坂本和義:原発性肝細胞癌の 理形態学的研究 ,微小肝癌について, 久留米医会誌 37,18-33,1976.

• 17) Okuda, K., Nakashima, T., Obata, H. and Kubo, Y.:Clinicopathological studies of minutehepatocellular carcinoma. Gastroenterology 73, 109-115, 1979.

• 18) 中島敏郎, 猪狩民生:細小肝癌, 内科 Mook, No. 18, 30-37, 1982.

• 19) 山崎 晋,長谷川博, 幕内雅敏:細小肝癌の臨床病理学的分析と, それにもとつく新しい概念の切除法-27切除例の検討-,肝臓 22(13), 1714-1723, 1981.

• 20) 日高久光:原発性肝癌の病理形態学的研究, 肝硬変症を伴わない肝細胞癌について, 肝臓 21, 754-763, 1980.

• 21) Shikata, T., Uzawa, N., Yoshiwara, N. and Yamazaki, S,:Staining method of Australia antigen in paraffin section. Jap. Exp. Med. 44, 25-36, 1974.

• 22) Gibson, J. B.:Histological typing of tumours of the liver, biliary tract and pancreas. International histological classification of tumours No. 20, Geneva, WHO, 1978.

• 23) 中島敏郎, 川野芳朗, 白井文夫, 神代正道・他:肝細胞癌の発育様式からみた癌組織内HBsAgの分布について, 肝臓 22, 755, 1981.

• 24) Nakashima, T., Kojiro, M., Kawano, Y., Shirai, F. et,al.:Histological growth pattern of hepatocellular carcinoma. Relationship to orcein(hepatitis B surface antigen) positive cells in cancer tissue. Hum Pathol. 13, 563-568, 1982.
  pubmed

• 25) 倉富晋太郎:肝細胞癌の病理形態学的研究, 血管構築よりみた進行性肝癌ならびに血管内腫瘍塞栓の病理, 肝臓 17, 517-527, 1976.

• 26) 荒川正博, 古賀正広, 鹿毛政義:原発性肝癌の病理形態学的研究, 肝細胞癌における門脈内腫瘍血栓と食道静脈瘤との関係について,肝臓 20, 941-947, 1979.

• 27) 桑尾定明:原発性肝癌の病理形態学的研究, 肝細胞癌の肝血管系における腫瘍血栓について, 肝蔵 20, 828-838, 1979.

• 28) Okuda, K., Musha, H., Yoshida, T., Kanda, Y. et al.:Demonstration of growing casts of hepatocellular carcinoma in portal vein by celiac angiography. The thread and streaks sign. Radiology. 117, 303-309, 1975.
  pubmed

• 29) 森 亘:ヘパトーマの転移に関する研究, 特に肝硬変との関係について. 日病会誌 45, 224-236, 1956.

• 30) 宮地 徹, 今井 茂:10年間 (1946-1955) におけるわが国の肝癌剖検例639例の病理学的研究, 肝臓 1, 100-102, 1960.

• 31) Nakashima, T., Okuda, K., Kojiro, M., Jimi, A. et al.:Pathology of hepatocellular carcinoma in Japan. 232 consecutive cases autopsied in ten years. Cancer.51, 863-877, 1983.
  pubmed

• 32) Edmondson, H. A. and Steiner, P. E.:Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies. Cancer,7, 462-503, 1954.

• 33) Sherlock, S., Fox, R. A., Naizi, S. P. and Scheuer, P. J.:Chronic liver disease and primary liver-cell carcinoma with hepatitis-associated (Australia) antigen in serum. Lancet. I, 1243-1247, 1970.

• 34) Vogel, C. L, Peter, P. A., Mody, N. and Barker, L. F.:Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Lancet. ii,621-624,1970.

• 35) Tong, M. J., San, S. C, Schaeffer, B. T., Chang, N.K. et al.:Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med. 75, 687-691, 1971.

• 36) Aden, D. P., Fogel, A., Plotkin, S., Damjanov, J. et, al.:Controled synthesis of HBsAg in a differentiated human liver carcinoma. derived cell line. Nature. 282, 615-616, 1979.

• 37) Brechot, C., Hadchouel, M., Scotto, J. et al.:State of hepatits B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and-negative liver diseases. Proc. Natl Acad. Sci. USA. 78, 3906-3910, 1981.

• 38) Shafritz, D. A., Shouval, D., Sherman, H. I. et al.:Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. New Engl J. Med. 305, 1067-1073,1981.
  pubmed

• 39) Shafritz, D. A. and Kew, M. C.:Identification of integrated hepatitis B virus DNA sequencesin human hepatocellular carcinolna. Hepatology. 1, 1-8, 1981.

• 40) Nayak, N. C., Dhar, A., Sachdeva, R.,Mittal, A. et al.:Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver. Int. J. Cancer. 20, 643-654, 1977.

• 41) 田中釣一, 豊川秀治, 内田俊和, 鵜沢輝子・他:ヘパトームの腫瘍細胞中のB型関連抗原, 肝臓 18, 689, 1977.

• 42) 飛鳥田一朗, 三枝苗成, 斉藤礼郎, 秋庭真理子・他:肝細胞癌組織内HBsAgについて, 肝臓 18, 691, 1977.

• 43) Deodhar, K. P.,Tapp, E. and Scheuer, P. J.:Orcein staining of hepatitis B antigen in paraffin section of liver biopsies. J. Clin. Path.28,66-70, 1975.
  pubmed

• 44) Sakurai, M. and Miyaji, T.:Orcein staining of hepatitis B surface antigen in paraffin sections of liver on autopsy cases. Acta Hepato-Gastroenterol. 24, 334-339, 1977.

• 45) Kawano, Y.:Localization of hepatitis B surface antigen in hepatocellular carcinoma. Acta Pathol. Jpn. 33(6):1087-1093, 1983.
  pubmed

• 46) 長与又郎:肝硬変, 病理解剖学的方面, 日病理会誌 4, 31-72, 1915.

• 47) 三宅仁:肝臓の病理, 肝硬変症を中心として, 日病理会誌 49, 589-632, 1960.

• 48) Mallory, T. D.:Case records of Massachusetts General Hospital, case 33441. New Engl. J.Med. 237, 673-676, 1947.

• 49) Lin, T.:Tumors of the liver, In Gastroenterology, ed. Bockus, HL., Philadelphia. W B Sauders, 522-533, 1976.

• 50) Kojiro, M., Kawabata, K., Kawano, Y. and Shirai, F.:Hepatocellular carcinoma presenting as intrabile duct tumor growth. A clinicopathologic study of 24 cases. Cancer.49, 2144-2147, 1982.
  pubmed

• 51) 荒川正博, 徳田恵子, 桑尾定明, 磯村 正・他:原発性肝癌の病理形態学的研究, 右房内に腫瘍血栓のみられた肝細胞癌の5剖検例, 久留米医会誌 40, 1218-1227, 1977.

• 52) 金山隆一, 広瀬昭一郎, 波江源四郎, 蓮村 靖・他:腫瘍の浸潤により右房内に球状血栓栓塞をおこして死亡した肝癌の1例, 綜合臨床 18, 825-829, 1969.

• 53) 加登康洋, 黒崎正夫, 小林健一, 杉本恒明・他:右房内に腫瘍による巨大球状血栓を生じた肝癌の1列, 内科 28, 349-353, 1971.

• 54) Anthony, P. P., Vogel, C. L. and Barker, L. F.:Liver cell dysplasia:A premalignant condition. J. Clin. Path. 26, 217-223, 1973.
  pubmed

• 55) Sakurai, M.:Liver cell dysplasia and hepatitis B surface and core antigens in cirrhosis and hepatocellular carcinoma of autopsy cases. Acta Pathol. Jpn. 28,705-719, 1978.
  pubmed

• 56) Omata, M., Mori, J., Yokosuka,O., Iwama, S. et al.:Hepatitis B virus antigen in liver tissue in hepatocellular carcinoma and advanced chronic liver disease-relationship to liver cell dysplasia. Liver.2, 125-132, 1982.
  pubmed

• 57) Cohen, C., Berson, S.D . and Geddes, E. W.:Liver cell dysplasia. Association with hepatocellular carcinoma. cirrhosis and hepatitis B virus antigen carrier status. Cancer.44, 1671-1676, 1979.
  pubmed

• 58) 坂本真一, 川原田信, 谷内 昭:シンポジウム, 原発性肝癌をめぐる諸問題I, 肝硬変結節のもつ前癌病変としての意義, 肝臓 19, 1093-1095, 1978.

• 59) 沖田 極,児玉隆吉:シンポジウム, 原発性肝癌をめぐる諸問題II, 前癌性病変の検討, 肝臓 19, 1096-1097, 1978.

肝細胞癌の発育速度

P.284 掲載の参考文献

• 1) Okuda, K., Musha, H., Nakajima, Y. et at.:Clinicopathologic features of encapsulated hepatocellular carcinoma. a study of 26 cases. Cancer.40, 1240-1245, 1977.

• 2) 岡崎伸生, 吉野正幡, 吉田孝宣・他:肝細胞癌の発育速度と早期診断. 肝臓 22, 1142, 1981.

• 3) Collins, V. P., Loeffler, R. K. and Tivey, H.:Observation on growth rates of human tumors. Am J. Roentgenul. 76, 988-1000, 1956.

• 4) Schwartz, M.:A biomathematical approach to clinical tumor growth. Cancer. 14, 1972-1294, 1961.

• 5) Yoshino, M.:Growth kinetics of hepatocellular carcinoma. Jpn. J. Clin. Oncol.13,45-52, 1983.
  pubmed

• 6) 小田野幾雄, 日向 浩,原 敬治・他:肝細胞癌の早期発見に関する臨床的研究 特に腫瘍倍加時間より解析したスクリーニング理論. 日医放会誌, 43, 582-588, 1983.

• 7) 真島康雄, 酒見泰介, 酒井輝文・他:肝細胞癌の発育速度. 肝臓 24, 677, 1983.

• 8) Shackney, S. E., McCormack, G. W. and Cuchural, G. J.:Growth rate patterns of solid tumors and their relation to responsiveness to therapy, An analytical review. Ann Int. Med. 89, 197-121, 1978.

• 9) 服部 信, 小林健一, 澤武紀雄・他:原発性肝癌の高危険群 high risk group. 癌の臨床 28,706-709, 1982.

• 10)草間 悟:アンケート集計, 乳癌の natural history. 日癌治会誌 16, 567-203, 1981.

• 11)岡崎伸生, 吉野正噴, 吉田孝宣:Slow growing liver cell carcinoma. 内科 Mook, 18, 38-43, 1982.

B型肝炎ウイルスとレトロウイルスの比較

P.290 掲載の参考文献

• 1) Pfeiffer,P. and Hohn,T.:Involvement of reverse transcription in the replication of Cauliflower Mosaic Virus, A detailed model and test of some aspects, Cell.33, 781-789, 1983.
  pubmed

• 2) Summers, J.:Three recentry described animal virus models for human hepatitis B virus, Hepatology. 1, 179-183, 1981.

• 3) Summers, J. and Mason, W. S.:Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate, Cell. 29, 403-415, 1982.
  pubmed

• 4) 畑中正一:ウイルスとガン, 岩波新書 154,1981.

• 5) Molnar-Kimber, K. L, Summers, J., Toylor, J. M. and Mason, W. S.:Protein covalently found to minus-strand DNA intermediates of duck hepatitis B virus, J. Virol. 45, 165-172, 1983.

• 6) Wimmer, E.:Genome.linked proteins of viruses. Cell. 28, 199-201, 1982.
  pubmed

• 7) Nomoto, A., Detjen, B., Pozzatti, R. and Wimmer, E.:The location of the polis genome protein in viral RNAs and its implication for RNA synthesis, Nature. 268, 208-213, 1977.

• 8) Mellado, P. R., Penalva, H. A., Inciarte, M. R. and Salas, M.:The protein covatently. linked to the 5'-termini of the DNA of Bacillus subtitis phage φ29 is involved in the initiation of DNA replication, Virol.104, 84-96, 1980.

• 9) Ikeda, J. E., Enomoto, T. and Hurwitz, J.:Adenoviral protein-primed initiation of DNA chains in vitro, Proc. Natl. Acad. Sci. 68, 2559-2563, 1982.

• 10) Varmus, H.:Reverse transcription in plants? Nature. 304,116-117, 1983.
  pubmed

• 11) Ruiz-Opazo, N., Chakraborty, P. R. and Shafritz, D. A.:Evidence for supercoiled hepatitis B virus DNA in chimpanzee liver and serum Dane particles:possible implications in persistent HBV infection. Cell 29,129-138,1982.
  pubmed

• 12) Brechot, C., Hadchouel, M., Scotto, J., Fonck, M., Rotet, F., Vyas, G. N. and Tiollais, P.:State of hepatitis B virus DNA in hepatocyte of patients with hepatitis B surface antigen-positive and-negative liver diseases. Proc. Natl. Acad. Scl 78, 3906-3910, 1981.

• 13) Shafritz, D. A., Shouval, D., Sherman, H.I., Hadziyannis, S. J. and Kew, M. C.:Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellularcarcinoma. New Angl. J. ed. 305, 1067-1073, 1981.

• 14) Dejean, A., Vitvitski, L., Brechot, C., Trepo, C., Tiollais, P. and Charney, P.:Presence and state of woodchuck hepatitis virus DNA in liver and serum of woodchucks:Further allalogies with human hepatitis B vlrus. Virol.121, 195-199, 1982.

• 15) Ogston, C. W., Jonak, G. J., Rogler, C. E., Astrin, S. M. and Summers, J.:Cloning and structural analysis of integrated Woodchuck hepatitis virus sequences from hepatocellular carcinomas of woodchucks, Cell.29,385-394,1982.
  pubmed

• 16) 畑中正一:ヒト細胞中の Oncogene, 代謝 Vol.19 臨時増刊号「癌'82」67-73,1982.

• 17) Dejean, A., Brechot, C., Tiollais, P. and Wain-Hobson, S.:Characterization of integrated hepatitis B viral DNA cloned from a human hepatoma and the hepatoma derived cell line PLC PRF/5, Proc. Natl Acad. Sci.,80.2505-2509,1983.
  pubmed

肝細胞癌の臨床

P.304 掲載の参考文献

• 1) 野田八嗣, 福岡賢一, 宮森弘年, 田中延善, 加登康洋, 小林健一, 服部 信, 中西功夫, 桑島 章:脾転移により特発性脾破裂をみた肝細胞癌の一例, 肝臓 23,1083-1087,1982.

• 2) Horie, Y., Snou, T., Hirayama, C. and Nagasako, K.:Spontaneons rupture of the spleen secondary to metastatic hepatocellular carcinoma:A report of a case and review of the liter.ature. Amer. J. Gastroenterology.77,882-884,1982.

• 3) 森 亘:ヘパトームの転移に関する研究-特に肝硬変症との関係について, 日本病理学会誌 45, 224-236, 1956.

• 4) William, R. B. and Richard, E.:Spontaneous rupture of the spleen from metastatic carcinoma. JAMA. 240, 53-54, 1978.

• 5) Hynes, E. H., Silverstein, N. M. and Fowcett, J. F.:Spontaneous rupture of the spleen in leukemia, Cancer.17,1356-1360,1964.

• 6) Nakashima, T., Okada, K., Kojiro, M., Jimi, A., Yamaguchi, R., Sakamoto, K. and Ikari, T.:Pathology of hepatocellular carcinoma in Japan. 232 consecutive cases autopsied in ten years.Cancer. 51, 863-877, 1983.

• 7) 杉本立甫, 森田宣人, 水木正雄, 小林健一, 安念有聲 :膜様物形成によるBudd-Chiari症候群と原発性肝癌を合併した一部検例,肝臓 17, 472-477,1976.

• 8) 太田明生, 亀田治男, 山田英夫, 多川 斉, 上田英雄, 大森亮雄, 常喜栄昭:Chiari病およびBudd-Chiari症候群について, 内科 22, 979-984, 1968.

• 9) Boyer, T. D.:Portal hypertension and its complications. Bleeding esophageal varices ascites, and spontaneous bacterial peritonitis, pp.482-484, in Hepatology A Textbook of Liver Disease. ed, by D. Zakim and T. D. Boyer. W. B. Saunders Co., Philadelphia London, Toronto, Mexico City, Rio de Janeiro, Sydney, Tokyo,1982.

• 10) 加登康洋, 黒崎正夫, 小林健一, 杉本恒明, 高田 昭, 津田功雄:右房内に腫瘍による巨大球状血栓を生じた肝癌の一例, 内科 28,349-353,1971.

• 11) Kato, Y., Tanaka, N., Kobayashi, K., Ikeda, T., Hattori, N. and Nonomura, A.:Growth of hepatocellular carcinoma into the right atrium:Report of five cases. Ann Intern. Med.99 (4) , 472-474, 1983.
  pubmed

• 12) Hahne,O. H. and Climie, A. R. W.:Right atrial thrombi with ball-valve action. Amer. J. Med. 32, 942-949, 1962.

• 13) 小林健一:原発性肝癌の臨床,内科 Mook 18 肝癌 (服部信編集企画), 金原出版 p.87, 昭和57年.

• 14) 中村 暁,牧野 博, 高桜英輔,野々村昭孝 :胃にBorrmann2型の転移を有し, 高脂血症を伴った肝細胞癌の一剖検例, 肝臓 24(8) ,914-918,1983.

• 15) 柴田哲男, 中野 哲,北村公男, 綿引 元,武田 功, 小沢 洋, 浜野康次:胃に血行性転移を来した肝細胞癌の一剖検例, 日本消化器病学会雑誌 78,1998-2002,1981.

• 16) Horie, Y., Katoh, S., Yoshida, H., Imaoka, T., Snou, T. and Hirayama, C.:Pedunculated hepatocellular carcinoma, Report of three cases and review of literature, Cancer.51,746-751,1983

• 17) 岡崎伸生, 服部 信, 神田裕三, 荒木英爾:赤血球増多症と高脂血症を伴った原発性肝癌,日本消化器病学会誌 69,775,1972.

• 18) Santer, M. A., Waldmann, T. A. and Fallon, H. J.:Erythrocytosis and hyperlipemia as manifestations of hepatic carcinoma. Arch. Intern. Med.120, 735-739, 1967.
  pubmed

わが国における肝細胞癌発生の西高東低現象

P.314 掲載の参考文献

• 1) 宮地 徹:肝癌と肝硬変の統計的観察. 肝臓-構造, 機能, 病態生理-, 高橋忠雄監修, 三浦 義彰, 斉藤 守, 織田敏次編, 医学書院, 東京,pp.702-722,1972.

• 2) 小幡 裕, 久満董樹, 本池洋二・他:肝炎, 肝硬変, 肝癌の関連-臨床の立場より-, 肝胆膵 5, 955-961, 1982.

• 3) 服部 信, 小林健一, 澤武紀雄・他:肝炎と肝癌, 臨床成人病 11, 1209-1213, 1981.

• 4) 西岡久寿弥:肝癌と肝炎ウイルス 現況と展望, 肝胆膵 5, 905-910, 1982.

• 5) 志方俊夫:肝炎, 肝硬変, 肝癌の関連-病理の立場より, 肝胆膵 5, 947-953, 1982.

• 6) 高田 昭, 高瀬修二郎:アルコールと肝硬変, 臨床科学 17, 1274-1281, 1981.

• 7) 厚生省, 厚生の指標, 1977年, 1978年, 1979年, 1980年, 1981年.

• 8) Okada, K., Kamiyama,I., Inomata, M. et al.:E antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N. Engl. J. Med. 294, 746-749, 1976.

• 9) 福田信臣, 小島峯雄, 足立信幸・他:乳幼児におけるHBウイルスcarrier成立年齢について, 肝臓 19 ,936-941 ,1 978.

• 10) 鈴木 宏:慢性肝炎の病因と病態-B型肝炎, 内科 Mook,慢性肝炎. 阿部正和, 河合 忠一, 尾前照雄編, 金原出版, 東京, pp.6 9-77, 1978.

• 11) 松下 寛:肝硬変の疫学-我が国における最近の発生状況とその発生要因, 特にHBVとの関連について-, 臨床科学 17,1309-1317, 1981.

• 12) 日本赤十字社:血液事業の現状, 1979年度.

• 13) 棟久龍夫, 中田恵輔,深堀愛子・他:五島列島富江町における肝癌, 肝硬変に関する臨床病理学的研究, 診断と治療 70,1223-1227, 1982.

• 14) 寺尾 清:マイコトキシンと肝癌, 肝胆膵 5,911-917,1982.

• 15) 倉田 浩, 宇田川俊一,坂部フミ・他:病因としての食品汚染マイコトキシン類の検索,肝疾患の病因をさぐる-長崎県五島列島における肝癌, 肝硬変症に関する疫学,臨床,病理学的地域調査-高岡善人,宮地 徹,斉藤 守,拭石季枝編, 医歯薬出版, 東京,pp.161-225,1977.

• 16) 小林健一:トロトラスト,塩化ビニール, 蛋白同化ホルモン・経口避妊薬と肝腫瘍,内科Mook, 肝癌,阿部正和,尾前照雄,河合忠一編,金原出版,東京,pp.66-73,1982.

肝癌の疫学, ことにアフリカ, 東南アジア, 中国における肝細胞癌について

P.327 掲載の参考文献

• 1) Munoz, N and Linsell, A.:Epidemiology of primary liver cancer. Epidemiology of the Digestive Tract. Correa P, Haenszel, W., eds. Hague, Martinus Nijhoff. 161-195, 1982.

• 2) Okuda, K., Musha, H., Nakajima, Y. et al.:Clinicopathological features of encapsulated hepatocellular carcinoma. A study of 26 cases. Cancer.40, 1240-1945,1977.
  pubmed

• 3) Okuda, K. and the Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Cancer.45, 2663-2669, 1980.

• 4) Higginson, J.:The epidemiology of primary carcinoma of the liver. In:Tumors of the liver. Pack GT, Islami AH, eds. Berlin, Springer.39-52,1970.

• 5) Harington, J. S., McGlashan, N. D., Bradshaw, E., Geddes, E. W. and Purves, L. R.:Aspatial and temporal analysis of four cancers in African gold miners from southern Africa. Br.J.Cancer.31, 665-678, 1975.

• 6) Simson,I. W.:Membranous obstruction of the inferior vena cava and hepatocellular carcinomain South Africa. Gastroenterology.82,171-178,1982,

• 7) van der Merwe, C. F. and Arts, M. S. C,:Primary liver cancer in the Transvaal. Hepato-Gastroenterol.28, 233-235, 1981.

• 8) Beasley, R. P., Hwang, L. Y., Lin, C. C. and Chien, C. S.:Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet.2, 1129-1133, 1981.

• 9) Robertson, M. A., Harington, J. S. and Bradshaw, E.:The cancer pattern in Africans at Barawanath Hospital, Johannesburg:Br. J. Cancer. 25, 377-384, 1971.

• 10) Kew, M. C. and Geddes, E. W.:Hepatocellular carcinoma in rural Southern African blacks. Medicine. 61,98-108, 1982.
  pubmed

• 11) Macnab, G. M., Urbanowica, J. M., Geddes, E. W. and Kew, M. C.:Hepatitis-B surfaceantigen and antibody in Bantu patients with primary hepatocellular cancer. Br J Cancer. 33, 544-548, 1976.

• 12) Anthony, P. P.:Primary carcinoma of the liver:astudy of 283 cases in Ugandan Africans.J.Path. Bact.110, 37-49, 1973.

• 13) Vogel, C L., Anthony, P. P., Mody, N. and Barker, L F.:Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Lancet.2,621-624,1970.
  pubmed

• 14) Anthony, P. P., Vogel, C. L, Sadikali, F. et al.:Hepatitis-associated antigen and antibodyin Uganda:correlation of serological testing with histopathology. Brit Med-J.1,403-406, 1972.

• 15) Prince, A. M., Szmuness, W., Michon, J. et al.:A case/control study of the association between primary liver cancer and hepatitis B infection in Senegal Int. J. Cancer.16,376-383,1975.

• 16) Steiner, P. E.:Cancer of the liver and cirrhosis in Transsaharan Africa and the United States. Cancer.13, 1085-1166, 1960.

• 17) Li, F. P. and Shiang, E. L.:Cancer mortality in China(Guest editorial) . J. Natl. Cancer Inst.65, 217-221, 1980.

• 18) Terry, W. B.:Organ specific cancers. Primary cancer of the liver. In:Cancer in China,Kaplan, H. S, Tsuchitani, P. J., eds. Alan R Liss, New York.101-111,1978.

• 19) Su, D.:Drinking water and liver cancer. An epidemiologic approach to the etiology of this disease in China. Chin. Med. J. 92, 748-756, 1979.

• 20) Editorial. Liver cancer:something in the water. Lancet 1, 747-748, 1980.
  pubmed

• 21) Tong, M. J., Sun, S. C., Schaeffer, B. T. et'zl.:Hepatitis-associated antigen and hepato.cellular carcinoma in Taiwan. Ann Intern Med. 75, 687-691,197L

• 22) Beasley, R. P.:Hepatitis B virus as the etiologic agent in hepatocellular carcinoma-epidemiologic considerations. Hepatology. 2, 21S-26S. 1982.

• 23) Beasley, R. P., Lin, C. C., Chien, C. S., Chen, C. J. and Hwang, L. Y.:Geographic distribution of HBsAg carriers in China. Hepatology.2,553-556,1982.
  pubmed

• 24) Sakuma, K., Takahara, T., Okuda, K.,et al.:Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests:a prospective study. Gastroenterology. 83, 114-117, 1982.
  pubmed

• 25) Tock, E. P. C. and Shanmugaratnam, K.:Epidemiology of primary liver cancer in Singapore.Ann Acad. Med.9, 193-195, 1980.

• 26) Lee, Y. S.:Hepatic cirrrhosis in Singapore:differences between the Chinese and Indian ethnic groups. Trop. Geogr. Med. 31, 329-338 ,1979.

• 27) Yap, E. H., Ong, Y. W., Simons, M. J. et al.:Australia antigen in Singapore. II. Differential frequency in Chinese, Malays and Indians. Vox Sang.22,371-375,1972.
  pubmed

• 28) Skinhφj, P., Hanssen, J. P. H., Nelsen, M. H. et al.:Occurrence of cirrhosis and primary liver cancer in an Eskimo population hyperendemically infected with hepatitis B virus. Am. J.Epidemiol.108,121-125,1978.

• 29) Viranuvatti, V., Damrongsak, C., Chainuvatti, T. and Hitanant, S.:Carcinoma of the liver in Thailand, trends in two decades. Ann Acad. Med.9, 196-198, 1980.

• 30) Hou, R. T.:The relationship between primary carcinoma of the liver and infestation with Clonorchis sinensis. J. Pathol Bacteriol. 72, 239-246, 1956.

• 31) Stitnimankarn, T.:Primary hepatic carcinoma in Thailand. Gann. 18, 123-124, 1976.

• 32) Basa, G. F., Hirayama, T. and Cruz-Basa, A. G.:Cancer epidemiology in the Philippines. Natl. Cancer Inst. Monogr. 47, 45-56,1977.
  pubmed

• 33) Alvarez, S. Z.:Hepatocellular carcinoma in the Philippines. Trop Gastroenterol l,124-128,1980.

• 34) Nishioka, K., Hirayama, T., Sekine, T. et al.:Australia antigen and hepartocellular carcinoma. Gann.14,167-175,1973.

• 35) Lingao, A. L., Domingo, E.O. and Nishioka, K.:Hepatitis B virus profile of hepatocellularcarcimma in the Philipines. Cancer.48,1590-1595,1981.
  pubmed

肝細胞癌の高危険群

P.336 掲載の参考文献

• 1) 平山 雄:肝癌の疫学, 肝胆膵 5, 897-904, 1982.

• 2) 小川秀資:わが国の肝硬変-最近の動向, Medicina. 9, 662-663, 1972.

• 3) 平川弘泰:肝疾患の死因ならびに予後に関する研究, 肝臓 22, 848-858, 1981.

• 4) 小林健一:肝硬変の臨床とその予後, とくに肝細胞癌への進展, 服部 信編 ウイルス肝炎から肝細胞癌へ, 癌と化学療法社, 東京, 201頁,1982.

• 5) 日本肝癌研究会:原発性肝癌症例に関する追跡調査-第4報-,肝臓 20, 433-441, 1979.

• 6) Kobayashi, K., Kumagai, M., Kameda, S. et al.:Hepatoma development during long term follow-up of liver cirrhosis. Acta Hepato-Gastroent. 25,344-349,1978.

• 7) 福田善弘, 河崎恒久, 宮村正美・他:肝細胞癌における血中HBe抗原・抗体の検索と考察, 肝臓 22, 859-865, 1981.

• 8) 古賀満明, 南野 毅, 角田悦郎・他:HB抗原系のマーカーからみた肝硬変, 肝癌の経過と予後, 肝臓 23, 965, 1982.

• 9) Garceau, A. J.:The natural history of cirrhosis. II. The influence of alcohol and prior hepatitis on pathology and prognosis. New Engl. J. Med. 271,1173-1179, 1964.
  pubmed

• 10) Saunders, J. B., Walters, J. R. F., Davies, P. et al.:A 20-year prospective study of cirrhosis. Brit. Med. J.282,263-266,1981.

• 11) 武内重五郎, 奥平雅彦, 高田 昭・他:わが国における アルコール性肝障害の実態-全国集計の成績から-, 日消誌 76,2178-2185,1979.

• 12) 高田 昭, 高瀬修二郎, 根井仁一・他:大酒家肝硬変と原発性肝癌, 肝臓 21, 1252, 1980.

• 13) 大西久仁彦, 岩間章介, 飯田真司・他:長期アルコール飲用の肝硬変症ならびに肝癌発生におよぼす影響-とくにHBs抗原持続感染との関係より, 肝臓 21,1647-1654,1980.

• 14) 鵜沼直雄, 山口 肇, 樫田光夫・他:アルコール性肝障害における禁酒後一過性AFP上昇について, 肝臓 21,76,1980.

• 15) Lee, F,I.:Cirrhosis and hepatoma in alcoholics. Gut. 7, 77-85,1 966.

• 16) 鵜沼直雄,山口 肇, 樫田光夫・他:アルコール摂取中断によるAFPの上昇と原発性肝細胞癌の発生, 肝臓 22, 318, 1981.

• 17) 古田精一, 小池ゆり子, 長田敦夫・他:肝癌発生の臨床病理学的研究-肝炎・肝硬変からの追跡例44例を中心に-, 肝蔵 20,839-851,1979.

• 18) 武藤泰敏:ビタミンA (レチノイド) と癌-特に肝細胞癌を中心として, ビタミン 56,555-561, 1982.
  Medical*Online

肝細胞癌の早期スクリーニング方式

P.348 掲載の参考文献

• 1) 松下 寛:厚生省肝炎研究連絡協議会 昭和56年度研究報告.

• 2) 厚生統計協会:国民衛生の動向, 昭和58年.

• 3) Beasley, R. P., et al.:Hepatocellular carcinoma and hepatitis B virus-a prospective study of 22707 men in Taiwan-Lancet II, 1129, 1981.

• 4) 小幡 裕・他:慢性肝疾患におけるヘパトーマ発生について, 肝臓 17, 335-347, 1976.

• 5) 斉藤明子:超音波検査による細小肝癌の診断と進展形式の検討, 肝臓 24, 1459-1460, 1983.

肝細胞癌の早期診断方法

P.369 掲載の参考文献

• 1) 幕内雅敏・他:正常肝内管状構造の描出と超音波断層上の特徴およびその臨床的意義, 超音波医学 5, 274, 1978.

• 2) Bandai, Y. et al.:Sonographic differentiation between the umbilical portion of the left portal vien and intrahepatic bile ducts. J. Clin. Ultras ound.8, 207, 1980.

• 3) Makuuchi, M. et al.:The inferior right hepatic vein:ultrasonic demonstration. Radiology. 148, 213, 1983.
  pubmed

• 4) 大藤正雄・他:超音波リニア電子スキャンによる小肝細胞癌の診断 とくに他検査との対比による診断能の検討, 肝臓 22, 119, 1981.

• 5) 品川 孝・他:肝の超音波診断病理所見との対比による検討, 第37回日本超音波医学会論文集, p. 65, 1980.

• 6) 稲吉 厚・他:肝癌の超音波診断 (第2報), 第37回日本超音波医学会論文集, p.69,1980.

• 7) 渡辺五朗・他:超音波診断法「肝臓」,新医療 7, 107,1980.

• 8) 板井悠二, 幕内雅敏:超音波・CTによる消化器, 病診断, 文光堂, 1982.

• 9) 秋本 伸・他:小肝癌超音波像の組織学的背景, 第37回日本超音波医学会論文集,p.67, 1980.

• 10)真島康雄・他:肝癌の超音波診断と病理所見との対比,日消病会誌 78 (supl) ,409, 1981.

• 11)上所洋・他:切除可能であった肝細胞癌11例の超音波像,第36回日本超音波医学会論文集,p. 137, 1980.

• 12) 尾崎俊彦・他:肝腫瘍の総合画像診断, 第38回日本超音波医学会論文集, p.563, 1981.

• 13) 杉山 高・他:当院における血管腫12例の検討, 第38回日本超音波医学会論文集, p.213, 1981.

• 14) 上所 高・他:肝血管腫の超音波像, 第38回日本超音波医学論文集, p.215, 1981.

• 15) 秋本 伸・他:肝血管腫超音波像の検討, 第38回日本超音波医学会論文集, p.217, 1981.

• 16) 岡崎正敏・他:肝癌の血管造影門脈所見の意義, 手術適応および予後との関係. 日消病会誌 77, 758, 1980.

• 17) 幕内雅敏・他:新たに開発した術中超音波検査用探触子, 映像情報 11, 1167, 1979.

• 18) 幕内雅敏・他:肝手術のための術中超音波検査, 超音波医学 7, 39, 1980.

• 19) 幕内雅敏・他:肝切除における術中超音波検査法の意義, 臨外 35, 1297, 1980.

• 20) 幕内雅敏・他:リアルタイム装置の新しい応用, 術中超音波検査, 超音波医学 7,263, 1980.

• 21) 幕内雅敏・他:肝の術中超音波検査-特に最近の亜区域切除術について, 外科治療 44, 579,1981.

• 22) 幕内雅敏・他:肝癌における術中超音波検査, 肝胆膵 3, 305, 1981.

• 23) Makuuchi, M. et al.:Intraoperative ultrasonic examination for hepatectom. Jpn. J. Clin. Oncol 11, 367, 1981.

• 24) 幕内雅敏・他:腹部手術における術中検査の意義, 術中超音波検査, 日外会誌 82, 1094, 1981.

• 25) Yu, Y. et al.:Experiencein resection of small hepatocellular carcinoma. Chin. Med. J.93, 491, 1980.

• 26) Holm, H. H. and Kristensen, J. K.:Ultrasonically guided puncture technique. Munksgaard, Copenhagen, 1980.

• 27) 済陽高穂・他:エコー下肝狙撃生検, 第37回日本超音波医学会論文集,p.852, 1980.

• 28) 高安賢一・他:超音波下肝腫瘍生検とその止血法について, 第38回日本超音波医学会論文集,p. 417, 1981.

P.380 掲載の参考文献

• 1) Wild, J. J.:The use of pulse-echo ultrasound for early detection:history and prospects. Ultrasound in Tumor Diagnosis. ed. by Hill, C. R. et al. Pitman Medical,1978.

• 2) 山川邦夫・他:腹腔鏡下超音波診断法, 日超医会講演論文集 5,41,1963.

• 3) 平田健一郎・他:超音波腹腔鏡に関する研究, I型およびII型試作機に関する検討, 日超医会講演論文集 39,413-414,1981.

• 4) 福田守道, 美馬聡昭・他:超音波腹腔鏡-肝への応用-イメージ診断 2,55-61,1982.

• 5) 山中恒夫, 井戸健一・他:超音波体腔内走査法による腹部疾患の診断, 第2報, 腹腔鏡下電子リニア走査型超音波診断装置 (プロトタイプ) の評価, Gastroent. Endoscopy,24,608-615,1982.

• 6) 美馬聡昭・他:超音波診断を主体とした肝癌の集団検診, 第一報. 日超医会講演論文集 40,491-492, 1982.

• 7) 福田守道,斉藤甲斐之助, 平田健一郎, 寺田省樹, 中野良昭, 美馬聡昭:特殊な超音波診断法-超音波内視鏡および超音波腹腔鏡, 医学のあゆみ 123,331-341,1982.

• 8) 福田守道,美馬聡昭:「シンポジウム. 超音波による集団検診」超音波を主体とした肝癌集検, 日超医会講演論文集 42,9-10,1983.

• 9) 福田守道,美馬聡昭:超音波腹腔鏡, 臨床超音波シリーズ,「肝・脾」, 南江堂, 東京, 143-157, 1983.

P.390 掲載の参考文献

• 1) Takashima, T. and Matsui,O.:Infusion hepatic angiography in the detection of small hepatocellular carcinomas. Radiology. 136, 321-325, 1980.
  pubmed

• 2) 高島 力, 新 正浩, 松井 修・他:SS-hepatic arteriography-いわゆる"hypervascular"といわれている転移性肝癌発見のための新しい方法-, 日本消化器病学会雑誌 71, 1042-1049, 1974.

• 3) 松井 修:肝space occupying lesionの診断に対するinfusion hepatic angiographyの臨床的有用性について-, 日本医放会誌 39, 1-16, 1979.

• 4) 小野原信一, 小山隆夫,内山典明・他 :Balloon occlusion hepatic angiography-肝内腫瘤性病変と胆嚢の描出能について ,日本医放会誌 43, 905-912, 1983.

• 5) Prando, A., Wallace, S., Bernardino, M. E., et al.:Computed tomographic arteriography of the liver. Radiology. 130, 697-701, 1979.
  pubmed

• 6) Freeny, P. C. and Marks W. M.:Computed tomographic arteriography of the liver. Radiology.148, 193-197, 1983.
  pubmed

• 7) 伊藤 広, 松井修, 高島 力・他:細小肝癌診断に対するCT arteriographyの有用性, 臨放 27, 349-354, 1982.

• 8) 草野正一, 三屋公紀:肝癌の切除療法-画像診断からみた手術適応-,肝胆膵 5, 1081-1089, 1982.

• 9) Matsui, O., Kadoya, M., Takashima, T. et al.:Dynamic sequential computed tomography during arterial portography in the detection of hepatic neoplasms. Radiology.146, 721-727, 1983.
  pubmed

• 10) 今野俊光・他:原発性肝癌の新治療法:油性リンパ管造影剤リピオドールと親油性高分子制癌剤スマンクスの肝動脈内投与とその臨床成績, 癌と化学療法 9,2005-2015,1982.
  Medical*Online

• 11) 大藤正雄・他:肝癌の画像診断,画像診断 2, 268-275, 1982.

• 12) 長田芳子:細小肝癌における超音波所見の病理学的研究, 日本消化器病学会雑誌 78, 685-691, 1981.

• 13) 小林健一・他:肝硬変における肝細胞癌合併の予知について, 日本消化器病学会雑誌 80, 1959, 1983.

• 14) 松井 修, 高島 力 :肝癌の血管造影診断, 内科 Mook 18, 肝癌,服部 信編, 1982.

• 15) 大藤正雄・他:肝癌診断法の進歩-超音波映像下細胞診-,肝胆膵 5, 1057-1063, 1982.

• 16) 幕内雅敏,長谷川博,山崎 晋:肝癌診断法の進歩-超音波診断法-,肝胆膵 5, 1043-1049, 1982.

P.400 掲載の参考文献

• 1) Matsui,O. et al.:Dynamic sequential computed tomography during arterial portography in the derection of hepatic neoplasms. Radiology. 146, 721-727, 1983.

• 2) 竹本和正・他:肝細胞癌のCT像 (Dynamic CTの有用性について), 日医放 43, 529-538, 1983.

• 3) 石川浩一:原発性肝癌に関する追跡調査-第一報-, 肝臓 17,1976.

• 4) 葦沢龍人, 木戸長一郎:肝癌診断法の進歩-CTスキャン-, 肝・川・膵 5, 1051-1056, 1982.

• 5) 金沢 右, 木戸長一郎:石灰化を伴う転移性肝癌のCT像, 臨放 28, 595-599, 1983.

• 6) Alfidi, R. J., Haaga, J. R., Havrilla, T. R., Pepe, R. G. and Cook, S. A.:Computed tomography of the liver. Am. J. Roentgenol. 127, 69-74, 1977.

• 7) Alfidi, R. J. and Haaga, J. R.:Computed body tomography. Radiol. Clin. North Am.14, 563-570, 1976.
  pubmed

• 8) Alfidi, R. J. and Laval-Jeantet, M.:A promising contrast agent for computed tomography of the liver and spleen. Radiology.121, 491, 1976.

• 9) Araki, T., Itai, Y., Furui, S. and Tasaka, A.:Dynamic CT densitometry of hepatic tumors. AJR. 135, 1037-1043, 1980.
  pubmed

• 10) Inamoto, K., Sugiki, K. et al.:CT of hepatoma. Am. J. Roentgenol.136, 349-353, 1981.

• 11) Itai, Y., Nishikawa, J. and Tasaka, A.:Computed tomography in the evaluation of hepatocellular carcinoma. Radiology.131, 165-178, 1979,
  pubmed

• 12) Ita;Y., Araki, T., Furui, S., Tasaka, A., Atomi, Y. and Kuroda, A.:CT of hepatoma:Effects of portal vein obstruction. AJR.136, 349-353, 1981.

• 13) Itai, Y., Araki, T., Furui, S. and Tasaka, A.:Differential diagnosis of hepatic masses on computed tomography with particular refference to hepatocellular carcinoma. J. Comput. Assist. Tomogr.5,834-842,1981.

• 14) Korobkin, M., Kirks, D. R., Sullivan, D. C., Mills, S. R. and Bowie, J. D.:Computed tomography of primary liver tumors in children. Radiology.129, 441-445, 1981.

• 15) Kunstlinger, F., Federle, M. P., Moss, A. A. and Marks, W.:Computed tomography of hepatocellular carcinoma. AJR. 134, 431-437, 1980.
  pubmed

• 16) Wilms, G., Baert, A.I., Marchal, G. and Bruneel, M.:CT demonstration of gas formation after renal tumor embolization. J. Comput. Assist. Tomogr.3, 838-839, 1979.
  pubmed

P.407 掲載の参考文献

• 1) Berk, R. N.:Diagnostic Imaging of the Liver and Bile Ducts. Invest. Radiology.13, 265-278, 1978.

• 2) Whalen, J. P.:Radiology of the Abdomen:Impact of New Imaging Methods. Am. J. Roentgenol.133, 585-618, 1979.

• 3) Pestanick, J. P., Ram, P., Turner, D. A. et al.:The Relationship of Computed Tomography, Gray-Scale Ultrasonography, and Radionuclide Imaging in the Evaluation of Hepatic Masses. Semin. Nucl. Med.9, 8-21, 1979.

• 4) 鈴木 豊:Angerカメラとオートフルオロスコープ, 日本臨牀 37, 80-86, 1979.
  Medical*Online

• 5) 久田欣一, 飯沼 武, 有水 昇・他:核医学イメージングの規格化に関する勧告, Radioisotopes 28, 708-718, 1979.

• 6) Mettler, F. A. Jr., Shea, W. H. Jr., Guiberteau, M. J. et al.:Improvement in Visualization of Hepatic Lesions with Upright Views. J. Nucl. Med.18, 1128-1130, 1977.
  pubmed

• 7) Holder, L. E., Ashare, A. B., Tomsick, T. et al.:The Gamut Approach to Scintigram Interpretation-Diagnostic Aid and Teaching Method. J. Nucl. Med.16, 1121-1124, 1975.
  pubmed

• 8) Drum, D. E. and Beard, J. M.:Scintigraphic Criteria for Hepatic Metastases from Cancer of Colon and Breast. J. Nucl. Med.17, 677-680, 1976,

• 9) Holder, L. E. and Saenger, E. L.:The Use of Nuclear Medicine in Medicine in Evaluating Liver Disease. Semin. Roentgenol.10,215-222,1975.

• 10) Brill, A. B. and Patton, D. D.:Radioisotopic Methods in Diagnosis and Assessment of Liver Metastases. Int. J. Radiat. Onc. Biol. Phys.1, 981-990, 1976.

• 11) 久田欣一,油野民雄:超音波診断による肝細胞癌の診断, 癌と化学療法 6(補3), 537-545, 1979.

• 12) Ell, P. J. and Khan,O.:Emission Computed Tomography.:Clinical Applications. Semin.Nucl. Med. 11, 50-60, 1981.
  pubmed

• 13) 小山田日吉丸, 福喜多博義,照井頭二・他:回転椅子による肝の横断シンチグラフィーについて, 核医学 18, 63-73, 1981.

• 14) 山本和高, 百々義廣, 向井孝夫・他:回転型ガンマカメラによる肝ECTの検討-(2) 臨床的検討-核医学 19, 935-941, 1982.
  Medical*Online

• 15) Strauss, L., Bostel, F., Clorius, J. H. et al.:Single-Photon Computed Tomography(SPECT) for Assessment of Hepatic Lesions. J. Nucl. Med. 23, 1059-1065, 1982.
  pubmed

• 16) Sullivan, D. C., Taylor, K. J. W. and Gottschalk, A.:The Use of Ultrasound to Enhance the Diagnostic Utility of the Equivocal Liver Scintigraph. Radiology.128,727-732, 1978.

• 17) 利波紀久, 久田欣一, 三嶋勉・他:RI-Angiographyの肝腫瘍質的診断への応用,臨牀放射線15, 118-125, 1970.

• 18) 油野民雄, 利波紀久, 久田欣一:肝RIアンギオグラフィ, 肝血液プールシンチグラフィ(earlyおよびdelayed) による肝腫瘍血流状態の評価について, Radioisotopes.25,402-406,1976.

• 19) Suzuki, T., Honjo,I., Hamamoto, K. et al.:Positive Scintiphotography of Cancer of the Liver with 67Ga-citrate. Am. J. Roentgenol.,11, 92-103, 1971.

• 20) Eddleston, A. L. W. F., Rake, M.O., Pagaltos, A. P. et al.:75Se.selenomethionine in Scintiscan Diagnosis of Primary Hepatocellular Carcinoma. Gut 12,245-249,1971.

• 21) 平井秀松:腫瘍の放射免疫測定法, 診断と治療 70, 1506-1513, 1982.

• 22) Grossman, Z. D., Wistow, B. W., Bryan, P. J. et al.:Radionuclide Imaging, Computed Tomography, and Gray-Scale Ultrasonography of the Liver.:A Comparative Study. J. Nucl. Med. 18, 327-332,1977.
  pubmed

• 23) Bryan, P. J., Dinn. W. M., Grossman, Z. D. et al.:Correlation of Computed Tomography,Grey-Scale Ultrasonography, and Radionuclide Imaging of the Liver in Detecting Space-Occupying Processes. Radiology. 124, 387-393, 1977.
  pubmed

• 24) Snow, J. H. Jr.,Goldstein, H. M. and Wallece, S.:Comparison of Scintigraphy, Sonography and Computed Tomography in the Evaluation of Hepatic Neoplasms. Am. J. Roentgenol. 132, 915-918, 1979.

• 25) Kamin, P. D., Bernardino, M. E. and Green, B.:Ultrasound Manifestations of Hepatocellular Carcinoma. Radiology, 131, 459-461, 1979.
  pubmed

• 26) Broderick, T. W., Gosink, B., Menuck, L. et al.:Echographic and Radionuclide Detectionof Hepatoma. Radiology, 135, 149-151, 1980.

• 27) 長田芳子:細小肝癌における超音波所見の臨床病理学的研究, 日本消化器病学会雑誌 78, 685-691, 1981.

• 28) Kudo, M., Ibuki, Y., Fujimi, K. et al.:Clinical Evaluation of Single-Photon Emission Computed Tomography of Screening of Small Hepatocellular Carcinoma(abstract) . J. Nucl. Med .24, p.29, 1983.

• 29) Stakianakis, G. N. and Deland, F. H.:Radioimmunodiagnosis and Radioimmunotherapy. J.Nucl. Med. 23, 840-850, 1982.

• 30) Goldenberg, D. M.:Tumor Imaging with Monoclonal Antibodies. J. Nucl Med. 24, 360-362, 1983.
  pubmed

• 31) Yonekura, Y., Benua, R. S., Brill, A. B. et al.:Increased Acculnulation of 2-Deoxy-2-(18F) Fluoro-D-Glucose in Liver Metastases from Colon Carcinoma. J. Nucl. Med. 23, 1133-1137, 1982.
  pubmed

肝細胞癌の腫瘍マーカー

P.418 掲載の参考文献

• 1) Pedersen, K.O.:Fetuin, a new globulin isolated from serum. Nature. 154, 575, 1944.

• 2) Bergstrand, C. G. and Czar, B.:Demonstration of a new protein fraction in serum from the human fetus. Scand. J. Clin. Lab. Irivest. 8, 174-178, 1956.

• 3) Abelev, G.I., Perova, S. D., Khramkova, N.I. et al.:Production of embryonalα-globulin by transplantable mouse hepatoma. Transplantation. 1, 174-180, 1963.

• 4) Tatarinov, Ju. S.:New data on the embryo-specific antigenic components of human blood serum. Vopr. Med. Kim. 10, 584-588, 1964.

• 5) 石井 勝,池原英夫, 戸澤辰雄・他:a-fetoprotein Radioimmunoassayとその臨床的意義, 医学のあゆみ 79, 77-79, 1971,

• 6) 西 信三,平井秀松:a.-FetoproteinのRadioimmunoassayについて, 免疫実験操作法 (免疫学会扁), 215-221, 1971.

• 7) Nishi, S.:Isolation and characterization of a human fetalα-globulin from the sera of fetuses and a hepatoma patient. Cancer Res. 30, 2507-2513.

• 8) Alpert, E., Drysdale, J. W., Isselbacher, K. J. et al.:Human α-fetoprotein:Isolation, characterization and demonstration of microheterogeneity. B. J. Chem. 247, 3792-3798, 1972.

• 9) Ishii, M. and Ikehara, H.:Isolation and microhetergeneity of ratα-fetoprotein. Tumor Res. 8, 68-70, 1973.

• 10) Ruoslahti, E., Engvall, E., Pekkala, A. et al.:Developmental changes in carbohydrate moiety of human alpha-fetoprotein. Int. J. C.ancer. 22, 515-520. 1978.

• 11) Yoshima, H., Mizouchi, T., Ishii, M. et al.:Structure of the asparagine-linked sugar chains ofα-fetoprotein purified from human ascites fluid. Cancer Res. 40, 4276-4281, 1980,

• 12) Nishi, S. and Yamazaki, H.:Monoclonal antibodies against AFP:Applications in immunoassay and affinity chromatography. Abstracts of the Proceedings of the Tenth Annual Meetingof the International Society for Oncodevelopmental Biology and Medicine. A69, 1982.

• 13) Gitlin, D. and Boesman, M.:Serum α-fetoprotein, albumin and 7-globulin in the human conceptus. J. Clin. Invest. 45, 1826-1838, 1966.

• 14) Gitlin, D. and Boesman , M.:Sites of serum α-fetoprotein synthesis in the human and in the rat. J. Clin. Invest. 46, 1010-1016, 1967.

• 15) Irlin,I. S., Perova, S. D. and Abelev, G.I.:Changes in biological properties of mouse hepatoma during long term caltivation in vitro. Int. J. Cancer. 1, 337-347, 1966.

• 16) 志方俊夫, 榊原耕子:ヘパトーマ細胞における α-フェトプロテインの産生-とくにペルオキシダーゼ抗体法による検索,医学のあゆみ 81, 27-28, 1972.

• 17) Miura, K., Law, S. W. T.,.Nishi, S. et al.:Isolation of a-fetoprotein messenger RNA from mouse yolk sac. J. Biol. Chem 245, 5515-5521, 1979.

• 18) Eiferman, F.A., Young, P. R., Scott, R. W. et al.:Intragenic amplilication and divergence in the mouse α-fetoprotein gene. Nature 294, 713-718, 1981.

• 19) D'Eustachio,P., Ingram, R.S. Tilghman, S.M. et al.:Murine α-fetoprotein and albumin;Two evolutionarily linked proteins encoded on the same mouse chromosome.Somatic Cell Genetics. 7, 289-294, 1981.

• 20) Ingram, S., Scott, R. W. and Tilghman, S. M.:α-fetoprotein and albumin genes are illtranddem in the mouse genome. Proc. Natl, Acad. Sci. USA. 78, 4694-4698, 1981.

• 21) Gitlin,D. and Boesman, M.:Fetus specific serum protein in several mammals and their relation to human-fetoprotehn. Comp. Biochem. Physiol. 21, 327-336, 1967
  pubmed

• 22) 向島 達, 長谷川博, 服部 信:手術患者におけるα-Fetoproteinの減少率とその予後,医学のあゆみ 75, 485-486, 1972.

• 23) 石井 勝,戸澤辰雄, 井上英士・他:妊婦血清中のα-fetoprotein.,医学のあゆみ 83,529-530, 1972.

• 24) Nunez, E. A., Benassayag, C., Engelmann, F.et al.:Binding of estrogens to serum proteins of rats treated with hepatocarcinogenic compounds. Biomedicine. 514-520, 1972.

• 25) Ruoslahti, E. and Seppala, M.:Alpha-fetoprotein in cancer and fetal development. Advance Cancer Res.29, 275-346, 1979.
  pubmed

• 26) Caldwell, J. L., Severson, C. D. and Thompson, J. S.:Human AFP:Embryonic α-globulin with in vitro immunosuppresive activity. Fed. Proc. 32, 979, 1973.

• 27) 向島 達:Latex photometric immunoassay(LPIA)について, 臨床病理 31, 254-261, 1983.
  Medical*Online

• 28) Ruoslahti, E. and Seppiila, M.:α-fetoprotein in normal human serum. Nature. 255, 161-162, 1971.

• 29) Hull, E. W., Carbone, P. P., Gitlin, D. et al.:α-Fetoprotein in monkey with hepatoma. J.Natl. Cancer Inst. 42, 1035-1044, 1969.

• 30) Sell, S.:Distribution of a-fetoprotein-and albumin-containing cells in the livers of Fischer rats fed four cycles of N-2-fiuorenylacetamide. Cancer Res.38, 3107-3113, 1978.

• 31) Onoe, T., Dempo, K. Kaneko, A. et al.:Significance ofα-fetoprotein appearance in the early stage of azo-dye carcinogenesis. Gann. Mono. on Cancer Res.14, 233-243, 1973.

• 32) Anthony, P. P., Vogel, C. L. and Brker, L. F.:Liver cell dysplasia:a premalignant condition. J. Clin. Pathol. 26, 217-223, 1973.

• 33) Shanghai, Coordinating Groups of Research on Liver Cancer:Diagnosis and treatment of primary hepatocellular carcinoma in early stage. Clin. Med. J. 92, 801-806, 1979.

• 34) 長島秀夫, 渡辺明治, 東 俊宏・他:フェトプロテイン産生の調節機構からみた肝癌の診断,日本内科学会誌 69, 228.

• 35) 石井 勝,戸澤辰雄,井上英士・他:α-fetoprotein,日本臨牀 31, 1869-1877, 1973.
  Medical*Online

• 36) Sherlock, S.,Fox, R. A., Niazi, S. P. et al.:Chronic liver disease and primary liver-cell cancer with hepatitis-associated(Australia) antigen in serum. Lancet.1, 1243-1247, 1970.
  pubmed

• 37) Vogel, C. L.,Anthony, P. P., Mody, N. et al.:Hepatitis-associated antigen in Uganda patient with hepatocellular carcinoma, Lancet. 2, 621-624, 1970.
  pubmed

• 38) 遠藤康夫, 江藤澄哉, 飯野四郎・他:α1-globulin による原発性肝癌の診断, 肝臓 10, 143-146, 1969.

• 39) 向島 達, 下平克子,服部 信・他:α1-Fetoglobulin による原発性肝癌の診断, 肝臓 11, 325-333, 1970.

• 40) 石井 勝, 池原英夫,井上英士・他 :肝細胞癌とα-Fetoprotein., 臨床成人病 1, 339-343, 1971.

P.429 掲載の参考文献

• 1) Meister, A.:On the enzymology of amino acid transport. Science, 180, 33-39, 1973.
  pubmed

• 2) 谷口直之, 横沢紀子:グルタチオン代謝からみた腫瘍マーカーとしてのγ-グルタミルトランスペプチターゼ, Oncologia.1, 31-43, 1982.

• 3) Rutenburg, A. M. et al.:Electrophoretic mobilities of serum γ-GTP and its clinical application in hepatobiliary disease. J. Lab. Clin. Med. 69, 504, 1967.

• 4) 沢武紀雄, 中源雅俊, 米川正夫・他:原発性肝癌患者血清に特異的に出現するγ-GTP isoenzyme, 医学のあゆみ 98, 670-672, 1976.

• 5) Sawabu, N., Nakagen, M., Yoneda, M. et al.:Novelγ-GTP isoenzyme specifically found in sera of patients with hepatocellular carcinoma. Gann, 69, 601-604, 1978.

• 6) Hattori, N., Sawabu, N., Nakagen, M. et al.:Biochemistry of human liver cell carcinoma special reference to novelγ-GTP isoenzyme specific to hepatocellular carcinoma. Thatcher, N.(ed.) , Advances in medical oncology, research and education, vol. 9, p.119-128, Digestive Cancer, Pergamon, Oxford,1979.

• 7) Sawabu, N., Nakagen, M., Ozaki, K. et al.:Novelγ-GTP isoenzyme as diagnostic tool of hepatocellular carcinoma. Ann. Acad. Med. 9, 206-209, 1980.

• 8) 沢武紀雄, 中源雅俊, 若林時夫・他:Tumor marker, 最近の進歩と限界性,γ-GTP, 日本臨床 38, 4606-4613, 1980.

• 9) 中源雅俊:肝細胞癌に特異性高いnovel γ-GTP isoenzymeに関する臨床病理学的研究,日内会雑誌 70, 1697-1706, 1981.

• 10) Sawabu, N., Nakagen, M., Ozaki, et al.:Clinical evaluation of specific γ-GTP isoenzyme in patients with hepatocellular carcinoma. Cancer.51, 327-331, 1983.

• 11) Meister, A., Tate, S. S. and Griffith,O. W.:γ-GTP, Methods in Enzymol Jakoby. W. B. (ed.).77, 237-253, Acad. Press, New York, 1981.

• 12) Albert, Z., Rzucidlo, Z. and Starzyk, H.:Comparative biochemical and histochemical studies on the activity ofγ-GTP in the organs of fetus, newborns and adult rats. Acta histochem.37, 34-39, 1970.

• 13) Kalengayi, M. M. R., Ronchi, G. and Dosmet, V. J.:Histochemistry of γ-GTP in rat liver during aflatoxin B1-induced carcinogenesis. J. Natl. Cancer Inst. 55, 579-582, 1975.

• 14) Fiala, S. and Fiala, E. S.:Activation by chemical carcinogens of γ-GTP in rat and mouse liver. J. Natl. Cancer Inst. 51, 151-158, 1973.

• 15) Cameron, R., Kellen, J., Farber, E. et al.:γ-GTP in putative premalignant liver cell populations during hepatocarcinogenesis. Cancer Res. 38, 823-829, 1978.

• 16) Sells, M. A., Katyal, S. L. Sell, S. et al.:Induction of foci of altered,γ-GTP positive hepatocytes in carcinogen treated rats fed a cholin-deficient diet. Brit. J. Cancer. 40, 274-283, 1979.

• 17) Jalanko, H. and Ruoslahti, E.:Differential expression of AFP andγ-GTP in chemical and spontaneous hepatocarcinogenesis. Cancer Res. 39, 3495-3501, 1979.

• 18) Kitagawa, T., Watanabe, R. and Sugano, H.:Induction ofγ-GTP activity by dietary phenobarbital in `spontaneous"hepatic tumors of C3H mice. Gann.71, 536-542, 1980.

• 19) Laishes, B. A., Ogawa, K., Farber, E. et al.:γ-GTP A positive marker cultured rat liver cells derived from putative premalignant and malignant lesions. J. Natl. Cancer Inst. 60, 1009-1016, 1978.

• 20) Huberman, E.,Montesano, R,,Drevon C. et al.:γ-GTP malignant transformation of cultured liver cell Cancer Res. 39, 269-271, 1979.

• 21) Taniguchi, N.:Purification and some properties ofγ-GTP from azo dye-induced hepatoma. J.Biochem. 75, 473-480, 1974.

• 22) Taniguchi, N., Saito, K. and Takakuwa, E.:γ-GTP from azo dye-induced hepatoma and fetal rat liver. Biochim. Biophys. Acta. 391, 265-271, 1975.

• 23) Iwami, K., Yasumoto, K., Fushiki, T. et al.:Bovineγ-GTP-Immunological identity and varying affinities for concanavalin A. J. Biochem. 84, 1237-1243,1978.

• 24) Show, L. M., Petersen. Arcjer, L., London, J. W.et al.:Electrophoretic, kinetic, and immunoinhibition properties of γ-GTP from various tissues compared. Clin, Chem. 26, 1523-1527, 1980.

• 25) Haseby, N.:Separation and characterization of humanγ-GTP. Clin. Chim. Acta. 111, 39-45, 1981.

• 26) Tsuchida, S., Imai, F. and Sato, K.:Immunological characterization ofγ-GTP in human serum. J. Biochem. 89, 775-782, 1981.

• 27) Tsuchida, S., Hoshino, K., Sato, K. et al.:Purification ofγ-GTP from rat hepatomas and hyperplastic hepatic nodules, and comparison with the enzyme from rat kidney. Cancer Res. 39, 4200-4205, 1979.

• 28) 山下克子, 谷口直之,木幡 陽・他:γ-GTPの糖鎖構造-その癌性変化-,生物物理化学27, 93-98, 1983.

• 29) Kokat, F. and Kuska, J.:Uber die Bedeutung der Isoenzyme derγ-GTP in der Klinische Diagnostik. Clin. Chim. Acta. 11, 118-121, 1965.

• 30) Orlowski, M. and Szczeklik, A.:Heterogeneity of serumγ-GTP in hepatobiliary diseases. Clin. Chim. Acta, 15, 387-391, 1967.

• 31) Azzopardi,O. and Jayle, M. F.:Formes moleculaires de laγ-GTP. Clin. Chim. Acta.43, 163-169, 1973.

• 32) Fujisawa, K., Kurihara, N. et al.:Carcinoembryonic character of r-GTP in primary hepatoma. Leevy CM, ed. Diseases of the liver and biliary tract. S. Karger, Basel,1976, p.13-17.

• 33) Jones, D. D., Williams, G. et al.:Multiple molecular forms ofγ-GTP during human pregnancy. Enzyme. 17, 139-145, 1974.

• 34) Staeffen, Ballan, P. et al.:Quantitative study of the multimolecular forms of γ-GTP by acrylamide gel electrophoresis. Path. Biol 23, 615-622, 1975.

• 35) Miyazaki, S. and Okumura, M.:Change of serum γ-GTP level and isoenzyme pattern in hepatobiliary pancreatic disease. Clin. Chim. Acta. 40, 193-197, 1972.

• 36) Hetland,O., Andersson, T. R. et al.:The heterogeneity of the serum activity of γ-GTP in hepatobiliary diseases as studied by agarose gel electrophoresis. Clin. Chim. Acta. 62, 425-431, 1975.

• 37) Patel, S. and O'gorman, P.:Demonstration of serum γ-GTP isoenzyme using cellogel electrophoresis. Clin. Chim. Acta. 49, 11-17, 1973.

• 38) 澤武紀雄:ポリアクリルアミド電気泳動法γ-GTPアイソザイム分析, 臨床検査 26, 592-599, 1982.

• 39) 澤武紀雄, 千代英夫,服部 信:腫瘍および免疫学的検査 α-Fetoprotein, 消化器外科 3, 1266-1270, 1980.

• 40) Kojima, J., Kanatani, M., Nakamura, N. et al.:Electrophoretic fractionation of serum γ-GTP in human hepatic cancer. Clin. Chim. Acta. 106, 165-172, 1980.

• 41) 澤武紀雄, 若林時夫, 尾崎監治・他:肝細胞癌の腫瘍マーカー, 組み合せ診断能および進行度との 関係を中心に, 癌の臨床29, 672-677, 1983.

• 42) Orlowski, M. and Meister, A.:Isolation of γ-GTP from hog kidney. J. Biol. Chem. 240, 338-347, 1965.

• 43) Toya, D., Sawabu, N., Ozaki, K. et al.:Purification ofγ-GTP from human hepatocellular carcinoma, and comparison with enzyme from kidney., N. Y. Acad. Sci. 417, 86-96, 1984.

• 44) Sawabu, N., Toya, D., Ozaki, K. et al.:Clinical value and some properties of novelγ-GTP isoenzyme specific to sera of hepatocellular carcinoma. Markita, A. et al(ed.) , Gann Monograph on cancer Res., vol. 29, p 291-298, Japan Scientific Societies Press, Tokyo,1983.

• 45) Yamamoto, H., Sumikawa, K., Higashino, K. et al.:γ-GTP from human hepatoma tissue in comparison with normal liver enzyme. Clin. Chim. Acta.111,229-237,1981.

• 46) Selvaraj, P.,Balasubramanian, K. A. and Hill, P. G.:Isolation ofγ-GTPfrom human primary hepatoma and comparison of its kinetic and catalytic properties with the enzyme from normal adult and fetal liver. Enzyme. 26, 57-63, 1981.

• 47) Selvaraj, P. and Balasubramanian, K. A.:Sobuble forms ofγ-GTP in human adult liver, fetal liver, primary hepatoma compared. Clin. Chem. 29, 90-95, 1983.

• 48) Sato, K., Tsuchida, S., Waragai, Z. et al.:Properties of molecular forms ofγ-GTP and uridine diphosphate'glucuronyltransferase as hepatic preneoplastic marker enzymes. Makita, A.,et al(ed) , Gann Monograph on Cancer Res.29, 23-31, Japan Scientific Societies Press,Tokyo, 1983

P.438 掲載の参考文献

• 1) Hayaishi, O. and Uena, K.(eds.):ADP-ribosylation reactions. Academic Press, New York, London. 1982.

• 2) Ueda, K., Kawachi, M., Oka, J. and Hayaishi, O.:In novel ADP-ribosylations of regulatory enzyme and proteins (Smulson, M. E. and Sugimura, T., eds.) . Elsevire/North Holland, New York, 47-56, 1980.

• 3) Tsopanakis, C., Leeson, E., Tsopanakis, A. and Shall, S.:Purification and properties of poly (ADP-ribose) polymerase from pig thymus nuclei. Eur. J. Biochem. 90, 337-345, 1978.
  pubmed

• 4) Hilz, H. and Kittler, M.:On the localization of poly ADP. ribose synthetase in the nucleus. Hoppe-Seyler's Z. Physiol. Chem. 349, 1793-1796, 1968.

• 5) Oikawa, A., Itai, Y., Okuyama, H., Hasegawa, S. and Sugimura, T.:Studies on polymer of adenosine diphosphate ribose:VI. Radioautographic demonstration of incorporation of NAD into nuclear macromolecule. Exp. Cell Res. 57, 154-156, 1969.

• 6) Miwa, M., Sugimura, T., Inui, N. and Takayama, S.:Poly(adenosine diphosphate ribose) synthesis during the cell cycle of transformed hamster lung cells. Cancer Res.33, 1306-1309, 1973.
  pubmed

• 7) Payne, J. F. and Bal, A. K.:Cytological detection of poly(ADP-ribose) polymerase. Exp.cell Res. 99, 428-432, 1976.
  pubmed

• 8) Ikai, K., Ueda, K. and Hayaishi,O.:Immunohistochemical demonstration of poly(adenosine diphosphate-ribose) in nuclei of various rat tissue. J. Histochem. Cytochem. 28, 670-676, 1980.

• 9) Kanai, Y. and Sugimura, T.:Comparative studies on antibodies to poly(ADP-ribose) in rabbits and patients with systemic lupus erythematosus. Immunology.43, 101-110, 1981.
  pubmed

• 10) Fukushima, M., Okayama, H., Takahashi, Y. and Hayaishi, O.:Characterization of the NAD+glycohydrolase associated with the rat liver nuclear envelope. J. Biochem. 80, 167-176, 1976.

• 11) Leiber, U., Kittler, M. and Hilz, H.:Enzymes of poly(ADPR) metabolism in proliferating and nonproliferating liver tissues. Hoppe-Seyler's Z. Physiol 354, 1347-1350, 1973.

• 12) Althaus, F. R., Lawrence, S. D., Sattler , G. L. and Pitot, H. C.:ADP-ribosyltransferase activity in cultured hepatocytes. Interaction with DNA repair. J. Biol. Chem. 257, 5528-5535, 1982.
  pubmed

• 13) Althaus, F. R., Lawrence, S. D., He, Y. Z., Sattler, G. L., Tsukada, Y. and Pitot, H. C.:Effects of altered(ADP-ribose)n metabolism on expression of fetal functions by adult hepatocytes. Nature. 300, 366-368, 982.

• 14) Yoshihara, K.:Complete dependency of poly(ADP-ribose) synthesis on DNA and its inhibition by actinomycin D. Biochem. Biophys. Res. Commun. 47, 119-125, 1972.
  pubmed

• 15) Niedergang, C., Okazaki, H. and Mandel, P.:Properties of purified cell thymus poly(adenosine diphosphate ribose) polymerase:Comparsion of the DNA-independent and the DNA-dependent enzyme. Eur. J. Biochem. 102, 43-57, 1979.

• 16) Benjamin, R. C. and Gill, D. M.:ADP-ribosylation in mammalian cell ghosts. J. Biol. Chem. 255, 10493-10501, 1983.

• 17) Ohgushi, H., Yoshihara, K. and Kamiya, T.:Bovein thymus poly(adenosine diphosphate ribose) polymerase. J. Biol Chem. 225, 6205-6211, 1980.

• 18) Durkacz, B. W., Omidiji,O., Gray, D. A. and Shall, S.:(ADP-ribose) n participate in DNA excision repair. Nature. 283, 593-596, 1980.
  pubmed

• 19) Jacobson, M. K., Levi, V., Juarez-Salinas, H., Barton, R. A. and Jacobson, E. L.:Effect of carcinogenic N-alkyl-N-nitroso compound on nicotinamide adenine dinucleotide metabolism. Cancer Res. 40, 1797-1802, 1980.
  pubmed

• 20) Rankin, P. W., Jacobson, M. K., Mitchell, V. R. and Busbee, D. L:Reduction of nicotinamide adenine dinucleotide by ultimate carcinogen in human lymphocytes. Cancer Res.40, 1803-1807, 1980.
  pubmed

• 21) Creissen, D. and Shall, S.:Regulation of DNA ligase activity by poly(ADP-ribose) . Nature. 296, 271-272, 1982.
  pubmed

• 22) Yamamoto, H., Uchigata, Y. and Okamoto, H.:Streptozotocin and alloxan induced DNA strand breaks and poly(ADP-ribose) synthesis in pancreaticislet. Nature. 294, 284-286, 1981.

• 23) Cayama, E., Tsuda, H.,Sarma, D. S. R. and Farber,E.:Initiation of chemical carcinogenesis requires cell proliferation. Nature. 275, 60-62, 1978.

• 24) Higgins, G. M. and Anderson, R. M.:Experimental pathology of the liver restoration of the white rat following partial surgical removal. Arch. Pathol 12, 186-202, 1931.

• 25) Peraino, C, Fry, R. J. M. and Grube, D. D.:Mechanisms of tumor promoting and carcinogens. In Carcinogenesis(Slaga, T. J., Sivak, A. and Bontwell, R. K., eds) . Raven Press, New York, vol.2, 421-432, 1978.

• 26) Pitot, H. C., Barsness, L, Goldswarthy, T. and Kitagawa, T.:Biochemical characterization of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine. Nature. 271, 456-458, 1978.

• 27) Ito, N., Tatematsu, M., Imaida, K., Hasegawa, R. and Murasaki, G.:Effects of various promotors of the induction of hyperplastic nodules in rat liver. Gann. 71, 415-416, 1980.

• 28) Kitagawa, T.:Histochemical analysis of hyperplastic lesions and hepatomas of liver of rats fed 2-Huorenylacetamide. Gann. 62, 207-216, 1971.
  pubmed

• 29) Solt, D. B., Medline, A. and Farber, E.:Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am. J. Pathol. 88, 595-618, 1977.

• 30) Takahashi, S., Ohnishi, T., Denda, A. and Konishi, Y.:Enhancing effect of 3-aminobenzamide on induction ofγ-glutamyl-transpeptidase positive foci in rat liver. Chem. Biol. Interactions. 39, 363-368, 1982,

P.449 掲載の参考文献

• 1) 沖田 極,竹本忠良:肝細胞癌における腫瘍マーカーの存在. "ウイルス性肝炎から肝細胞癌へ" (服部 信編) ,癌と化学療法社, 東京, 259-273, 1982,

• 2) 安藤啓次郎, 沖田 極・他:肝細胞癌早期診断のためのscreening法の検討-肝細胞癌合併high risk gruop炭定の試み, 肝臓 22, 1162-1169, 1981.

• 3) Kubo, Y. and Shimoyama, Y.:Arterial injection chemotherapy, In "Hepatocellular Carcinoma" (ed. by K. Okuda & R. L.Peters) , A Wiley Medical Publication, New York, 477-490, 1976

• 4) Okita,K.,Farber, E. et al.:Localization of alpha-fetoprotein by immunifluorescence in hyper'plastic nodules during hepatocarcinogenesis induced by 2-acetylaminofluorene. Cancer Res. 34, 2578-2763, 1974.

• 5) Edmondson, H. A. and Steiner, D. E.:Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies. Cancer. 7, 462-503, 1954.

• 6) Thung, S. N., Popper, H. et al.:Distribution of the five antigens in hepatocellular carcinoma. Lab. Invest. 41, 101-105, 1979.
  pubmed

• 7) Okita, K. and Farber, E.:An antigen common to preneoplastic hepatocyte populations and to liver cancer induced by n-2.fluorenylacetamide, ethionine or other hepatocarcinogens. Gann Monogr. Cancer Res.17, 283-299, 1978.

• 8) Okita, K., Farber, E. et al :A new common marker for premalignant hepatocytes inducedin the rat by chemical carcinogens. J. Natl. Cancer Inst.54, 199-202, 1975.

• 9) Lin, J. C., Hiasa, Y. et al.:Preneoplastic antigen as a marker for endoplasmic reticulum ofputative premalignant hepatocytes during liver carcinogenesis. Cancer Res. 37, 1972-1981, 1977.
  pubmed

• 10) Levin, W., Anthony, Y. H. L. et al.:Identification of epoxide hydrolase as the preneoplasticantigen in rat liver hyperplastic nodules. Proc. Natl. Sci. USA.75, 3240-3243, 1978.

• 11) Enomoto, K., Ying, T. S. et al.:Immunohistochemical study of epoxide hydrolase during experimental liver carcinogenesis. Cancer Res. 41, 3281-3287, 1981.
  pubmed

• 12) Novikoff, A. B., Novikoff, P. M. et al.:Immunocytochemical localization of epoxide hydrasein hyperplastic nodules induced in rat liver by 2-acetylaminofluorene. Proc. Natl. Acad. Sci.USA. 76, 5207-5211, 1979.
  pubmed

• 13) Ogino, M., Okita, K et al.:Some bioehemical properties of the preneoplastic antigen in ratliver hyperplastic nodules. Gann, 73, 349-353, 1982.

• 14) Bently, P. and Oesch, F.:Enzymes involved in activation and inactivation of carcinogens and mutagens. In "Primary liver tumors" (ed. by H. Remmer, H. M. Bolt, P. Bannasch and H.Popper) , MTP Press Limited, Lancaster, p.239-252, 1978.

• 15) Okita, K., Noda, K. et al.:Cytochrome p-450 in hyperplastic liver nodules during hepatocarcinogenesis with n-2-fluorenylacetamide in rats. Gann. 67, 899-902, 1976.

• 16) Omura, T. and Sato, R.:The carbon monoxide-binding pigment of liver microsomes.I:evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2391, 1964.
  pubmed

• 17) 佐藤清美:肝前癌性病変の指標酵素-特に薬物代謝系酵素について, Oncologia.1, 103-120, 1982.

• 18) 荻野昌昭, 沖田 極・他:・新しいglutathione S-transferaseの1分子種の精製と発癌過程における意義, 日消誌 81(4) ,印刷中.

• 19) Kalengayi, M. M. R., Ronchi, G. et al.:Histochemistry of a-GTP in rat liver during aflatoxin Bi-induced carcinogenesis. J. Natl Cancer Inst. 55, 579-582, 1975.

• 20) Cameron, R., Kellen, J. et al.:a-GTP in putative premalignant liver cell populations during hepatocarcinogenesis. Cancer Res. 38, 823-829, 1978.

• 21) 野田健一,江崎隆朗・他:ヒト原発性肝癌におけるepoxide hydrolaseの局在について, 肝臓 22, 1613, 1981.

P.456 掲載の参考文献

• 1) Halliday, W.J. and Miller,S.:Leukocyte adherence inhibition:a simple test for cell-mediated tumor immunity and serum blocking factors. Int. J. Cancer. 9, 477-483, 1972.
  pubmed

• 2) Holt, P. J., Roberts, L. M., Fimmel, P. J. and Keast, D.:The LAI microtest:a rapid and sensitive procedure for the demonstration of cell-mediated immunity in vitro. J. Immunol Methods. 8, 277-288, 1975.

• 3) Grosser, N. and Thomson, D. M. P.:Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes. Cancer Res. 35, 2571-2579, 1975.

• 4) Russo, A. J., Nordin, A. A. and Goldrosen, M. H.:Aradio(51Cr) micro-tube leukocyte adherence inhibition assay:specific tumor-associated immunity in the murine tumor systme. J. Immunol. Methods.31,259-269,1979.

• 5) Morizane, T. and Sjogren, H.O.:A leukocyte adherence inhibition(LAI) assay of antitumor immunity in rats using selective radioimmunological assessment of adherence of T lymphocytes and monocytes. Int. J. Cancer.31,803-812,1983.
  pubmed

• 6) Morizane, T., Kumagai, N., Tsuchimoto, K., Watanabe, T. and Tsuchiya, M.:Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay. Cancer Res.40,2928-2934,1980.

• 7) 土屋雅春,森実敏夫, 熊谷直樹,渡辺 哲,土本寛二:Tube LAI assayとRepeated tube LAI assay ,臨床免疫 13,704-714,1981.

• 8) 熊谷直樹, 森実敏夫, 中村達也, 稲垣恭孝, 渡辺 哲, 大家友二, 石井裕正, 土屋雅春:Micro LAI assayを用いた腫瘍特異抗原認識細胞の同定, 消化器と免疫 No.7.医歯薬出版,227-231,1981.

• 9) Halliday, W. J.:Historical background and aspects of the mechanism of leukocyte adherence inhibition. Cancer Res.39,576-581,1980.

• 10) 熊谷直樹,稲垣恭孝, 斉藤英胤, 松村 茂, 川村直見, 中村達也,渡辺 哲,土本寛二, 森実敏夫 夫,石井裕正, 土屋雅春:LAI assayにおける血清因子, 消化器と免疫 No.10.医歯薬出版, 97-101, 1983.

• 11) Thomson, D. M. P. and Grosser, N.:Immunological mechanism of tube leukocyte adherence inhibition. Cancer Res.39,576-581,1979.

• 12) Morizane, T. and Sjogren, H.O.:Detection of different status of immunity to colon cancer in rats by a leukocyte adherence inhibition assay assassing the adherence of T lymphocytes and monocytes selectively. Int. J. Cancer.31,813-816,1983.

• 13) Reisfeld, R. A. and Pellegrino, M. A.:Salt extraction of soluble HL-A Antigens. Science. 172, 1134-1136, 1971.
  pubmed

• 14) Peterson, P. A.,Rask, L. and Lindblom, J. B.:Highly purified papain-slubilized HL-A antigens contain B2-microglobulin. Proc. Nat. Acad. Sci. U.S.A.71,35-39,1974.

• 15) Thomson, D. M. P., Rauch, J. E., Weatherhead, J. C., Friedlander, P.,O'Connor, R., Groosser, N., Shuster, J. and Gold, P.:Isolation of human tumor.specific antigens associated with β2-microglobulin. Br. J. Cancer.37,753-.775,1978.

• 16) 土屋雅春,熊谷直樹,渡辺 哲,土本寛二,森実敏夫:LAIおよびrepeated LAI assayを用いた腫瘍特異抗原の検出, 最新医学 36,894-900,1981.

P.465 掲載の参考文献

• 1) Denk, H., Franke, W. W., Kerjaschki, D. et al.:Mallory bodies in experimental animals and man. Int Rev Exp Path.20,77-121,1979.
  pubmed

• 2) French, S. W.:The Mallory body:Structure, composition and pathogenesis. Hepatol 1,76-83, 1981.

• 3) 中沼安二, 太田五六:Mallory体・「ウイルス肝炎から肝細胞癌へ」服部 信編,癌と化学療法社, p.282-288, 1982.

• 4) Norkin, S. A. and Campagna-Pinto, D.:Cytoplasmic hyaline inclusions in hepatoma-histochemical study.. Arch Path.86,25-32,1968.
  pubmed

• 5) Borenfreund, E., deHarven, E. and Garra, L:Mallory body-like abnormalities in carcinoma induced by cultured transformed rat liver cells. Hepatol.1, 408-415, 1981.

• 6) Meierhenry, E. F., Ruebner, B. H., Gershwin, M. E. et al.:Dieldrin-induced Mallory bodies in hepatic tumors of mice of different strains. Hepatol.3, 90-95, 1983.

• 7) Meierhenry, E. F., Ruebner, B. H., Gershwin, M. E. et al.:Mallory body formation in hepatic nodules of mice ingesting dieldrin. Lab Invest.44, 392-396, 1981.
  pubmed

• 8) Denk, H., Eckerstorfer, R., Gschnait, F. et al.:Experimental induction of hepatocellular hyalin (Mallory bodies) in mice by griseofulvin treatment.1. Light microscopic observations. Lab Invest. 35, 377-382, 1976.
  pubmed

• 9) Borenfreund, E., Higgins, P.J. and Bendich, A.:In vivo-in vitro rat liver carcinogenesis:modification in protein synthesis and ultrastructure. Ann NY Acad Sci. 349, 357-372, 1980.
  pubmed

• 10) Sternberger, L.:Immunohistochemistry. Englewood Cliffs, N J.:Prentice Hall, 1974.

• 11) Taylor, C. R.:An immunohistological study of follicular lymphoma, reticulum cell sarcoma and Hodgkin's disease. Europ J Cancer.12, 61-75, 1976.

• 12) Glenner, G. G., Folk, J. E. and McMillan, P. J.:Histochemical demonstration of a γ-glutamyl transpeptidase-like activity. J Histochem Cytochem. 10, 481-489, 1962.

• 13) Hensen, D. E.:Heterogeneity in tumors. Arch Path Lab Med.106, 597-598, 1982.

肝細胞癌の治療

P.477 掲載の参考文献

• 1) 日本肝癌研究会:臨床・病理原発性肝癌取り扱い規約,金原出版 KK,東京,1983.

• 2) 山崎 晋,長谷川博,幕内雅敏:肝癌の治療2肝癌の外科的治療, 臨床科学 18(7), 806-813, 1982.

• 3) 山崎 晋,幕内雅敏,阿部一九夫・他:細小肝がんに対する肝亜区域切除, 手術 35(10), 1199-1202, 1981.

• 4) 第83回日本外科学会総会シンポジウム「肝癌治療の進歩」大阪,1983年4月.

• 5) 山崎 晋,長谷川博,幕内雅敏:がんの臨床,肝臓癌,治療 64(2),403-407,1982.

• 6) Couinaud, C.:La Segmentation Hepatique in La Foie. p.17, Paris, 1957.

• 7) 小林健一:肝硬変の臨床とその予後, とくに肝細胞癌への進展, ウイルス肝炎から肝細胞癌へ (服 部信・編) p.211, 癌と化学療法社, 東京, 1982.

• 8) 斎藤達雄, 大橋泰彦:肝癌の姑息的治療-抗癌剤療法-,肝胆膵 5(6) ,1177-1182, 1982.

• 9) 岡崎伸生:肝癌最近のトピックス, 化学療法, 内科 52(3) ,482-484, 1983.

• 10) 佐藤守男,山田龍作:肝癌の姑息的治療-動脈塞栓術(TAE)-,肝胆膵 5(6),1169-1175. 1982.

• 11) 岡本英三, 田中信孝,川中若樹・他:肝癌の姑息的治療-肝動脈結紮療法-,肝胆膵 5(6), 1159-1164, 1982.

• 12) 吉田杢介, 神谷岳太郎,川口英弘・他:肝癌の姑息的治療-切除不能肝癌に対する門脈枝結紮術-, 肝胆膵 5(6), 1165-1168, 1982.

P.485 掲載の参考文献

• 1) 日本肝癌研究会:原発性肝癌に関する追跡調査-第5報-,肝臓 23, 675-681,1982.

• 2) 三浦 健・他:原発性肝癌に対する化学療法,癌と化学療法 6,117-129,1979.

• 3) 三浦健・他:体内埋込み式動注ポンプInfusaid-200を用いた動注化学療法と極超短波温熱療法の併用による肝癌の治療, 日癌治学会誌 17,312,1982.

• 4) 沢 靖彦:制癌剤の動脈内one shotによる肝細胞癌の治療,肝臓 20, 852-859, 1979.

• 5) 小山善之:固型がん化学療法直接効果判定基準, "癌化学療法,癌免疫療法の効果判定基準と制癌剤開発"斉藤達雄編,サイエンスフォーラム, p.28, 1981.

• 6) 久保保彦・他:肝癌の化学療法における効果判定の問題点,癌の臨床 26, 675-677, 1980.

• 7) 真島康雄・他:肝細胞癌の発育速度,肝臓 24, 677, 1983.

• 8) 亀田治男:肝細胞癌長期生存例の検討,集計結果,肝細胞癌,亀田治男編,中外医学社,p.1-30, 1983.

• 9) Kubo, Y. et al.:Intra-arterial FAM treatment in patients with hepatocellular carcinoma. "Proc. int. workshop for chemotherapy on hepatic tumors" p.18, 1982.

• 10) 永末直文・他:切除不能原発性肝癌に対する治療方針と成績,肝臓 20, 209, 1979.

• 11) 三浦 健・他:肝癌の化学療法,臨床成人病 10, 995, 1980.

• 12) 平井賢治・他:Adriamycin による肝細胞癌の治療,癌と化学療法 8, 1264-1269, 1981.
  Medical*Online

• 13) 江里口直文:肝細胞癌の化学療法による組織学的変化に関する研究, 肝臓 20, 1071-1083, 1979.

• 14) Kato, T. et al.:Arterial chemoembolization with microencapsulated anticancer drug. JAMA. 245, 1123-1127, 1981.
  pubmed

P.495 掲載の参考文献

• 1) 貫野徹,門奈丈之,丸毛俊明・他:肝細胞癌に対する動脈塞栓法と抗癌剤one shot動注法の治療効果の比較検討, 肝臓 23, 622-628, 1982.

• 2) 木村道雄,大藤正雄,土屋幸浩・他:肝癌に対する肝動脈塞栓療法とその評価-単独塞栓療法と肝動脈内制癌剤one shot注入療法との比較による検討-,日消誌 80,68-75,1983.

• 3) 栗岡成人, 仲島信也,岡 博子・他:肝動脈塞栓術による原発性肝癌の超音波像の経時的変化, 肝蔵 23, 413-419, 1982.

• 4) 肝細胞癌60例に対する抗癌剤併用 transcatheter arterial embolization-血管像による検討-, 日医放会誌 41, 742-750, 1981.

• 5) 大石 元,大上庄一,居出弘一・他:肝細胞癌に対する肝動脈塞栓術後のCTによる効果判定,肝臓 22, 1569-1576, 1981.

• 6) 奥田邦雄・他:原発性肝癌症例に関する追跡調査 第4報-,肝臓 20, 433-441, 1979.

• 7) 石井勝:肝細胞癌におけるTumor marker I. AFP.「ウイルス肝炎から肝細胞癌へ」服部信 編,癌と化学療法社,東京,p. 237-248, 1982.

• 8) 松本由朗,麻田 勇,鈴木 敞・他:血中AFP動態からみたHepatomaの臨床分類-AFPによるHepatomaの早期診断のための基礎的研究-,肝臓 18, 847-855, 1977.

• 9) 秦 温信,品田佳秀,佐藤光一・他:肝癌切除の予後と血清AFP半減期,日癌治 16, 112-113, 1981.

• 10) 飯田修平,都築俊治:腫瘍マーカーによる肝細胞癌の診断と治療効果判定-実験的ならびに臨床的研究 ,日癌治 16, 113-115, 1981.

• 11) Breedis, C. and Young, G.:The blood supply of neoplasms in the hver. Am. J. Path.30, 969-986, 1954.

• 12) 山龍作,中塚春樹,中村健治・他:肝細胞癌に対するtranscatheter arterial embolization therapyの有用性と肝機能に及ぼす影響,日消誌 78, 214-221, 1981.

• 13) 佐藤守男,山田龍作:肝癌の姑息的治療-動脈塞栓療法(TAE)-,肝胆膵 5, 1169-1175, 1982.

• 14) 高島澄夫,中塚春樹,中村健治・他:肝細胞癌に対するtranscatheter arterial embolization予後不良例の検討 ,日消誌 80, 1623-163,1983.

• 15) 中塚春樹:ゼラチンスポンジの動脈内注入による非観血的抗腫瘍療法に関する基礎的,臨床的検討, 阪市医誌 28, 191-223,1979.

• 16) 貫野 徹,門奈丈之,針原重義・他:肝細胞癌に対する肝動脈塞栓術施行中の動脈性側副血行路形成について -2症例の検討- ,日消誌 80, 232-236, 1983.

• 17) Karnofsky, D. A.:Clinical evaluation of anticancer drugs, cancer chemotherapy. Gann Monograph.2, 223-234, 1967.

• 18) 向島達,長谷川博,服部信:手術患者におけるα1 Fetoglobulinの減少率とその予後,医学のあゆみ 75, 485-486, 1970.

• 19) 田中信孝,岡本英三,桑田圭司・他:切除不能肝癌に対する治療,日消誌 79, 1651, 1982.

P.505 掲載の参考文献

• 1) 岡村 純,堀川真一,門田守人・他:肝癌の治療1,経カテーテル制癌剤動注兼塞栓療法(化学・塞栓療法)-transcatheter chemo-embolization-臨床科学 18, 796-805, 1982.

• 2) 厚生省がん研究助成金,計画研究, 第15班:肝癌に対する集学的治療-Embolization を併用した肝切除の検討-,肝胆膵 5, 1195-1200, 1982.

• 3) 山田龍作,中塚春樹,中村健治・他:肝細胞癌に対するtranscatheter arterial embolization therapyの有用性と肝機能に及ぼす影響,日消誌 78, 214-221, 1981.

• 4) Ozawa, K.:Biological significance of mitochondrial redox potential in shock and multiple organ failure Redox theory. In:Molecular and Cellular Aspects of Shock and Trauma. Alan, R. Liss, Inc., New York, p.39-66, 1983.

• 5) Tani, T., Ozawa, K., Taki, Y. et al.:Short-term changes in blood hetone body ratios in the phase immediately after hepatic artery embolization. Am. J. Clin. Sci. in press.

• 6) Asano, M., Ozawa, K. and Tobe, T.:Postoperative prognosis as related to blood ketone body ratios in hepatectomized patients. Eur. Surg. Res. 15, 302-311, 1983.
  pubmed

• 7) Ozawa, K., Aoyama, H., Yasuda, K. et al.:Metabolic abnormalities associated with post-operative organ failure-Redox theory-. Arch. Surg. 118, 1245-1251, 1983.

• 8) Michels, N. A.:Newer anatomy of the liver and its variant blood supply and collateral circulation. Am. J. Surg.112, 337-347, 1966.
  pubmed

• 9) Michels, N. A.:Collateral arterial pathways to the liver after ligation of the hepatic artery and removal of the celiac axis. Cancer. 6, 708-724, 1953.

• 10) Koehler, R. E.,Korobkin, M. and Lewis, F.:Arteriographic demonstration of collateral arterial supply to the liver after hepatic artery ligation. Radiology. 117,49-54, 1975.

• 11) 中島敏郎,神代正道,坂本和義・他:原発性肝癌に関する研究,第1報, 原発性肝細胞癌の新しい肉眼分類, 肝臓 15, 279-291, 1974.

• 12) Nakashima, T. and Sakamoto, K.:A study of hepatocellular carcinoma among Japanese from the ponit of view of morphodevelopmental pathology. Gross anatomical types classified in its relation to capsule formation. Kurume Med. J.24, Suppl., S43-S62,1977.

• 13) 岡部正之:原発性肝癌の病理形態学的研究-肝細胞癌における癌結節の被膜ならびに隔壁の形成機転について, 肝臓 20,144-155, 1979.

P.518 掲載の参考文献

• 1) 岡本英三, 豊坂昭弘, 田中信孝:硬変合併肝癌の治療方針, 消化器外科 6, 1703-1709, 1983.

• 2) 岡本英三, 山中若樹, 京 明雄:CTによる肝切除限界の予測, 消化器外科 4, 1373-1378, 1981.

• 3) 山中若樹, 岡本英三:重回帰分析を用いた肝切除の適応判定, 日外会誌 84, 126-133, 1983.

• 4) 京 明雄, 岡本英三, 豊坂昭弘, 植木重文, 田中信孝, 山中若樹:硬変合併肝癌における肝切除限界の術前予測について, 日消外会誌 13,90-94, 1980.

• 5) 長谷川 博, 山崎 晋, 幕内雅敏:硬変合併肝癌に対する肝切除例の術前, 術中, 術後管理, 消化器外科 6, 1719-1724, 1983.

• 6) 河野信博, 長尾 桓, 菅原克彦:硬変併存肝癌に対する肝切除の適応決定, 日消外誌 13,95-100,1980.

• 7) 岡本英三, 豊坂昭弘, 田中信孝:肝葉切除をめぐる諸問題, 日外会誌 84,172-176,1983.

• 8) Foster, J. H. and Berman, M. M.:Primary epitherial cancer in adults. Solid Liver Tumors, p-62-104, W. B. Saunders. Co, Philadelphia, 1977.

• 9) 藤巻茂夫:肝臓.赤崎兼義編,病理学各論I,南山堂,東京,p.347, 1964.

• 10) 吉田富三:肝臓,吉田富三,武田勝男編,病理学各論,中巻,第3版,南山堂,東京,p.218-219, 1961.

• 11) Anthony, P. P., Vogel, C. L. and Baker, L. F.:Liver cell dysplasia:a premalignant condition. J. Clin Pathol 26, 217-223, 1973.

• 12) 奥平雅彦,佐々木憲一:原発性肝癌は多中心性発生か,肝胆膵 5, 933-937, 1982.

• 13) Shanmugaratnam, K.:Primary carcinoma of the liver and Biliary tract. Br. J. Cancer. 10, 232, 1963.

• 14) MacDonald, R. A.:Cirrhosis and primary carcinoma of liver:Changes in their occurrence at the Boston City Hospital. New Engl. J. Med. 225, 1179, 1956.

• 15) Ying YUen-Ying, et al.:Primary carcinoma of liver special reference to histogenesis and its relationship to liver cirrhosis. Chinese Medical Journal 82, 279, 1963.

• 16) Patton, R. B. and Horn, R. C. Jr.:Primary liver carcinoma, Autopsy study of 60 cases. Cancer. 17, 757, 1964.
  pubmed

• 17) 貴家学:東大病理教室における原発性肝癌110例の統計的研究, 附, 原発性肝癌における副枝血行 に就て. 癌 23, 341, 1929.

• 18) Gastafson, E. G.:An analysis of 62 cases of primary carcinoma of the liver based on 24,400 necropsies at Bellevue Hospital Ann. Int. Med. 11, 889, 1937.

• 19) Edmondson, H. A. and Steiner, P. E.:Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer.7,462, 1954.
  pubmed

• 20) Cruickshank, A. H.:The pathology of 111 cases of primary hepatic malignancy collected in the Liverpool region. J. Clin. Path. 14, 120, 1961.
  pubmed

• 21) 山崎 晋,長谷川博, 幕内雅敏:直径5cm以下の細小肝癌23切除例の検討. 日外会誌 81, 129, 1981.

• 22) 本庄一夫, 鈴木 敵:肝癌に対する門脈右枝又は左枝結紮術. 癌の臨床 16, 567-573, 1970.

• 23) 桑尾定明:原発性肝癌の病理組織学的研究, 肝細胞癌の肝内血管系における腫瘍血栓について. 肝臓, 20, 828-838, 1979.

• 24) 倉富晋太郎:肝細胞癌の病理形態学的研究. 血管構築よりみた進行性肝癌並びに血管内腫瘍血栓の 病理, 肝臓 17, 517-527, 1976.

• 25) 日本肝癌研究会:原発性肝癌に関する追跡調査, -第4報-,肝臓 20, 433-441, 1979.

• 26) Okuda, K.:The liver cancer study group of Japan:Primary liver cancers in Japan. Cancer. 45, 2663, 1980.

• 27) 菅原克彦:原発性肝癌切除成績とその向上への歩み,日外会誌 82, 1127, 1981.

• 28) 山崎 晋:細小肝癌に対する肝亜区域切除, 手術 35, 1199-1202, 1981.

P.524 掲載の参考文献

• 1) Yabrov, A. A.:Interferon:Anticancer agent having multifarious activity. In:Progress in Clinical Cancer, Edited by Ariel IM, Grure & Stratton, New York, p.99-145,1982.

• 2) Hovanessian, A. G. and Wood, J. N.:Anticellular and anticellular effects of pppA (2'p5'A)n. Virology. 101, 81-90, 1980.
  pubmed

• 3) Borden, E. C., Hogan, T. F. and Voelkel, J. G.:Comparative antiproliferative activity in vitro of natural interferons α and β for diploid and transformed human cells. Cancer Res.42, 4948-4953, 1982.

• 4) Fleischmann, W. R. Jr.:Potentiation of the direct anticellular activity of mouse interferons:Mutual synergism and interferon concentration dependence. Cancer Res. 42, 869-875, 1982.
  pubmed

• 5) 石原和之:Human fibroblast interferon(Hu IFN-β) による皮膚悪性腫瘍に対する臨床的研究. 局所投与を中心とした検討. J. Jpn. Soc. Cancer Ther.18(1), 41-53, 1983.

• 6) 江崎幸治, 小川一誠:診断と治療 71(1), 180-184, 1983.

• 7) Brechot, C., Pourel, C., Louise, A. et al.:Presense of integrated hepatitis B virus DNA seguences in cellular DNA of human hepatocellular carcinoma. Nature. 286, 533-535, 1980.米原 伸:インターフェロンのレセプター. 医学のあゆみ 125(1), 1-9,1983.

• 8) 樋上義伸,平井信行,池田 正・他:ヒト肝細胞癌由来培養細胞に対するヒト腺芽細胞インターフェロンの効果.肝臓 22(8), 1194, 1981.

• 10) Louie, B. A. C., Gallagher, J. G., Sikora, K. et al.;Follow-up observations of the effect of human leukocyte interferon in non-Hodgkin's lymphoma. Blood. 58, 712-718, 1981.

• 11) 元雄良治,岡井高,鵜浦雅志・他:.インターフェロンが有効であった著明な肝転移を伴う直腸カルテノイドの1例.日本消化器病学会誌 80(8) ,1646-1650, 1983.

• 12) Leandersson, T. and Lundgren, E.:Antiproliferative effect of interferon on a Burkitt's lymphoma cell line. Exp Cell Res. 130, 421-426, 1980.
  pubmed

肝細胞癌切除と肝予備能

P.534 掲載の参考文献

• 1) Honjo,I. and Mizumoto, R.:Primary carcinoma of the liver. Am. J. Surg. 128, 31-36, 1974.
  pubmed

• 2) Healey, J. E. and Schroy, P. C.:Anatomy of the biliary ducts within the human liver. Arch. Surg. 66, 599-616, 1953.
  pubmed

• 3) 水本龍二,大沢二郎,河野有朋・他:肝硬変を合併せる原発性肝癌の手術可能限界.最新医学 27, 553-556, 1972.

• 4) 0wren, P. A.:Normotest in liver diseases. Farmakoterapie. 25, 46-59, 1969.

• 5) 小沢和恵,武田博士:肝障害.外科治療 31, 612-618, 1974.

• 6) Moody, F. G., Rikkers, L. F. and Aldrete,I. S.:Estimation of the functional reserve of humanliver. Ann. Surg. 180, 592-598, 1974.

• 7) 武藤泰敏,高橋善弥太:肝胆道疾患における血漿Lecithin Cholesterol Acyltransferase(LCA) の測定とその臨床的意義.肝臓 12, 630-637, 1971.

• 8) 水本龍二,野口孝:肝機能予備力と手術危険度 肝臓外科 .肝胆膵3, 887-895, 1981.

• 9) Mizumoto, R., Kawarada, Y. and Noguchi, T.:Preoperative estimation of operative risk in liver surgery, with special referece to functional reserve of remnant liver following major hepaticresection. Jpn. J. Surg.9, 343-349, 1979.

肝細胞癌切除後長期生存例の検討

P.544 掲載の参考文献

• 1) 村上文夫, 岡村 純,大城 孟・他:肝疾患の外科治療法, 診療 23, 265-277, 1970.

• 2) 石川浩一, 小坂淳夫:原発性肝癌切除例の手術成績,肝臓 14, 409-410, 1973.

• 3) 石川浩一:原発性肝癌に関する追跡調査 第3報. 肝臓 17, 460-465, 1976.

• 4) 日本肝癌研究会:原発性肝癌に関する追跡調査 第4報. 肝臓 20, 433-441,1979.

• 5) 日本肝癌研究会:原発性肝癌に関する追跡調査 第5報-. 肝臓 23, 675-681, 1982.

• 6) Ochsner, J. L, Meyers, B. E. and Ochsner, A.:Hepatic Lobectomy, Amer. J. Surg.121, 273-282, 1971.
  pubmed

• 7) Fortner, J. G., Kim, D. K., Maclean, B. J. et al.:Major hepatic resection for neoplasma:personal experience in 108 patients, Ann. Surg.188, 363-369, 1978.

• 8) Raynor, A. C., Fitts, C. T. and Henninger, G. R.:Long-term survival after massive liver resection for hepatocellular carcinoma. Southern Med. J.67, 977-980, 1974.

• 9) 葛西洋一,玉置 明:早期肝癌の手術.外科診療 18, 1177-1183, 1976.

• 10) 葛西洋一,佐々木英制:問題となる癌の治療の実際.肝癌.Medicina. 14,1139-1141, 1977.

• 11) Ong, G. B. and Chan, P. K. W.:Primary liver cancer. Surg. Gynec. Obster. 143, 31-38, 1976.

• 12) 金 清一,高三秀成,有井滋樹・他:切除し得た肝細胞性肝癌30例の病理組織学的研究 特に予後因子について .肝臓 20, 284-290, 1979.

• 13) 菅原克彦,梅田裕:肝癌の切除療法 切除成績 肝胆膵5, 1131-1137, 1982.

• 14) 高崎 健,武藤晴臣,原田瑞也・他:切除しえた原発性肝癌60例の予後の検討.肝臓 23, 159-164, 1982.

• 15) Wu, M., Han, C. and Xiaohua, Z.:Primary hepatic carcinoma resections over 18 years. Chinese Medical Journal. 93, 723-728, 1980.

• 16) Adson, M. and Weiland, L. H.:Resection of primary solid hepatic tumors. Amer. J. Surg. 141, 18-21, 1981.
  pubmed

• 17) Iwatsuki, S., Byers, W., Starzl, T. E. et al.:Experience with 150 liver resections. Ann. Surg.197, 247-253, 1983.

• 18) Thompson, H. H., Tompkins, R. K., Longmire, W. P. Jr. et, al.:Major hepatic resections. A 25 year experience. Ann. Surg. 197, 375-388, 1983.

• 19) 都築俊治:肝癌の術後成績,日医会誌 90, 79-87, 1983.

• 20) 金清一,高三秀成,有井滋樹・他:切除しえた肝細胞性肝癌36例の予後因子-とくに切除断端と肝内転移について.医学のあゆみ 112, 670-672, 1980.

• 21) 山口国太郎,倉恒宏正,小路敏彦・他:肝癌の内科的治療.臨床と研究 50, 1683-1687, 1973.
  Medical*Online

• 22) Tull, J. C.:Primary carcinoma of the Iiver:A study of 135 cases. J. Pathol. Bacteriol.35, 557-562, 1932.

• 23) Inouye, A. A. and Whelan, T. J.:Primary liver cancer:A review of 205 cases in Hawaii. Amer. J. Surg. 138, 53-61, 1979.
  pubmed

• 24) Lieber, C. S., Seitz, H. K, Garro, A. J. et al.:Alcohol-related diseases and carcinogenesis. Cancer Res.39, 2863-2886, 1979.
  pubmed

• 25) Cochrane, A. M. G., Murray-Lyon,I. M., Brinkley, D. M. et al.:Quadruple chemotherapy versus radiotherapy in the treatment of primary hepatocellular carcinoma. Cancer, 40, 609-614, 1977.

• 26) Johnson, P. F., William, R., Thomas, H, et al.:Induction of remission in hepatocellular carcinoma with doxorubicin. Lancet.1, 1006-1009, 1978.

• 27) 西岡幹男,西村秀男,原田俊則・他:長期間生存した原発性肝癌患者の臨床的検討,肝臓 18, 548-553, 1977.

• 28) 沢 端彦:制癌剤の肝動脈内one shotによる肝細胞癌の治療.肝臓 20, 852-860, 1979.

• 29) 山田竜作,貫野徹,井本正己・他:肝細胞癌に対する動脈塞栓療法施行例の予後に及ぼす因子の検討.肝臓 22, 1577-1582, 1981.

• 30) 亀田治男編:肝細胞癌, 長期生存例の検討.中外医学社, 東京,1983.

細小肝細胞癌

P.561 掲載の参考文献

• 1) 石川浩一:原発性肝癌症例に関する追跡調査-第3報.肝臓 17,460-465, 1976.

• 2) 日本肝癌研究会:原発性肝癌取扱い規約(案), 第17回肝癌研究会にて配布. 1981年6月.

• 3) 山崎 晋,長谷川博, 幕内雅敏:細小肝癌の臨床病理学的分析と,それぞれにもとつく新しい概念の切除法 -27切除例の検討.肝臓 22, 1714-1723, 1981.

• 4) 岡崎伸生:肝細胞癌の臨床,ウイルス肝炎から肝細胞癌へ(服部 信編集) .癌と化学療法社, 355-363, 1982.

• 5) Okuda, K., Nakashima, T., Obata, H. et al.:Clinicopathological studies of minute hepatocellular carcinoma. Gastroenterology. 73, 109-115, 1977.
  pubmed

• 6) 神代正道,中島敏郎:細小肝癌の病理学的研究 -切除例と剖検例の比較検討.日消誌,予報集 (第24回日消会,秋季大会,山形) ,p. 129, 1982.

• 7) Child, C. G. and Turcotte, J. G.:The liver and portal hypertension. Surgery and Portal Hypertension, ed. by Child, C. G., Chap.1, Saunders, Philadelphia, 1964.

• 8) Watanabe, A. and Nagashima, H.:Altered dynamics of alphafetoprotein production following pyridoxine and adenosine 5'-triphosphate administration to cirrhotic patients with or without primary hepatomas and to liver-injured and hepatoma-bearing rats. Oncodevelop. Biol. Med. 2, 313-321, 1981.
  pubmed

• 9) 山崎 晋,長谷川博,幕内雅敏:肝癌の外科的治療.臨床科学 18, 806-813, 1982.

• 10) 竹内利男, 池田健次, 熊田博光・他:細小肝癌における治療の選択. 日消誌 80 (臨時増刊) ,p. 440, 1983.

• 11) 山崎 晋, 幕内雅敏, 阿部一九夫・他:細小肝がんに対する肝亜区域切除.手術 35, 1199-1202, 1981.

• 12) 横田 峻, 河野幸裕,奈良政信・他:肝手術と肝網内系.日消外誌 13, 933-938, 1980.

• 13) 小林敏生, 大藤正雄,炭田正俊・他:小肝細胞癌の病態と治療,とくに肝動脈塞栓療法の有用性について.日消誌 80(臨時増刊) ,p.429, 1983.

• 14) 山田龍作, 中村健治:Transcatheter arterial embolization therapy.日本臨床 40, 183-190, 1982.
  Medical*Online

• 15) 山崎 晋, 長谷川博,幕内雅敏:肝癌の病態別術後生存率からみた肝切除適応.日消誌 80(臨時増刊) , p.434, 1983.

• 16) 中塚春樹,山田龍作:微少肝癌に対するtranscatheter arterial embolization.日消誌(第24回日消会 秋季大会, 予報集) ,p.135, 1982.

日本肝癌研究会全国アンケート集計成績

P.569 掲載の参考文献

• 1) 村上文夫,岡村 純,大城 孟・他:肝疾患の外科的治療法. 診療 23, 265-277, 1970.

• 2) 石川浩一,小坂淳夫:原発性肝癌切除例の手術成績.肝臓 14, 409-410, 1973.

• 3) 石川浩一:原発性肝癌症例に関する追跡調査.肝臓 17, 460-465, 1976.

• 4) 日本肝癌研究会:原発性肝癌症例に関する追跡調査.肝臓 20, 433-440, 1979.

• 5) 日本肝癌研究会:原発性肝癌に関する追跡調査.肝臓 23, 675-681, 1982.

• 6) Eggel, H.;Uber das primar carcinoma der Leber. Beiter Pathol Anat. 30, 506-604, 1901.

肝細胞癌化学療法の効果判定基準

P.576 掲載の参考文献

• 1) Karnofsky, D. A.:Meaningful clinical classification of therapeutic response to anticancer drugs. Clin. Pharmacol. There. 2, 709-712, 1961.
  pubmed

• 2) 山形敞一:癌化学療法の効果判定基準, 日癌治 2, 26-29, 1969.

• 3) 日本製薬工業協会:制癌剤の臨床効果判定に関する文献的考察,癌と化学療法 6, 855-860, 1979.
  Medical*Online

• 4) WHO, WHO handbook for reporting results of cancer treatment, Geneva, WHO, 1979.

• 5) 小山善之:固形がん化学療法直接効果判定基準,斉藤達雄編:癌化学療法・癌免疫療法の効果判定

• 6) Melia, W. M., Johnson, P. J. and Williams, R.:Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with Adriamycin. Cancer. 51, 206-210, 1983.
  pubmed

• 7) 岡崎伸生:触診による肝癌の腫瘍効果の判定,癌の臨床 26, 668-674, 1980.

• 8) 久保保彦・長崎嘉和・阿部正秀・他:肝癌の化学療法における効果判定の問題点,癌の臨床 26, 675-677, 1980.

• 9) 亀田治男:肝細胞癌長期生存例の検討,中外医学社,東京, 1983.

• 10) 岡崎伸生:肝癌における効果判定,斉藤達雄編:癌化学療法免疫療法の効果判定基準と制癌剤開発, サイエンスフォーラム,東京,p.154-161, 1981.

• 11) 斉藤達雄:固形がん化学療法効果増強の判定基準.斉藤達雄編:癌化学療法・癌免疫療法の効果判定基準と制癌剤開発.サイエンスフォーラム.東京, p.40-47, 1981.

• 12) Okazaki, N.:Systemic chemotherapy of hepatocellular carcinoma, Hepatocellular Carcinoma (Okuda & Peters Ed). John Wiley & Sons:p.469-475, 1976.

• 13) Vogel, C. L., Boyley, A. C., Brooker, R. J. et al.:A phace H study of adriamycin(NSC 123127) in patient with hepatocellular carcinoma from Zambia and the United states, Cancer. 39, 1923-1929, 1977.

• 14) Falkson, G., Moertel, C. G., Brooker, R. J. et'it.:Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial. Cancer. 42, 2149-2156, 1978.

• 15) Olweny, C. L. M., Katongole-Mbidde, E., Bahendeka, S. et al.:Further experience in treating patients with hepatocellular carcinoma in Uganda. Cancer., 46, 2717-2722, 1980. 基準と制癌剤開発. サイエンスフォーラム. 東京,p.28-39,1981.

肝細胞癌のリンパ節

P.589 掲載の参考文献

• 1) Hass, H.:Die Architektur der Lymphgefaβe der Leberkapsl in Ihren Beziehungen zur Binddegewebsstruktur und Flussigkeitsstromung. Virchows Arch Path Anat. 279, 384-403, 1936.

• 2) 釣スミ子:肝とリンパ系.脈管学 18, 233-238, 1978.

• 3) 怱那将愛:日本人のリンパ系解剖学, 東京, 金原出版.p.22-23, 1968.

• 4) 日本肝癌研究会:原発性肝癌取扱い規約, 金原出版, 東京, 1983.

• 5) 日本肝癌研究会:原発性肝癌に関する追跡調査-第5報-,肝臓 23, 675-681, 1982.

• 6) 日本肝癌研究会:第6回全国原発性肝癌追跡調査報告.

モノクローナル抗腫瘍抗体の作製とその応用

P.604 掲載の参考文献

• 1) Wakabayashi, S., Taniguchi, M., Tokuhisa, T., Tomioka, H. and Okamoto, S.:Cytotoxic T lymphocytes induced by syngeneic mouse melanoma cells recognize human melanomas. Nature. 294, 748-750, 1981.
  pubmed

• 2) Okada, Y.:Analysis of giant polynuclear cell formation caused by HVJ virus from Ehrlich's ascites tumor cells. Exp. Cell Res. 26, 98-128, 1982.

• 3) Kohler, G. and Milstein, C.:Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256, 495-497, 1975.
  pubmed

• 4) Hakomori, S. and Murakami, W.T.:Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines. Proc. Natl. Acad. Sci.59, 254-261, 1968.
  pubmed

• 5) Meezan, E.,Wu, H. C., Black, P. H. and Robbins, P. W.:Comparative studies on the carbohydrate-containing membrane components of normal and virus. transformed mouse fibroblasts. Biochemistry.8, 2518-2524, 1969.
  pubmed

• 6) Brady, R.O., Borek, C. and Bardley, R. M.;Composition and synthesis of gangliosides in rat hetatocyte and hepatoma cell lines. J. Bio. Chem. 244, 6552-6554, 1969.

• 7) Nakahara, K., Ohashi, T. and Oda, T.:Asialo GMI as a cell-surface marker detected ill acute lymphoblastic leukemia. New Engl. J. Med. 302, 674-677, 1980.

• 8) Young, W. W., Macdonald, E. M. S., Nowinski, R. C. and Hakomori, S.:Production of monoclonal antibodies specific for two distinct steric proteins of the glycolipid ganglio-Ntriosy-lceramide(asialo GM2). J. Exp. Med. 150, 1008-1019, 1979.

• 9) Breimer, M. E.:Adaption of mass sectrometry for the analysis of timor antigens as applied to blood group glycolipids of a human gastic carcinoma. Cancer Res. 40, 897-908, 1980.

• 10) Gahmberg, C. G. and Hakomori, S.:Altered growth behavior of malignant cells associated with changes in extrenally labeled glycoprotein and glycolipid. Proc. Natl. Acad. Sci.70, 3329-3333, 1973.
  pubmed

• 11) Sekiguchi, K. and Hakomori, S.:Functional domain structure of fibronectin. Proc. Natl. Acad. Sci. 77, 2661-2665, 1980.
  pubmed

• 12) Buck, C. A., Glick, M. C. and Warren, L.:Glycopeptides from the surface of control and virus-transformed cells. Science. 172, 169-171, 1971.
  pubmed

• 13) Warren, L.,Fuhrer, J. P. and Buck, C. A.:Surface glycoproteins of normal and transformed cells:A difference determined by sialic acid and a growth. dependent sialyl transferase. Proc. Natl Acad. Sci. 69, 1838-1842, 1972.

• 14) Ogata, S., Muramatsu, T. and Kobata, A.:New structural characteristic of the large glycopeptides from transformed cells. Nature. 259, 580-582, 1976.
  pubmed

• 15) Takasaki, S., Ikehara, H. and Kobata, A.:Increase of asparagine-linked oligosaccharides with branched outer chains caused by cell transformation. Biochem. Biophys. Res. Commun. 92, 735-742, 1980.

• 16) Koyama, K., Nudelman, E., Fukuda, M. and Hakomori, S.:Correlation of glycosylation in a membrane protein with a molecular weight of 150,000 with tumorigenic property of rat fibrosarcoma variants. Cancer Res. 39, 3677-3682, 1979.

癌の増殖促進因子

P.612 掲載の参考文献

• 1) 吉竹佳乃, 足達綱三郎,山田幸生・他:培養細胞と増殖因子. 代謝 19, 33-40, 1982.

• 2) Gospodarowicz, D. and Moran, J. S.:Growth factors in mammarian cell culture. Ann Rev. Biochem. 45, 531-558, 1976.

• 3) Gospodarowicz, D.:Growth factors for animal cells in culture. Lymphokines. 4, 1-33, 1981.

• 4) 久留 勝, 神前五郎:悪性腫瘍より分離された増殖促進物質について, 癌の臨床 7, 70-81,1961.

• 5) 西川克三, 長尾嘉信, 山田幸生:ガン細胞と増殖因子, 組織培養 8, 39-45, 1982.

• 6) Nair, B. K. and DeOme, K. B.:A growth-stimulating factor from solid mouse mammary tumors. Cancer Res. 33, 3222-3226, 1973.

• 7) Folkman, J.:Tumor angiogenesis, in Cancer(Becker, F. F. ed.) , Plenum Publishing Co., New York, Vol.3, 173-180, 1976.

• 8) Ausprunk, D. H. and Folkman, J.:Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res.14, 53-65, 1977.
  pubmed

• 9) 西川克三, 長尾嘉信:Tumor angiogenesis factor, 細胞成長因子(日本組織培養学会編), 朝倉書店, 印刷中.

• 10) Shields, R.:Growth factors for tumors. Nature. 272, 670-671, 1978.
  pubmed

• 11) Nishikawa, K.:Intracellular DNA synthesis factor from rat Rhodamine fibrosarcoma. Biochem Int. 4, 169-175, 1982.

• 12) Yoshitake, Y., Nishikawa, K. and Adachi, K.:DNA synthesis-stimulating activities for BALB/3T3 cells present in histone and nonhistone protein fractions from rat Rhodamine fibrosarcoma. Cell Struc. Func. 7, 229-243, 1982.

• 13) 吉竹佳乃, 足達綱三郎, 西川克三:がん細胞の細胞内増殖因子, 生体の科学 33, 396-401, 1982.

• 14) Sporn, M. B. and Todaro, G. J.:Autocrine secretion and malignant transformation of cells. New Engl. J. Med. 303, 878-880, 1980.
  pubmed

• 15) Kaplan, P. L, Anderson, M. and Ozanne, B.:Transforming growth factor(s) production enables cells to grow in the absence of serum:An autocrine system. Proc. Natl. Acad. Sci. USA. 79, 485-489, 1082.

• 16) Richmond, A., Lawson, D. H., Nixon, D. W. et al.:Extraction of a melanoma growth stimulatory activity from culture medium conditioned by the HsO294 human melanoma cell line. Cancer Res. 43, 2106-2112, 1983.
  pubmed

• 17) Nishikawa, K. and Okitsu, C.:Control of BALB/3T3 growth by factors present in tumor extract. in Control of Proliferation in Animal Cells(Sato, G. and Ross, R. ed.), Cold Spring Harbor Press, New York, Vol.6, 441-452, 1979.

• 18) Gospodarowicz, D.:Purification of a fibroblast growth factor from bovine pituitary. J. Biol.Chem. 250, 2515-2520, 1975.
  pubmed

• 19) Nishikawa, K., Yoshitake, Y., Okitsu, C. et al.:Growth factors localized in tumor nuclei. in Control Mechanisms in Animal Cells (Jimenez de Asua, L. et al. ed.), Raven Press, New York, 279-284, 1980.

• 20) DeLarco, J. E. and Todaro, G. J.:Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. USA. 74, 4001-4005, 1978.

• 21) Todaro, G. J., Fryling, C. and DeLarco, J. E.:Transforming growth factors produced bycertain human tumor cells. Proc. Natl. Acad. Sci. USA. 77, 5258-5262, 1980.

• 22) Roberts, A. B., Lamb, L. C., Newton, D. L. et al.:Transforming growth factors:Isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc.Natl. Acad. Sci. USA. 77, 3494-3498, 1980.
  pubmed

• 23) Maciag, T.:Transforming growth factors. Trends Biochem. Sci.8, 265, 1983.

• 24) Marquardt, H., Hunkapiller, M. W., Hood, L, E. et al.:Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells:Amino acid sequence homology with epidermal growth factor. Proc. Natl. Acad. Sci. USA. 80, 4684-4688, 1983.
  pubmed

• 25) Gregory, H.:Isolation and structure of urogastrone and its relationship to epidermal growthfactor. Nature. 257, 325-327, 1975.

• 26) Roberts, A. B., Anzano, M. A., Lamb, L. C. et al.:Isolation from murine sarcoma cellsof novel transforming growth factors potentiated by EGF. Nature. 295, 417-419, 1982.

• 27) Roberts, A. B.,Anzano, M. A., Lamb, L. C. et al.:New class of transforming growth factors potentiated by epidermal growth factor:Isolation from non-neoplastic tissues. Proc Natl Acad. Sci. USA. 78, 5339-5343, 1981.
  pubmed

• 28) Frolik, C. A., Dart, L. L., Meyers, C. A. et al.:Purification and initial characterization of a type β transforming growth factor from human placenta. Proc. Natl. Acad. Sci. USA. 80, 3676-3680, 1983.

• 29) Associan, R. K., Komoriya, A., Meyers, C. A. et al.:Transforming growth factor-β in human platelets. J. Biol Chem. 258, 7155-7160, 1983.

• 30) Moses, H. L, Branum, E. L, Proper, J. A. et al.:Transforming growth factor production by chemically transformed cells. Cancer Res. 41, 2842-2848, 1981
  pubmed

• 31) Sporn, M. B., Roberts, A. B., Shull, J. H. et al.:Polypeptide transforming growth factorsisolated from bovine sources and used for wound healing in vivo. Science. 219, 1329-1330, 1983.
  pubmed

• 32) 大野忠夫:血小板由来成長因子(PDGF), 生体の科学 33, 374-380, 1982.

• 33) Doolittle, R. F., Hunkapiller, M. W., Hood, L. E. et al.:Simian sarcoma virus onc gene, v-sis, is derived from the gene(or genes) encoding a platelet-derived growth factor. Science.221, 275-277, 1983.
  pubmed

• 34) Waterfield, M. D., Scrace, G. T., W hittle, N. et al.:Platelet-derived growth factor is structuarally related to the putative transforming protein p28sis of simian sarcoma virus. Nature. 304, 35-39, 1983.

• 35) Duel, T. F., Huang, J. S., Huang, S. S. et al.:Expression of a platelet devired growth factor-like protein in simian sarcoma virus transformed cells. Science. 221, 1348-1350, 1983.

• 36) Robbins, K. C., Antoniades, H. N., Devare, S. G. et at.:Structural and immunological similarities between simian sarcoma virus gene product(s) and human platelet-derived growth factor. Nature. 305, 605-608, 1983.
  pubmed

• 37) 清水信義:癌の蛋白キナーゼとEGF, 代謝(癌'82) 19, 103-114, 1982.

• 38) Ek, B., Westermark, B., Wasteson, A. et al.:Stimulation of tyrosine. specific phosphorylationby platelet'derived growth factor. Nature. 295, 419-420, 1982.

• 39) Heldin, C-H., Westermark, B., and Wasteson, A.:Chemical and Biological properties of a growth-factor from human-cultured osteosarcoma cells:Resemblance with platelet.derived growth factor. J. Cell. Physiol. 105, 235-246, 1980.
  pubmed

• 40) Dicker, P., Pohjanpelto, P., Pettican, P. et al.:Similarities between fibroblast-derived growth factor and platelet-derived growth factor. Exp. Cell Res. 135, 221-227, 1981.
  pubmed

• 41) DeLarco, J. E. and Todaro, G. J.:A human fibrosarcoma cell line producing multiplication stimulating activity(MSA)-related peptides. Nature. 272, 356-358, 1978.

• 42) 西川克三, 長尾嘉信:Tumor growth factor. 臨床検査Mook (服部 信編), 金原出版,印刷中.

発癌におけるプロモーターの役割

P.620 掲載の参考文献

• 1) Berenblum,I. and Shubik, P.:The role of croton oil application associated with a single painting of a carcinogen, in tumor induction of mouse's skin. Br. J. Cancer. 1, 379-382, 1947.
  pubmed

• 2) Hecker, E.:Phorbol esters from croton oil chemical nature and biological activities. Naturwissenschaften. 54, 282-284, 1967.
  pubmed

• 3) Fujiki, H. Mori, M. Nakayasu, M. et al.:Indole alkaloids:dihydroteleocidin B, teleocidinand lyngbiatoxin A as members of a new class of tumor promoters. Proc. Natl Acad. Sci.U.S.A. 78, 3872-3876, 1981.

• 4) Rose, S. P., Stan, R., Passovoy, S. D. et al.:Epidermal growth factor enhancement of skintumor induction in mice. Experientia. 32, 913-915, 1976.

• 5) Jick, H.,Watkins, R. N., Hunter, J. R. et al.:Replacement estrogens and endometrial cancer. New Engl. J. Med. 300, 218-222, 1979.
  pubmed

• 6) Reddy, B. S., Watanabe, K., Weisburger, H. et'al.:Promoting effect of bile acids in coloncarcinogenesis in germ-free and conventional F344 rats. Cancer Res. 37, 3238-3242, 1977.

• 7) Doll, R. and Peto, R.:Mortality in relation to smoking:20 years'observation on male British doctors. Br. Med. J.2, 1525-1536, 1976.
  pubmed

• 8) Day, N. E. and Brown, C. C.:Multistate models and primary prevention of cancer. J.Natl. Cancer Inst. 64, 977-989, 1980.

• 9) Weber, J. and Hecker, E.:Cocarcinogens of the diterpene ester type from croton flavens L. and esophageal cancer in Curacao. Experientia. 34, 679-682, 1978.
  pubmed

• 10) Kopelovich, L, Bias, N. E. and Helson, L.:Tumor promoter alone induces neoplastic transformation of fibroblasts from humans genetically predisposed to cancer. Nature. 282, 619-621, 1979.
  pubmed

• 11) Mondal, S., Brankow, D. W. and Heidelberger, C.:Two-stage chemical oncogenesis in cultures of C3H/10T1/2 cells. Cancer Res. 36, 2254-2260, 1976.
  pubmed

• 12) Driedger, P. E. and Blumberg, P. M.:Specific binding of phorbol ester tumor promoters. Proc.Natl. Acad. Sci. U.S.A. 77, 567-571, 1980.
  pubmed

• 13) Diamond, L, O'Brien, T. G. and Baird, W. M.:Tumor promoters and the mechanisln of tumor promotion. Adv. Cancer Res. 32, 1-74, 1980.
  pubmed

• 14) Blumberg, P. M., Driedger, P. E. and Rossow, P. W.:Effect of a phorbol ester on transformation sensitive surface protein of chicken fibroblasts. Nature. 264, 446-447, 1976.

• 15) Lee, L. S. and Weinstein,I. B.:Tumor promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors. Science. 202, 313-315, 1978.
  pubmed

• 16) Fitzgerald, D. J. and Murray, A. W.:Inhibition of intercellular communication by tumor promoting phorbol esters. Cancer Res. 40, 2935-2937, 1980.
  pubmed

• 17) O'Brien, T. G., Simsiman, R. C. and Boutwell, R. K.:Induction of the polyalnine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res. 35, 1662-1670, 1975.
  pubmed

• 18) Frantz, C. N., Stiles, C. D. and Scher, C. D.:The tumor promotor 12-0-tetradecanoylphorbol-13-acetete enhances the proliferative response of Balb/c-3T3 cells to hormonal growth factors. J. Cell Physiol. 100, 413-424, 1979.

• 19) Diamond, L., O'Brien, T. G. and Rovera, G.:Tumor promoters:Effects on proliferation and differentiation of cells in culture. Life Sci. 23,1979-1988, 1978.
  pubmed

• 20) Rovera, G.,O'Brien T. G. and Diamond, L.:Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture. Proc. Natl. Acad. Sci. USA. 74, 2894-2898, 1977.
  pubmed

• 21) Yamamoto, N. and Zur Hausen, H.:Tumor promoter enhances transformation of human leukocytes by Epstein-Barr virus. Nature. 280, 244-245, 1979.
  pubmed

• 22) Colleta, G., DiFiore, P. P., Ferrentino, M. et al.:Enhancement of viral gene expression in Friend erythroleukemic cells by 12-O-tetradecanoyl phorbol-13-acetate. Cancer Res. 40, 3369-3373, 1980,

• 23) Hellman, K. B. and Hellman, A.:Induction of type-C retrovirus by the tumor promoter TPA. Int. J. Cancer. 27, 95-99, 1981.
  pubmed

• 24) Pietropaolo, C, Laskin, J. D. and Weinstein,I. B.:Effect of tumor promoters on sarc gene expression in normal and transformed chick embryo fibroblast. Cancer Res. 41, 1565-1571, 1981.
  pubmed

• 25) Keller, R.:Suppression of natural antitumor defense mechanisms by phorbol esters. Nature. 282, 729-731, 1979.

• 26) Laskin, D. L, Laskin, J. D., Kessler, F. K. et al.:Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters. Cancer Res. 41, 4523-4528, 1981.
  pubmed

• 27) Peraino, C., Fry, R. J. M. and Staffeldt, E.:Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res. 31, 1506-1512, 1971.

• 28) Peraino, C., Fry, R. J. M. and Staffeldt, E.:Enhancement of spontaneous hepatic tumorigenesis in C3H mice by dietary phenobarbital. J. Natl. Cancer Inst. 51, 1349-1350, 1973.

• 29) Adlercreutz, H. and Tenhunen, R.:Some aspects of the interaction between natural andsynthetic female sex hormones and the liver. Am. J. Med. 49, 630-648, 1970.
  pubmed

• 30) Baum, J. K., Holtz, F., Bookstein, J. J. et al.:Possible association between benign hepatomas and oral contraceptives. Lancet. 2, 926-929, 1973.
  pubmed

• 31) Johnson, F. L,Feagler, J. R.,Lerner, K. G. et' al.:Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet. 2, 1273-1276, 1972.

• 32) Solt, D. and Farber, E.:New principle for the analysis of chemical carcinogenesis. Nature. 263, 701-703, 1976.

• 33) Kayano, T., Nomura, K., Hino,O. et al.:Failure of phorbol ester TPA to promote growth of in vivo-initiated rat hepatocytes transferred into a culture system. Gann, 73, 354-357, 1982.
  pubmed

• 34) Brechot, C., Pourcel, C., Louise, A. et al.:Presence of integrated hepatitis B virus DNAsequences in cellular DNA of human hepatocellular carcinoma, Nature. 286, 533-535, 1980.

• 35) Tiollais, P., Charnay, P. and Vyas, G. N.:Biology of hepatitis B virus. Science. 213, 406-411, 1981.
  pubmed

• 36) Rechavi, G., Givol, D. and Cannani, E.:Activation of a cellular oncogene by DNA arrangement-possible involvement of an IS-like element. Nature. 300, 607-611, 1982.

• 37) Goldstein, B. P., Witz, G., Amoruso, M. et al.:Stimulation of human polymorphonuclearleukocyte superoxide anion radical production by tumor promoters. Cancer lett. ll, 257-262, 1981.

• 38) Emerit I. and Cerutti, P. A.:Tumor promoter phorbol-12-myristate-13-acetate induces chromosomal damage via indirect action. Nature. 293, 144-146, 1981.
  pubmed

• 39) Slaga, T. J., Klein-Szanto, A. J. P., Triplett, L. L. et al.:Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science. 213, 1023-1025, 1981.

• 40) Borek, C. and Troll, W.:Modifiers of free radicals inhibit in vitro the oncogenic actions ofx-rays, bleomycin, and the tumor promoter 12-O-tetradecanoylphorbol 13-acetate. Proc. Natl Acad. Sci. U.S.A. 80, 1304-1307, 1983.

• 41) Varshavsky, A,:Phorbol ester dramatically increases incidence of methotrexate-resistant mouse cells:possible mechiansms and relevance to tumor promotion. Cell. 25, 561-572, 1981.
  pubmed

アルコールと肝細胞癌

P.629 掲載の参考文献

• 1) Tuyns, A. J. Epidemiology of alochol and cancer. Cancer Res. 39, 2840-2843, 1979.

• 2) 武内重五郎,. 奥平雅彦, 高田 昭・他:わが国におけるアルコール性肝障害の実態 -全国集計の成績から-. 消会誌 76, 2178-2184, 1979.

• 3) Lamu, L.:Efude de statistique clinique de 131 cas de cancer del'oesophage et du cardia. Acrh. Mal. Appar. Dig. Mal. Nutr. 4, 451, 1910.

• 4) Schwartz, D ., Leilouch, J., Flamant, R. et al.:Alcohol et cancer-Resultants dune enquete retrospective. Rev. Fr. Etud. Clin. Biol. 7, 590-604, 1962.

• 5) World Health Organization:Cancer agents that surround us. World Health. 9, 16-17, 1964.

• 6) Rothman, K. and Keller, A.:The effect of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx. J. Chronic Dis. 25, 711-716, 1972.
  pubmed

• 7) 平山雄:肝癌最近のトピックス-疫学. 内科 52, 408-418, 1983.

• 8) Szmunes, W.:Hepatocellular carcinoma and the hepatitis B virus:Evidence for a causal association. Prog. Med. Virol.24, 40-69, 1978.

• 9) 日本肝癌研究会:原発性肝癌症例に関する追跡調査 -第4報-. 肝臓 20, 433-440, 1979.

• 10) Mori, W. and Shah, M.:Acomparative geo-pathological study of liver cirrhosis and primary hepatic cancer between Gambrige and Tokyo. Gann. 63, 765-771, 1972.

• 11) Johnson, P. T., Krasner, N., Portmann, A. L. et al.:Hepatocellular carcinoma in Great Britain:Influence of age, sex, HBsAg status and aetiology of underlying cirrhosis. Gut.19, 1022-1026, 1978.

• 12) Omata, M., Aschcavai, M., Liew, C. T. et al・:Hepatocellular carcinoma in the U.S.A., Etiological considerations. Localization of hepatitis B antigens. Gastroenterology.76, 279-287, 1979.

• 13) Lehmann, F. G, and Wegener, T.:Etiology of human liver cancer:Controlled prospective study in liver cirrhosis. J. Toxicol. Environ. Health. 5, 281-299, 1979.
  pubmed

• 14) 根井仁一:大酒家肝硬変と原発性肝癌. 金医大誌 6, 1-6, 1981.

• 15) 佐々木憲一, 奥平雅彦:肝硬変-肝癌への進展. 臨床と研究 60, 434-439, 1983.
  Medical*Online

• 16) Popper, H., Rubin, E., Krus, S. et al.:Post-necrotic cirrhosis in alcoholics. Gastroenterology. 39, 669-686, 1960.

• 17) Lee, I. F.:Cirrhosis and hepatoma in alcoholics. Gut. 7, 77-85, 1966.

• 18) Leevy, C. M., Gellene, R. and Ning, N.:Primary liver cancer in cirrhosis of the alcoholics. Ann. NY. Acad. Sci. 114, 1026-1040, 1964.

• 19) 柄沢 勉, 志方俊夫, 櫛田智子・他:目本人大酒家の肝病変-特に米国人大酒家肝病変との比較病理. 肝臓 20, 115-123, 1979.

• 20) Purilo, D. T. and Gottlieb, L S.:Cirrhosis and hepatoma occuring at Boston City Hospital (1917-1968). Cancer. 32, 458-462, 1973.

• 21) Wands, J. R., Carter, E. A., Bucher, N. L. R. et al.:Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication. Gastroenterology.77, 528-531, 1979.

• 22) 鵜沼直雄,山口 肇, 樫田光夫・他:アルコール摂取中断によるAFPの上昇と原発性肝細胞癌の発生. 第16回日本肝臓学会総会, 1980.

• 23) Lieber, C. S., Seitz, H. K., Garo, A. J. et al.:Alcohol-related disease and carcinogenesis. Cancer Res. 191, 798-803, 1979.

• 24) Iseri,O. H., Lieber, C. S. and Gottlieb, L S.:The ultrastructure of fatty liver induced by prolonged ethanol injection. Am. J. Pathot .48, 535-555, 1966.

• 25) Ishii, H.,Joly, J,-G. and Lieber, C. S.:Effect of ethanol on the amount and enzyme activities of hepatic rough and microsomal membrane. Biochem. Biophys. Acta. 291, 411-420, 1973.

• 26) Chakrabory, P. R., Ruiz-Opazo, N., Shouval, D. et al.:Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line. Nature. 286, 531-533, 1980.

• 27) Shafritz, D. A. and Kew, M. C.:Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas. Hepatology.1, 1-8, 1981.
  pubmed

• 28) Ohnishi, K., Iida, S., Iwana, S. et al.:The effect of chronic habitual alcohol intake onthe development of liver cirrhosis and hepatocellular carcinoma:Relation to hepatitis B surface antigen carriage. Cancer. 49, 672-677, 1982.

• 29) 周防武昭,堀江 裕,岸本幸広:肝癌に及ぼすアルコールの影響.第16回日本肝臓学会西部会, 1981

• 30) Vitale, J. J. and Gottlieb, S. L.:Alcohol and alcohol-related deficiencies as carcinogens. Cancer Res. 35, 3336-3338, 1975.

• 31) Leevy, C. M., Thompson, A., and Baker, H.:Vitamins and liver injury. Am. J. Clin. Nutr. 23, 493-499, 1970.
  pubmed

• 32) Morgan, A. G., Kelleher, J., Walker, B. E. et al.:Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis. Gut. 17, 113-118, 1976.
  pubmed

• 33) Bjelke, E.:Dietary vitamin A and human lung cancer. lnt. J. Cancer. 15, 561-565, 1975.

• 34) Wynder, E. L., Nutritional carcinogenesis. Ann. NY. Acad. Sci. 300, 360-378, 1977.
  pubmed

• 35) Roger, A. E. and Newberne, P. M.:Nutrition and aflatoxin carcinogenesis. Nature. 299, 72-63, 1971.

• 36) Kanagasundaran, N., Kakuma, N. S., Chen, T. et al.:Alcoholic hyaline antigen(AHAg) and antibody(AHAb) in alcoholic hepatitis. Gastroenterology. 73, 1368-1373, 1977.

• 37) Zetterman, R. K., Luisada-Opper, A. and Leevy, C. M.:Alcoholic hepatitis:Cell-mediated immunological response to alcoholic hyalin. Gastroenterology. 70, 382-384, 1976.
  pubmed

• 38) Sorrell, M. F. and Leevy, C. M.:Lymphocyte transformation and alcoholic liver disease. Gastroenterology. 63, 1020-1024, 1972.

• 39) Brayton, R. G., Stokes, P. E., Schwarts, M. S. et al.:Effect of alcohol and various diseaseon leucocyte mobilization, phagocytosis and intracellular bacterial killing. N. Engl. J. Med. 282, 123-128, 1970.

• 40) Mezey, E.:Alcoholic liver disease:Roles of alcohol and malnutrition. Am. J. Clin. Nutr. 33, 2709-2718, 1980.
  pubmed

• 41) Penn,I.:Depressed immunity and the development of cancer. Clin. exp. Immunol. 46, 459-474, 1981.
  pubmed

輸血と肝細胞癌の発生

P.639 掲載の参考文献

• 1) Alter, H. J., Purcell, R. H., Holland, P. V. et al.:Clinical and serological analysis of transfusion associated hepatitis. Lancet.2, 838-841, 1975.
  pubmed

• 2) Dienstag, J. L., Feinstone, S. M., Purcell, R. H. et al.:Non-A non-B Post-transfusion hepatitis. Lancet. 1, 560-562, 1977.

• 3) Okochi, K.:Post-transfusion hepatitis in Japan. In Hepatitis Viruses, Edited by T, Oda. Univ. Tokyo Press, Tokyo, p 331-336, 1976.

• 4) Prince, A. M., Brotman, B., Grady, G. F. et al.:Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet. 2, 241-246, 1974.
  pubmed

• 5) 片山 透:輸血後ウイルス肝炎,特に非A非B型肝炎の研究.難治性の肝炎調査研究班,昭和54年度研究報告,p. 20-30.

• 6) 矢野右人:輸血後肝炎.臨床と研究 56, 726-733, 1979.
  Medical*Online

• 7) 矢野右人,古賀満明:輸血後非A非B型肝炎.肝胆膵 3, 197-202, 1981.

• 8) 鈴木 宏,三田村圭二:非B型輸血後肝炎.難治性の肝炎調査研究班,昭和53年度研究報告, p. 76-77.

• 9) 日本肝癌研究会:原発性肝癌に関する追跡調査.肝臓 23, 675-681, 1982.

• 10) 柴崎浩一,曾我憲二,本間 明・他:肝癌と非A非B型肝炎.日本臨床39, 3251-3256, 1981.

• 11) 本間 明:肝細胞癌127例の臨床病理学的研究.肝臓 24, 989-997,1983.

• 12) 市川文弘,曾我憲二:非A非B型肝炎.「ウイルス肝炎から肝細胞癌へ」服部 信編.癌と化学療法社,東京,p. 104-112, 1982.

• 13) 武藤泰敏,大山正己:輸血後肝炎とその予後.「ウイルス肝炎から肝細胞癌へ」服部 信編.癌と化学療法社,東京,p. 162-170, 1982.

• 14) 清沢研道,赤羽賢浩,小池ゆり子・他:非A非B型慢性肝疾患における輸血歴の意義について.日消誌 79, 46-54, 1982.

• 15) 大林 明,田中 慧,大竹寛雄・他:輸血と肝硬変,肝細胞癌との関連についての臨床疫学的研究.肝臓 24, 521-525, 1983.

• 16) 古田精市,小池ゆり子,長田敦夫・他:肝癌発生の臨床病理学的研究 肝炎,肝硬変からの追跡例44例を中心に-.肝臓 20, 839-851, 1979.

• 17) 山村伸吉,清沢研道,赤羽賢浩・他:輸血歴を有する非B型慢性肝疾患における輸血から肝疾患診断時までの期間.肝臓 22, 1042, 1981.

• 18) 市田文弘,本間 明,曾我憲二:ウイルス肝炎より肝細胞癌移行追跡例の分析,日本臨床40, 468-477, 1982.

• 19) 小林健一,本定秀雄,岡崎伸生・他:非A非B型肝炎と肝細胞癌の関連について.肝臓 23, 965, 1982.

• 20) Feinstone, S. M., Kapikian, A. Z., Purcell, R. H. et al.:Transfusion-associated hepatitis not due to viral hepatitis type A or B. NEJM. 292, 767-770, 1975,
  pubmed

• 21) Knodell, R. G., Conrad, M. E., Dienstag, J. L et al.:Etiological spectrum of post-transfusion hepatitis. Gastroenterology. 69, 1278-1285, 1975.
  pubmed

• 22) 佐々木博:非A非B型肝炎.「ウイルス肝炎」佐々木博編,新興医学出版社,東京, p. 20-25, 1983.

• 23) Knodell, R. G., Conrad, M. E., Ishak, K. G. et al.:Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Gastroenterology. 72, 902-909, 1977.

• 24) 原田英治:輸血後肝炎に関する臨床的研究,とくに非B型輸血後肝炎について.肝臓 21, 713-722, 1980.

• 25) 水野元夫, 山田剛太郎,西原 隆・他:非B型輸血後肝炎の臨床的検討. 肝臓 23, 603-610, 1982.

• 26) Berman, M., Alter, H. J., Ishak, K. G. et al.:The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med. 91, 1-6, 1979.
  pubmed

• 27) 古田精市, 清沢研道,赤羽賢浩・他:非A非B型肝炎の臨床. 肝胆膵 3, 205-213, 1981.

• 28) Koretz, R. L, Stone,O., Gitnick, G. L. et al.:The long-term course of non-A, non-B post'transfusion hepatitis. Gastroenterology. 79, 893-898, 1980.

• 29) Rakella, J. and Redeker, A. G.:Chronic liver disease after non-A, non-B viral hepatitis. Gastroenterology. 77, 1200-1202, 1979.

• 30) 原田英治, 油谷浩幸,吉川雄二・他:非A非B型輸血後肝炎より肝硬変に進展した1例. 肝臓 24, 1026-1031, 1983.

• 31) 佐藤俊一, 中沢一臣,小岡文志:慢性肝炎と肝癌.Medicina. 17, 868-870, 1980.

肝移植

P.652 掲載の参考文献

• 1) Starzl. T. E., Groth, C. T., Brettschneider, L. et al.:Orthotopic homotransplantation of the human liver. Ann. Surg. 168,392-415, 1968.

• 2) Starzl, T. E., Iwatsuki, S., Van Thiel, D. H. et al.:Evolution of liver transplantation. Hepatology. 2, 614-636, 1982.
  pubmed

• 3) Wonigeit, K., Broelsch, Ch., Neuhaus, P. et al.:Acute allograft rejection in clinical liver transplantation. Cyclosporine and steroids versus conventional immunosuppressive therapy, First International Congress on Cyclosporine at Houston USA,1983.

• 4) Starzl, T. E., Iwatsuki, S., Shaw, B. W. et al.:Liver transplantation. First International Congress on Cyclosporine at Houston U.S.A, 1983.

• 5) Welch, C. S.:Anote on transplantation of the whole liver in dogs. Transplantation Bull. 2, 54, 1955.

• 6) Cannon, J. A.:Transplantation Bull 3, 7, 1956.

• 7) Starzl, T. E., Kaupp, H. A., Brook, D. R. et al.:Reconstructive problems in canine liver homotransplantation with special reference to postoperative role of hepatic venous How, Surg,Gynecol. 111, 134-144, 1960.

• 8) Moore, F. D., W heeler, H. B., Demissianos, H. V. et al.:Experimental wholeorgan transplantation of the liver and of the spleen. Ann. Surg. 152, 374-387, 1960.

• 9) Starzl, T. E., Marchioro, T. L., Von Kaulla, K. N. et al.:Homotransplantation of the liver in humans. Surg. Gynecol Obstet. 117, 659-676, 1963.

• 10) Moore, F. D., Birtch, A. G., Dagher, F. et al.:Immunosuppression and vasoular insufficiency in liver transplantation. Ann. Ny. Acad. Sci. 102, 729-738, 1964.

• 11) Starzl, T. E., Marchioro, T. L, Rowlands, D. T. Jr. et al.:Immunosuppression after experimental and clinical homotransplantation of the liver. Ann. Surg. 160, 411-439, 1964.
  pubmed

• 12) Calne, R. Y. and Williams, R.:Liver transplantation in man.1 observations on technique and organization in five cases. Br. Med. J. 4, 535-540, 1968.

• 13) Calne, R. Y. and W illiams, R.:Orthotopic liver transplantation. Br. Med. J. 1, 471-476, 1977.

• 14) Calne, R. Y., Rolles, K., White, D. J. G. et al.:Cyclosporin A initially as the only immuno-suppressant in 34 patients of cadaveric organs;32 kidneys, 2 pancreases, and 2 livers. Lancet.2, 1033-1036, 1979.

• 15) Calne, R. Y.:Liver transplantation, Grune & Stratton, New York. 1983.

• 16) Broelsch, Ch. E., Neuhaus, P., Pichlmayr, R. et al.:Gegenwartiger Stand der Leber-Transplantation. 2. Gastroenterologie. 20, 117-122, 1982.

• 17) Fortner, J. G., Beattie, E. J. Jr., Shiu, M. H. et al.:Orthotopic and heterotopic liver homograft in man. Ann. Surg. 172, 22-32, 1970.

• 18) Fortner, J. G., Yeh, S. D. J., Kim, D. K. et al.:The case for and technique of heterotopic liver grafting. Transplant. Proc. ll, 269-275, 1979.

• 19) Starzl, T. E.:Experience in hepatic transplantation. W. B. Saunders Co., Philadelphia. 1969.

• 20) Starzl, T. E., Klintmalm, G.B. G., Weil, R.111. et al.:Liver transplantation with use of Cyclosporin A and prednisone. N. Engl J. Med. 305, 266-269, 1981.

• 21) Iwatsuki, S., Starzl, T. E., Shaw, B. W. et'al.:Pediatric liver transplantation. Symposium on liver transplantation at Groningen. The Netherlands, 1983.

• 22) Van Thiel, D . H., Schade, R. R., Starzl, T. E. et al.:Liver transplantation in adults. Hepatology 2, 637-640, 1982.
  pubmed

• 23) Houssin,D., Franco, D., Corlette, M. B. et al.:Criteria for hepatic transplanatation in cirrhosis. Surg. Gynecol, Obstet. 151, 30-32, 1980.

• 24) Shaw, B. W., Hakala, T. R., Rosenthal J. T. et al.:Combination donor hepatectomy andnephrectomy and early functinal results of allografts. Surg. Gynecol. Obstet. 155, 321-325, 1982.

• 25) Rosenthal, J. T., Shaw, B. W., Hardesty, R. L. et al.:Principles of multiple organ procurement from cadaver donors. Ann. Surg., 198, 617-612, 1983.
  pubmed

• 26) Benichou, J., Halgrimson, C., Weil, R. III. et al.:Canine and human liver preservation for 6 to 18 hours by cold infusion. Transplantation. 24, 407-411, 1977

• 27) Pichlmayr, R.:Transplantations chirurgie. Springer-Verlag, Berlin. 1981.

• 28) Starzl, T. E., Putnam, C. W., Hansbrough, J. F. et al:Biliary complications after liver transplantation. Surgery 81, 212-221, 1977.
  pubmed

• 29) Borel, J. F., Feurer, C., Mugnee, C. et al.:Effects of the new antilymphocytic peptide cyclosporin A in animals. Immunology 32, 1017-1025, 1977.
  pubmed

• 30) Calne, R. Y., White, D. J. G., Thiru, S. et al.:Cyclosporin A patients receiving renalallografts from cadaver donors. Lancet 2, 1323-1327, 1978.

• 31) 奥田邦雄:肝臓移植の世界の現況. 日本医事新報 3103, 29-34, 1983.

• 32) Calne, R. Y.:Liver grafting. Transplantation. 35, 109-111, 1983,

• 33) Gunby, P.:Media-abetted liver transplants raise questions of equity and decency. JAMP 249, 1973-1982, 1983.